Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39455,0.0633244314492765,0.00270130163911797,0.0580298802366053,0.0686189826619477,2.1986388180968e-119
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39531,0.0613767042310324,0.00272417692888848,0.056037317450411,0.0667160910116538,1.3883976265042e-110
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,39428,-0.162152509677116,0.0078917055452465,-0.177620252545799,-0.146684766808433,1.53369827293473e-92
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,36847,-0.14182422612587,0.00817048880568342,-0.15783838418501,-0.125810068066731,1.05066870806119e-66
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,36916,-0.0740656280370527,0.00443410093357666,-0.0827564658668629,-0.0653747902072424,5.8070927003998e-62
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39355,-0.0854796796198546,0.0051683178642206,-0.095609582633727,-0.0753497766059823,6.68354727636452e-61
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,39123,-0.171556590925957,0.010747484754133,-0.192621661044058,-0.150491520807856,7.02306450852422e-57
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37203,0.0490810079510666,0.00314619164124947,0.0429144723342177,0.0552475435679156,2.30816919178335e-54
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,39455,-0.0546807054619355,0.00364744722936231,-0.0618297020314856,-0.0475317088923854,1.93444105937225e-50
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,39621,0.150126775027385,0.010181946148995,0.130170160575355,0.170083389479415,7.28143578026123e-49
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,39436,0.0389179850874997,0.00269108276773044,0.033643462862748,0.0441925073122513,4.38059001902264e-47
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,39509,-0.0397345887503983,0.00280376805392525,-0.0452299741360918,-0.0342392033647048,2.675424338593e-45
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),37006,0.210011003219113,0.0152190058187792,0.180181751814306,0.23984025462392,5.30237541505014e-43
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,37243,0.0280584449490547,0.00206595024065979,0.0240091824773615,0.0321077074207478,1.00508606667219e-41
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,39601,-0.0432460514160975,0.00319334322717816,-0.0495050041413667,-0.0369870986908283,1.5297763399284e-41
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,37164,-0.0796207086115047,0.00591100043681568,-0.0912062694676634,-0.068035147755346,4.49653862871631e-41
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,36880,-0.140022757625622,0.010465979368222,-0.160536077187337,-0.119509438063907,1.53283841183555e-40
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,36955,-0.0586617117690625,0.00443861951760057,-0.0673614060235596,-0.0499620175145653,1.30370406612035e-39
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,37255,-0.0461811098642122,0.00363679831872207,-0.0533092345689074,-0.0390529851595169,1.00618383957184e-36
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,39258,0.0578822123000688,0.00464121740734078,0.0487854261816809,0.0669789984184567,1.6137606742088e-35
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,38988,-0.102565728844644,0.00879435666131963,-0.119802667900831,-0.0853287897884576,2.72533369798552e-31
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,39428,-0.0351817892901446,0.00311723198346657,-0.041291563977739,-0.0290720146025501,2.01773400524038e-29
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,39636,0.0252641144568003,0.00224045782291423,0.0208728171238885,0.0296554117897122,2.24784257374817e-29
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,37243,0.0471847720023039,0.00422644456030346,0.0389009406641092,0.0554686033404987,8.29524613199204e-29
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,39462,-0.0934586311099649,0.00874446139205316,-0.110597775438389,-0.0763194867815407,1.44735303149098e-26
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39541,0.0246298483724376,0.00234195592007463,0.0200396147690913,0.0292200819757839,8.87771659323311e-26
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,39104,-0.0451433821811656,0.0043599564550842,-0.0536888968331306,-0.0365978675292006,4.8916379402536e-25
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,39455,0.0498114179323518,0.00488689538452442,0.0402331029786839,0.0593897328860197,2.56121815118399e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,39636,0.0256965541378296,0.00252121970717745,0.0207549635117618,0.0306381447638974,2.57516119981201e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,39636,-0.0236327467513375,0.00236687103533508,-0.0282718139805943,-0.0189936795220808,2.097683823018e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,39502,0.0173821017691491,0.00174360044237281,0.0139646449020984,0.0207995586361998,2.45874034430649e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39524,0.044302229370898,0.00444593326711425,0.0355882001673541,0.0530162585744419,2.56927193864678e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39462,0.0331095186150081,0.00337192626421378,0.0265005431371491,0.0397184940928671,1.0897322895266e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,37247,-0.0212420670913715,0.00216310721304972,-0.025481757228949,-0.0170023769537941,1.1087770943519e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39485,-0.0288005299726017,0.00295202139097792,-0.0345864918989184,-0.0230145680462849,2.02248433142039e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39428,-0.0293364077992565,0.00301691043451668,-0.0352495522509092,-0.0234232633476038,2.77302919616764e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39187,-0.0407535552972875,0.00428937047595857,-0.0491607214301663,-0.0323463891644087,2.39166477084794e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,39485,0.0371940663986832,0.0039375614321185,0.0294764459917309,0.0449116868056355,4.02970487899313e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,39485,-0.0489660446868513,0.00520470214829012,-0.0591672608974999,-0.0387648284762026,5.77203374407949e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39458,-0.0398748038852735,0.00424111274519167,-0.0481873848658492,-0.0315622229046978,6.11451756960865e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,37247,-0.0648055510638353,0.00692260769818659,-0.078373862152281,-0.0512372399753896,9.16438465436143e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,39106,-0.0485122714009766,0.00518330430360521,-0.0586715478360429,-0.0383529949659104,9.16882203928726e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,39414,-0.0324307464401185,0.00351770015434951,-0.0393254387426435,-0.0255360541375934,3.38198743184429e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,39654,0.0201674897047887,0.00219737792951606,0.0158606289629373,0.0244743504466402,4.94767539855418e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,39462,-0.0262150846365424,0.00286250487059384,-0.0318255941829063,-0.0206045750901784,5.95274170642611e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,39355,0.0281813020865955,0.00307807360151435,0.0221482778276273,0.0342143263455636,6.10184465012378e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39274,-0.0232657147016533,0.00257157392501902,-0.0283059995946906,-0.0182254298086161,1.64511870912776e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,36955,0.0315134644022773,0.00349255957423265,0.0246680476367813,0.0383588811677733,2.09444465262564e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39480,-0.0777638305361297,0.00867580706512935,-0.0947684123837832,-0.0607592486884762,3.51630449148441e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,37243,0.0365996887334539,0.00411628595067451,0.0285317682701319,0.0446676091967759,6.8337783546189e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,39485,-0.0521919153311731,0.00588652067614909,-0.0637294958564253,-0.0406543348059209,8.39558316418002e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,39455,0.022231999233782,0.0025294994834841,0.0172741802461532,0.0271898182214108,1.66907886554131e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39428,0.0312939908096829,0.0035863221189873,0.0242647994564678,0.038323182162898,2.91471921380293e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,36847,-0.042150313389195,0.00485767908604971,-0.0516713643978525,-0.0326292623805376,4.56535991381361e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,39462,0.0230659894857322,0.00267215755842402,0.0178285606712211,0.0283034183002433,6.62880166145453e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,39589,0.0221650533582628,0.00259426563020695,0.0170802927230571,0.0272498139934684,1.42047392712581e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,39589,0.0587304622873776,0.00690444647015281,0.0451977472058781,0.0722631773688771,1.96403793202692e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39455,0.0178112524432634,0.00209526953533742,0.0137045241540021,0.0219179807325248,2.06021413137561e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,39455,0.0247460550996852,0.0029239462932301,0.0190151203649542,0.0304769898344162,2.83856568488866e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,39654,0.0211430608390494,0.00251794525521437,0.0162078881388292,0.0260782335392696,4.98280473116268e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,39589,0.0270896906301098,0.00324517235480729,0.0207291528146876,0.0334502284455321,7.55778247737087e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37162,-0.0392331012400761,0.00470207691584481,-0.0484491719951319,-0.0300170304850203,7.93366472794146e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,39518,-0.0464788512765974,0.00557518693692442,-0.0574062176729693,-0.0355514848802256,8.29129661355118e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,39471,-0.0224945737616315,0.00270771863882602,-0.0278017022937305,-0.0171874452295325,1.05953460529183e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39462,0.043658614694052,0.00527309112179581,0.0333233560953322,0.0539938732927717,1.34022729975328e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,36955,-0.0229545020113234,0.00278285672598538,-0.0284089011942547,-0.0175001028283921,1.76308880059892e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,37243,0.0384919850226306,0.0046705242901903,0.0293377574138577,0.0476462126314036,1.86589968550636e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,37164,-0.0585796854746601,0.00711414825666304,-0.0725234160577197,-0.0446359548916006,1.98240732002894e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39526,0.0268245038003114,0.00326657921616992,0.0204220085366184,0.0332269990640045,2.35429076093268e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,39485,0.0239026490073052,0.00294373309191535,0.0181329321471511,0.0296723658674592,5.02769253232269e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,36955,0.025067881536957,0.00309301873677843,0.0190055648128712,0.0311301982610427,5.77893338781406e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,39654,0.0170834240952493,0.00211099346171169,0.0129458769102944,0.0212209712802042,6.27942410763233e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39355,-0.0491116575376142,0.00608531793631188,-0.0610388806927855,-0.0371844343824429,7.53121673500347e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,39428,-0.0955855776352519,0.0118667152923188,-0.118844339608197,-0.072326815662307,8.54788615454161e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,39601,-0.0174764699237414,0.002188375759007,-0.0217656864113951,-0.0131872534360877,1.49292506350037e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,39482,0.0360190071795374,0.00452765362327993,0.0271448060779088,0.0448932082811661,1.91315772424243e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39191,-0.0511243573549143,0.0064755490231746,-0.0638164334403365,-0.0384322812694921,3.10723176953139e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39563,-0.0207039690574329,0.00264000627825034,-0.0258783813628036,-0.0155295567520623,4.71454248843097e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,39531,-0.0272431576177979,0.00347503862208081,-0.0340542333170763,-0.0204320819185195,4.81815635954979e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39413,0.0220436106265115,0.00281492350199163,0.0165263605626079,0.0275608606904151,5.16435974645852e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,39303,0.0180114016430418,0.002301658847292,0.0135001503023495,0.0225226529837342,5.40027682548174e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,36916,-0.0249362418392847,0.00318763139005416,-0.0311839993637908,-0.0186884843147785,5.58076693059512e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,39541,0.0457542814626363,0.00588928130761947,0.0342112900997021,0.0572972728255705,8.41321178239055e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,39477,-0.0356256765445687,0.00460560026895415,-0.0446526530717188,-0.0265987000174186,1.09694813797797e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,39568,-0.028095647072721,0.00365625422242372,-0.0352619053486714,-0.0209293887967705,1.63296100760973e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",39654,0.0190070577299485,0.00248243718918957,0.0141414808391369,0.02387263462076,2.02359663204913e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,37269,-0.0243346833313665,0.00318529354965524,-0.0305778586886907,-0.0180915079740422,2.33167217699783e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39307,0.0287256792596278,0.00378193289735933,0.0213130907808035,0.0361382677384521,3.24842467916087e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,37164,-0.0676979770823071,0.00899618383015172,-0.0853304973894045,-0.0500654567752097,5.61847075053364e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,37203,-0.0850208655530618,0.0113510885796784,-0.107268999169231,-0.0627727319368921,7.33443856817735e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,39601,0.0297367212510847,0.00399228480526571,0.0219118430327639,0.0375615994694055,9.94594839533301e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39516,0.0294040332907753,0.00395051235564452,0.021661029073712,0.0371470375078386,1.03669475156838e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,39194,0.0263276692386934,0.00354102754802579,0.0193872552445628,0.0332680832328239,1.10289680182211e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,37221,-0.0344104145611582,0.00467465591425675,-0.0435727401531015,-0.025248088969215,1.93628461291662e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,39498,0.017116295267624,0.0023299400780921,0.0125496127145635,0.0216829778206845,2.14326240789631e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39319,-0.0466381790962382,0.00636202615804758,-0.0591077503660115,-0.034168607826465,2.40728127437836e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,39531,0.0258728519571636,0.00353754529105705,0.0189392631866918,0.0328064407276354,2.7278299380003e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39187,-0.0221783898078503,0.00304427272325695,-0.0281451643454339,-0.0162116152702666,3.37271116413693e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,36955,-0.0229779002409558,0.00316293329482246,-0.0291772494988079,-0.0167785509831038,3.95916053808671e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39499,0.0150747724574589,0.00209321547808866,0.0109720701204052,0.0191774747945127,6.22705745057363e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37221,0.0564878095571274,0.00784912202732474,0.0411035303835709,0.0718720887306839,6.51330082222046e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,39462,-0.0249282519501515,0.00346670863849456,-0.0317230008816008,-0.0181335030187021,6.74762898200013e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,39589,0.0288565115202265,0.00402280858444836,0.0209718066947077,0.0367412163457453,7.66467281527252e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,39531,0.0254105832675507,0.00358070513649254,0.0183924012000253,0.0324287653350761,1.33629813910605e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,39455,-0.0222529462846952,0.00313837121517356,-0.0284041538664354,-0.016101738702955,1.39490787168124e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39531,0.0228308971401119,0.00322709986743009,0.0165057813999489,0.0291560128802749,1.56319760435348e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37203,-0.0178411618550452,0.00252857681765372,-0.0227971724176465,-0.012885151292444,1.80466086266945e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,39636,0.0159912506881354,0.00226710964627156,0.0115477157814432,0.0204347855948277,1.81897724870859e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,39531,0.0167987785634758,0.00238579994932695,0.012122610662795,0.0214749464641567,1.98893436399778e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,39617,0.0389254067952494,0.00554783410439831,0.0280516519506287,0.0497991616398701,2.37425053054936e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,37146,0.0217231933025239,0.00309582983251897,0.0156553668307868,0.0277910197742611,2.38330118697666e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,39636,0.046599843740357,0.006652707527355,0.0335605369867412,0.0596391504939728,2.58017794541041e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,37203,-0.0437195765970187,0.00626703614890595,-0.0560029674488743,-0.031436185745163,3.18436651697372e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,39541,0.0247998002006128,0.00355963608047267,0.0178229134828864,0.0317766869183393,3.37291041543534e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,38417,-0.0242607640449856,0.00348597646798687,-0.0310932779222398,-0.0174282501677313,3.56625742144987e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,39534,-0.0207660911431968,0.00298580249489195,-0.026618264033185,-0.0149139182532085,3.67200297831507e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,39498,0.0153008964392296,0.0022006420319053,0.0109876380566952,0.019614154821764,3.72519770747657e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39450,-0.01179681826908,0.00169932691208467,-0.015127499016766,-0.0084661375213941,4.02300428443125e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,39470,0.0560226229443263,0.00809528015751303,0.0401558738356008,0.0718893720530519,4.68580478590572e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,39187,0.0300857539818535,0.00436131944566709,0.021537567868346,0.038633940095361,5.47671338236885e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,39428,0.0171014881602627,0.00250604981438042,0.0121896305240771,0.0220133457964484,9.18861006255602e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39033,-0.0327900435801699,0.00480614465231442,-0.0422100870987062,-0.0233700000616337,9.29787398946703e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,39400,-0.0198275962145306,0.00291407915883611,-0.0255391913658494,-0.0141160010632118,1.05570228653247e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,39330,-0.0312896441332668,0.00460217430736074,-0.0403099057756939,-0.0222693824908398,1.0944772239751e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39194,-0.0327211879088621,0.00482162805648915,-0.0421715788995808,-0.0232707969181434,1.19404901701405e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,39102,0.0273933799454724,0.00409482912366143,0.019367514863096,0.0354192450278488,2.31659565962675e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39499,0.0190814100996789,0.00285583139765859,0.0134839805602681,0.0246788396390898,2.44713434472826e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39455,-0.0303691849208302,0.00461801397722201,-0.0394204923161853,-0.021317877525475,4.98435451493043e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39462,-0.0302866529860307,0.00461916198243149,-0.0393402104715964,-0.021233095500465,5.67923790715699e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37255,-0.017563161049134,0.00267856762325866,-0.022813153590721,-0.012313168507547,5.70382501390185e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,36992,-0.0250027905966452,0.00381881924934686,-0.032487676325365,-0.0175179048679253,6.08879028559188e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,39123,-0.0353204666175066,0.00539896749751961,-0.0459024429126451,-0.0247384903223682,6.26799567916911e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37164,0.0574211094327018,0.00882551919250725,0.0401230918153876,0.074719127050016,7.9934400481947e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39324,0.0162757277349839,0.00250850794415192,0.0113590521644462,0.0211924033055217,8.96086452115269e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,39330,-0.0256891929755074,0.00395957622325072,-0.0334499623730788,-0.017928423577936,8.98130993528326e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,39479,-0.0432218577965791,0.00667333690146408,-0.0563015981234487,-0.0301421174697095,9.66005667179458e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,39455,0.0427772521926707,0.00660619511086699,0.0298291097753714,0.05572539460997,9.75508744098071e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,37255,0.0339007908014677,0.00524732482545543,0.023616034143575,0.0441855474593603,1.08073768271866e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,39355,0.0140976465257836,0.00218708798184463,0.0098109540813681,0.0183843389701991,1.18486836515279e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",39601,0.0412923805247008,0.00643445538844231,0.0286808479633539,0.0539039130860478,1.42754107697079e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,39601,-0.0214477549733377,0.00334803465542027,-0.0280099028979615,-0.014885607048714,1.53721321982341e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,39462,0.0267749814818803,0.00418342014652997,0.0185754779946816,0.0349744849690791,1.59714780371194e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39123,0.0260122909783687,0.00407368315479902,0.0180278719949626,0.0339967099617747,1.76039809877027e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39460,-0.0540407212451119,0.00846643976818646,-0.0706349431907573,-0.0374464992994664,1.78828929204159e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37243,0.0142832852840584,0.00223969260436283,0.00989348777950721,0.0186730827886095,1.863883812926e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,37164,0.0623419516679163,0.00980540231940332,0.0431233631218858,0.0815605402139468,2.11501831690351e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39504,0.01760761009536,0.00277352546179635,0.0121715001902392,0.0230437200004809,2.23716035832902e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39541,0.0113776702537881,0.00179695806530635,0.00785563244578767,0.0148997080617886,2.49449566436444e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37164,0.0479109069258028,0.00756649839886306,0.0330805700640312,0.0627412437875744,2.50183884431791e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,39428,-0.0449926995045996,0.00711331305495082,-0.0589347930923032,-0.031050605916896,2.60185500861757e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",36916,-0.0312149037012122,0.00494184531709978,-0.0409009205227278,-0.0215288868796967,2.76747082590316e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,39601,0.0189422226911156,0.00300842651646242,0.0130457067188492,0.0248387386633819,3.13055664465513e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,36916,-0.0308159720640008,0.00490611550233546,-0.0404319584485783,-0.0211999856794233,3.47289607322323e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,39125,-0.0271326483517733,0.00432654611842994,-0.035612678743896,-0.0186526179596507,3.68306463291812e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39419,0.0261293564609358,0.00417362728627466,0.0179490469798374,0.0343096659420341,3.93991985052919e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,36955,-0.0216320598556742,0.00345593648270919,-0.0284056953617842,-0.0148584243495642,3.99120644208056e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37162,-0.0209541389610848,0.00334988782494817,-0.0275199190979832,-0.0143883588241864,4.0980319573245e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",36916,0.049147166581893,0.00789451978184902,0.033673907809469,0.0646204253543171,4.95500979533862e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,39389,0.0131461998282034,0.00211525379088715,0.00900030239806459,0.0172920972583422,5.27036483250676e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39485,-0.0226162530112763,0.00365418305543497,-0.0297784517999288,-0.0154540542226237,6.20628573831555e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37255,-0.0123651183153473,0.00200039165730764,-0.0162858859636702,-0.00844435066702429,6.54869241032416e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,36880,-0.0231258185607296,0.00374777114217133,-0.0304714499993855,-0.0157801871220738,7.01675194949435e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39404,0.0324739295092061,0.00526442513929242,0.0221556562361929,0.0427922027822192,7.06887119046923e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,37228,-0.0242729016710321,0.00397326933678882,-0.0320605095711382,-0.016485293770926,1.03138208560366e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,39601,-0.0239634033596594,0.00392583327826382,-0.0316580365850565,-0.0162687701342623,1.05948480404231e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37144,0.0463441571548495,0.00759878455577641,0.0314505394255278,0.0612377748841713,1.09910934703562e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,37230,0.0388077441090342,0.00636440388910125,0.0263335124863958,0.0512819757316727,1.10761116400297e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,39541,0.0359280114794806,0.00589481764654793,0.0243741688922466,0.0474818540667145,1.12207630641384e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,39568,0.0231081359787868,0.00382319582417416,0.0156146721634055,0.0306015997941682,1.53688184927632e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39355,0.0302624515145001,0.00501124185771107,0.0204404174733864,0.0400844855556138,1.5884276879041e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,39104,-0.0312688249797098,0.00518266186957752,-0.0414268422440818,-0.0211108077153379,1.64460406850912e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,37269,0.0120999566889289,0.00200716714320032,0.00816590908825624,0.0160340042896015,1.7016773257703e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,39355,0.0182101474242721,0.00303410369157688,0.0122633041887814,0.0241569906597628,1.99641459119004e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,37255,-0.0240594846754662,0.00401539073442609,-0.0319296505149413,-0.016189318835991,2.13083732126643e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,39455,0.0204514031369888,0.00342029813250667,0.0137476187972757,0.0271551874767019,2.29014542680758e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,37196,0.0241828332754864,0.00405331627280941,0.01623833338078,0.0321273331701928,2.49309586415957e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39455,0.025257289071603,0.00423469541288457,0.0169572860623492,0.0335572920808568,2.51099134307161e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39498,0.0154792455860876,0.00259954698053139,0.0103841335042461,0.0205743576679292,2.66523750723782e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,36916,-0.035042266665423,0.00591601843537404,-0.0466376627987561,-0.0234468705320899,3.23895488487572e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,39482,0.0204559827202303,0.00345542993549361,0.0136833400466628,0.0272286253937978,3.29048374430129e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39541,0.0440192207001344,0.00744980407456152,0.0294176047139938,0.058620836686275,3.52082309771834e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,39462,-0.0400015746075359,0.00678012719761793,-0.053290623914867,-0.0267125253002047,3.71715210234422e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,39476,0.0274676467639523,0.00468178160535868,0.0182913548174493,0.0366439387104553,4.53297968105004e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39549,0.0369316390840728,0.00630590146167546,0.0245720722191889,0.0492912059489567,4.82031681497633e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,39589,-0.012048180089179,0.00206243453173013,-0.01609055177137,-0.0080058084069879,5.27227177851639e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,39475,0.0256423248870242,0.00442006437479691,0.0169789987124222,0.0343056510616261,6.71085336295848e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,39601,0.0318795899012839,0.0054969501697112,0.0211055675686499,0.0426536122339178,6.7836724887369e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,39601,-0.0301276523634723,0.00519922740037299,-0.0403181380682033,-0.0199371666587412,6.98280660574189e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,39187,0.0245946576362508,0.00427802699013279,0.0162097247355905,0.0329795905369111,9.15154602912813e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39462,0.041106075044771,0.00715943282870107,0.0270735867005169,0.0551385633890251,9.56414716553567e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37269,0.0133946948249594,0.00233286961236482,0.00882227038472439,0.0179671192651945,9.5843160343829e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,39601,-0.013404808071621,0.00233685910414664,-0.0179850519157484,-0.00882456422749357,9.86439093551957e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,39462,-0.0193484149360171,0.00339221630838506,-0.0259971589004518,-0.0126996709715823,1.19396202629838e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,39194,-0.0217761107350333,0.00382061745164479,-0.0292645209402571,-0.0142877005298095,1.22364697926636e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37247,-0.0313685358951621,0.00550468160055691,-0.0421577118322536,-0.0205793599580706,1.23518323815271e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39354,0.0289902299913868,0.00508900406593151,0.0190157820221611,0.0389646779606126,1.24499182842158e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39531,-0.0120314682608337,0.00211266230991894,-0.0161722863882749,-0.00789065013339259,1.25722479528297e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39428,-0.0293799404531218,0.00517506448980787,-0.0395230668531453,-0.0192368140530984,1.39446781669068e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,39162,0.0197018633204945,0.00348084240144393,0.0128794122136644,0.0265243144273246,1.54121981853308e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,37243,0.0259078254432844,0.00457939670118198,0.0169322079089677,0.034883442977601,1.56910686237732e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,39485,-0.03529639413495,0.00624821384612205,-0.0475428932733492,-0.0230498949965508,1.64272416382631e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39428,-0.0174956355777984,0.00309818536374771,-0.0235680788907439,-0.0114231922648529,1.6618065217106e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,39601,-0.0223108387684495,0.00395785441381458,-0.030068233419526,-0.0145534441173729,1.76017047234933e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,39541,-0.0376279183945929,0.006675570888988,-0.0507120373370094,-0.0245437994521764,1.76483934626639e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,39104,-0.0174686533328656,0.00310152914580321,-0.0235476504586399,-0.0113896562070913,1.81120641509236e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,39589,0.030823050895977,0.00547518374218921,0.0200916907612861,0.0415544110306679,1.83843319810944e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,39355,-0.019978744755333,0.00355548600382413,-0.0269474973228283,-0.0130099921878377,1.95355405300208e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37182,-0.040632486017767,0.0072331730892811,-0.0548095052727579,-0.026455466762776,1.97780036524687e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,39123,0.0260305557459394,0.00466736140723345,0.0168825273877618,0.035178584104117,2.48815239531855e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,39654,0.00754973449656129,0.00135397835458831,0.0048959369215682,0.0102035320715544,2.50354406041587e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,39434,0.0426395662499738,0.00765504534809148,0.0276356773677145,0.0576434551322331,2.58935868571988e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39526,0.0215000207254342,0.00386620147028859,0.0139222658436685,0.0290777756071998,2.72761393806619e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37164,0.0457466625107947,0.00824517944777504,0.0295861107931557,0.0619072142284338,2.94242698062744e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,39654,0.0127313664283382,0.00229605080097571,0.00823110685842584,0.0172316259982506,2.99026307799331e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39401,0.0162600912720781,0.0029343486733876,0.0105087678722384,0.0220114146719178,3.05317319811776e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39541,0.0569235124469287,0.0103162404104728,0.0367036812424019,0.0771433436514554,3.48814515645797e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39477,0.0191210229232018,0.00346585907169001,0.0123279391426894,0.0259141067037142,3.50604615407197e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,39553,-0.0212887883224372,0.00387525142912581,-0.0288842811235238,-0.0136932955213506,4.00362362845519e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,39427,0.0130924529646244,0.00238672073802218,0.00841448031810097,0.0177704256111479,4.18892127693553e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,39455,0.011346604052459,0.00206953474317691,0.00729031595583228,0.0154028921490858,4.25689098868364e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,36934,-0.0271775268104522,0.00496088751599609,-0.0369008663418045,-0.0174541872790998,4.37607136248678e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39455,0.017152172200619,0.00313779014170119,0.0110021035228847,0.0233022408783534,4.66804507306579e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39016,0.0179317081645179,0.00330232387654802,0.0114591533664838,0.024404262962552,5.72486065436899e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39541,0.0622378918867494,0.0115047810911435,0.0396885209481082,0.0847872628253906,6.40778309306846e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,39485,0.0396486400630209,0.00733046847770927,0.0252809218467107,0.0540163582793311,6.44380056006649e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39478,0.0235342664511274,0.00436003191761256,0.0149886038926068,0.032079929009648,6.85142169625929e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,37255,-0.0251070352297082,0.00465199059997022,-0.0342249368056499,-0.0159891336537666,6.8951981203219e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,39458,0.0822135819021294,0.0152385229228374,0.052346076973368,0.112081086830891,6.95183127808636e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,39462,0.0302195178144836,0.0056036133969959,0.0192364355563716,0.0412026000725955,7.03936351579501e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,39498,0.0113146073206866,0.00209945985234209,0.00719966601009613,0.0154295486312771,7.18002614505384e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,39516,0.0142569242824807,0.00265027939983105,0.00906237665881182,0.0194514719061495,7.58489934275293e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,39107,0.026292208251178,0.0048985618520031,0.016691027021252,0.0358933894811041,8.11262532182889e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,37269,0.0101655448607468,0.00190136122612147,0.00643887685754871,0.0138922128639449,9.12318296476097e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,37247,-0.0422670599680439,0.00791728901022934,-0.0577849464280934,-0.0267491735079944,9.52796070064363e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,39485,0.0170091958239535,0.00318794820507961,0.0107608173419974,0.0232575743059095,9.66799258095703e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39429,0.0167046053334517,0.00313089253176598,0.0105680559711904,0.0228411546957131,9.67143064773657e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,39462,0.0193370247813458,0.0036250304000655,0.0122319651972175,0.0264420843654742,9.73015279849673e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,39545,0.0130607765524631,0.00245972746770301,0.00823971071576515,0.017881842389161,1.11272046799542e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,39485,0.012273840323055,0.00231270418120524,0.0077409401278927,0.0168067405182173,1.1294106713406e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,39601,0.0131832120410264,0.00248750083506928,0.00830771040429065,0.0180587136777622,1.17565847432767e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,39470,0.01481835985398,0.00279610613068789,0.00933799183783178,0.0202987278701283,1.17670471627109e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39462,-0.0302219081068959,0.00570397045583516,-0.0414016902003328,-0.019042126013459,1.18473545876158e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39428,-0.0190919170035581,0.00361488845559099,-0.0261770983765165,-0.0120067356305998,1.29945467769931e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39428,-0.0254243933921597,0.00481848047308875,-0.0348686151194136,-0.0159801716649057,1.33557598633667e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37164,0.0517142828916292,0.00980567794125292,0.0324951541267735,0.0709334116564849,1.35736492683635e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37247,-0.0176985031241002,0.00336315262256998,-0.0242902822643373,-0.011106723983863,1.4442641123347e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39355,-0.0103867534484285,0.00197932961304799,-0.0142662394900026,-0.00650726740685447,1.56195762358248e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,37247,0.0124545241940101,0.00237345900613151,0.00780254454199235,0.0171065038460279,1.56713006782723e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39513,0.0105606176095355,0.00201473504984797,0.00661173691183347,0.0145094983072375,1.61260762607241e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,39411,0.0187252908846858,0.00358051829154953,0.0117074750332487,0.0257431067361228,1.72007404793609e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39455,0.0123042150197392,0.00235523771989343,0.00768794908874812,0.0169204809507304,1.77257474432602e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,39079,-0.031668986667663,0.00606510718062616,-0.0435565967416903,-0.0197813765936357,1.79906363574726e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,39516,0.0260595599362266,0.0050023488204039,0.0162549562482349,0.0358641636242182,1.91882556509905e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,39654,0.0191816257665111,0.00369047767743369,0.0119482895187411,0.0264149620142812,2.0449173780627e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,36947,-0.0205751715416781,0.00396648094348076,-0.0283494741909004,-0.0128008688924559,2.16748834871392e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37255,-0.0124702148822365,0.002411248226822,-0.0171962614068077,-0.00774416835766541,2.35494041833863e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39355,-0.0144168659846673,0.00279274187808006,-0.0198906400657042,-0.00894309190363033,2.47121108535547e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39104,-0.0248297630097341,0.00482206112564361,-0.0342810028159956,-0.0153785232034727,2.64987060664287e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,37057,0.0186830701145099,0.00363090702880582,0.0115664923380505,0.0257996478909693,2.70724801633245e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,39332,0.0229273654059626,0.00446679872950647,0.01417243989613,0.0316822909157953,2.88997394478252e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,39654,0.0096737973429028,0.00188540011800092,0.005978413111621,0.0133691815741846,2.91912172969868e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39462,-0.012203516823963,0.002388137711542,-0.0168842667385853,-0.00752276690934068,3.26017080372761e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,39381,0.0127883878869821,0.00250577843923115,0.00787706214608907,0.0176997136278752,3.37418252551613e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,39194,-0.0340481167560337,0.00667206040001408,-0.0471253551400613,-0.0209708783720061,3.38308681866965e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,39526,0.0445783442907119,0.00873599379823753,0.0274557964461664,0.0617008921352575,3.38668104781459e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,36955,0.0474532368182591,0.00933142792282435,0.0291636380895234,0.0657428355469949,3.72331931468857e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,37247,0.0428282991547015,0.0084231955495467,0.02631883587759,0.059337762431813,3.73674626200367e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37057,-0.0114038079086684,0.00225008582741829,-0.0158139761304082,-0.00699363968692853,4.07359335584995e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,39568,-0.0518703606309394,0.0102406747700417,-0.0719420831802211,-0.0317986380816576,4.12926054598033e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,39636,0.0322123983218092,0.0063640665253509,0.0197388279321214,0.0446859687114969,4.20600457072494e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,36992,-0.0239311740461495,0.00472900360933353,-0.0332000211204432,-0.0146623269718558,4.24055801475011e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,36955,0.0225648469337077,0.00446036246204349,0.0138225365081025,0.031307157359313,4.2750349038642e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,39355,-0.0227253282511934,0.00450018661586954,-0.0315456940182978,-0.0139049624840891,4.47346372411318e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,39541,0.0144465562385857,0.00286286423496482,0.00883534233805463,0.0200577701391167,4.55948912214426e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36823,0.0204961243006842,0.00406790455673054,0.0125230313694924,0.0284692172318761,4.75824655547925e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,37269,0.028316039437031,0.00562227539693722,0.017296379659034,0.0393356992150279,4.80814319417815e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39187,-0.0369904953424677,0.00734549151078527,-0.0513876587036068,-0.0225933319813286,4.81455658653172e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39123,-0.0270736262073456,0.00538097707071793,-0.0376203412659528,-0.0165269111487385,4.92775191072738e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37269,0.0111724214261738,0.00222257810236757,0.00681616834553331,0.0155286745068142,5.05504480553212e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39541,0.0483321106291617,0.0096267883543718,0.029463605454593,0.0672006158037305,5.21016570365168e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,39601,-0.0196893672087517,0.00393072668017671,-0.027393591501898,-0.0119851429156053,5.53032999149759e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,37221,0.0333801486720807,0.00668187558437643,0.0202836725267029,0.0464766248174585,5.94209998891627e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,39601,-0.012365312603352,0.00248295088979452,-0.0172318963473493,-0.00749872885935478,6.42549982539742e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37164,-0.0355281974223318,0.00715411857471835,-0.0495502698287798,-0.0215061250158839,6.91932849946548e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,36916,-0.0124966726483802,0.00251668274473542,-0.0174293708280616,-0.00756397446869879,6.94193981891212e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,39448,0.0441958222137306,0.00894185241645615,0.0266697914774766,0.0617218529499847,7.79278285016304e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,39589,0.012684154221703,0.00256647362995418,0.00765386590699286,0.0177144425364132,7.80519414004532e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,37237,0.0143958653888082,0.00291611607419564,0.0086802778833848,0.0201114528942317,8.0475570275238e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,39531,-0.0144141342544408,0.00292382102389711,-0.0201448234612791,-0.00868344504760243,8.31479926052157e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,36847,-0.0340292326576563,0.00690451257441567,-0.047562077303511,-0.0204963880118016,8.39136064641417e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,36955,-0.00961839341175481,0.00195250736335315,-0.013445307843927,-0.00579147897958264,8.49277772142852e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39427,-0.0208898510155438,0.00424104892625008,-0.0292023069109939,-0.0125773951200936,8.49848472769882e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,39462,0.0269902011477092,0.00548402924693466,0.0162415038237173,0.0377388984717011,8.67501536119102e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,39589,0.0255242103689517,0.00518933632632239,0.0153531111693598,0.0356953095685435,8.80854892725739e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,39187,0.0163313075675142,0.00332296714502052,0.009818291963274,0.0228443231717545,8.98854196919003e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",36916,-0.0155594165984873,0.00316577986534957,-0.0217643451345725,-0.0093544880624022,8.99687318364622e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,39462,0.0247862464533856,0.00504647675900141,0.0148951520057429,0.0346773409010284,9.12899077232467e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39461,0.0401177625316446,0.00817943726988666,0.0240860654826667,0.0561494595806224,9.45455676701163e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,37269,0.0280959228595684,0.00575873278803893,0.0168088065950121,0.0393830391241247,1.07995778949388e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,36955,0.0267992974354369,0.005495632924671,0.0160278569030817,0.037570737967792,1.09328995773868e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,39194,-0.0217046932984437,0.00445766310750533,-0.0304417129891541,-0.0129676736077332,1.13284412761475e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37249,0.00817860244857176,0.00168345830943016,0.00487902416208866,0.0114781807350549,1.19851858135591e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39462,0.0138917539445461,0.00286313794464464,0.00828000357304264,0.0195035043160496,1.23491603461822e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,39455,0.021431015794504,0.00441844427885152,0.012770865007955,0.030091166581053,1.24478372036789e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,39356,0.0119727570207823,0.00247139810300902,0.00712881673888459,0.0168166973026799,1.28189102871828e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39428,0.00841021911977278,0.00173883006259378,0.00500211219708897,0.0118183260424566,1.33317477118842e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39477,-0.0160778772964368,0.00332704985889559,-0.0225988950198722,-0.00955685957300147,1.3617961126328e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,36483,-0.0516218051206643,0.0107083887302631,-0.07261024703198,-0.0306333632093486,1.44813550796585e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39499,0.0124231211745795,0.00259197037009559,0.00734285924919214,0.0175033830999668,1.65937070345612e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,39495,-0.0278354273870862,0.00580782897628274,-0.0392187721806003,-0.016452082593572,1.66089035069297e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,39428,-0.0205386261826224,0.00429495180809865,-0.0289567317264957,-0.0121205206387491,1.75177513377187e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,39589,-0.0549908440891752,0.0115007628675599,-0.0775323393095926,-0.0324493488687578,1.75633449278309e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,39355,0.0140138158260571,0.00293344267746358,0.00826426817822845,0.0197633634738857,1.79393543231894e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39530,-0.0241619237877731,0.00507370419096703,-0.0341063840020685,-0.0142174635734777,1.93288156567147e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,39187,0.0311559384020093,0.00654799711944751,0.0183218640478921,0.0439900127561264,1.97290601514403e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",36916,0.0282529780580546,0.00594241307157797,0.0166058484377618,0.0399001076783474,2.01201978118517e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,39400,0.0326019740080162,0.00686795506743673,0.0191407820758402,0.0460631659401921,2.08400534398181e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37173,-0.0168325217271975,0.00355075708313892,-0.0237920056101498,-0.00987303784424525,2.15455141517662e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,39455,0.0499259016137294,0.01055963266963,0.0292290215812546,0.0706227816462042,2.2880809856997e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39428,0.0148028782376001,0.00313906653404541,0.00865030783087111,0.0209554486443291,2.43059972482463e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,39428,0.0312825243645413,0.00664291685006749,0.0182624073384091,0.0443026413906736,2.50977003795513e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39194,0.0272019593611732,0.0057838277687649,0.015865656934394,0.0385382617879524,2.58555599327948e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,37221,0.0243845106056147,0.00519269130525927,0.0142068356473065,0.0345621855639228,2.68160824919293e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,36880,0.0175226618182026,0.00374331383990617,0.0101857666919865,0.0248595569444186,2.88417279989588e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39187,-0.015419625593624,0.00329864309673454,-0.0218849660632237,-0.00895428512402435,2.97229622440423e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37183,0.0156041763391689,0.00335047064164741,0.00903725388153995,0.0221710987967978,3.23610640577876e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,36955,-0.0196180975908068,0.00422226774861342,-0.0278937423780891,-0.0113424528035245,3.41322676558042e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,39332,-0.018377974603469,0.00395694125794555,-0.0261335794690423,-0.0106223697378957,3.43835225403441e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37164,-0.0120922267893311,0.0026058760149743,-0.0171997437786807,-0.00698470979998147,3.51261670330711e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39194,0.029087210198537,0.00627473397491782,0.0167887316076981,0.041385688789376,3.58941027573164e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,36847,0.0243103175511969,0.0052506387878036,0.0140190655271018,0.034601569575292,3.69427897068965e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",36916,0.0311074489261838,0.0067364399456264,0.0179040266327561,0.0443108712196116,3.91731429952723e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",36847,0.0231517847988663,0.00501880838562154,0.0133149203630481,0.0329886492346845,4.00865211504882e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,36916,-0.0256239722345049,0.00556522007203064,-0.036531803575685,-0.0147161408933249,4.17937112222173e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,39654,0.028775915214165,0.00625234861562516,0.0165213119275396,0.0410305185007903,4.20994127695483e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,39312,0.0415365543077774,0.00903015441492782,0.0238374516545189,0.0592356569610359,4.26468035156887e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39462,0.0487744493276123,0.0106342094504036,0.0279313988048213,0.0696174998504033,4.54249960864286e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39462,0.0473843825745517,0.0103351039225914,0.0271275788862725,0.0676411862628308,4.58089982849767e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,37221,0.0303110865744488,0.0066200018458483,0.0173358829565861,0.0432862901923115,4.72265625276284e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37247,0.0133093186920361,0.0029068497276974,0.00761189322574924,0.019006744158323,4.72497864118251e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39187,0.0370620944766111,0.00810547733711425,0.0211753588958671,0.052948830057355,4.85919211054736e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39571,0.0169640261429727,0.00372037870131229,0.00967208388840059,0.0242559683975448,5.16145120225081e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37164,0.035313910723907,0.00775121731845479,0.0201215247797356,0.0505062966680784,5.26427725858169e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,39187,-0.0266720777856735,0.00585615410342699,-0.0381501398283904,-0.0151940157429566,5.29216790681591e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39462,0.0363638746121137,0.00798580402441783,0.0207116987242547,0.0520160504999726,5.3159207826097e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39531,0.0107791231239818,0.00237425505935579,0.00612558320764442,0.0154326630403191,5.66889423796592e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,37255,0.00906819791271917,0.00200088319788187,0.00514646684487071,0.0129899289805676,5.8929828356343e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37243,-0.0236812517709748,0.00523821132546796,-0.033948145968892,-0.0134143575730576,6.21402074398658e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37162,-0.0225949114012933,0.00500032697969982,-0.0323955522815049,-0.0127942705210816,6.27856808877651e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,37162,0.0148834091240434,0.00329798882957212,0.00841935101808203,0.0213474672300047,6.45289995875482e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,36916,-0.0205343792410838,0.00455543206693381,-0.0294630260922741,-0.0116057323898936,6.61411043179391e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,39355,0.0136378109220922,0.00302704506005977,0.007704802604375,0.0195708192398093,6.67763941276739e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,39428,0.0337152976957416,0.00749412637114432,0.0190268100082987,0.0484037853831844,6.88210979729325e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,39460,-0.0325344499545568,0.007233341337719,-0.046711798976486,-0.0183571009326275,6.91605583882201e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,37164,-0.0431304025178055,0.00959412334157468,-0.0619348842672919,-0.0243259207683192,7.00196945855807e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,36916,0.020516319831876,0.00457131525404463,0.0115565419339485,0.0294760977298035,7.25201359574633e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,36955,-0.0304875754296289,0.00679639803773086,-0.0438085155835814,-0.0171666352756764,7.32737930319418e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,39358,-0.0206598320251695,0.00460704068661183,-0.0296896317709287,-0.0116300322794103,7.36639216433235e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,39437,0.0448422864809068,0.0100030756110125,0.0252362582833223,0.0644483146784912,7.41990284481711e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,39477,0.0153482621163905,0.00342438854785368,0.00863646056259731,0.0220600636701837,7.44778114426435e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,37255,0.0320605314447576,0.00715757360027225,0.018031687188224,0.0460893757012912,7.55558306048977e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,39582,-0.0239390798757316,0.00536000990051701,-0.0344446992807449,-0.0134334604707182,8.01835597065476e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,36880,-0.0272781185769361,0.00611090807405873,-0.0392554984020912,-0.015300738751781,8.12122427710462e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,39455,-0.0258145006477225,0.00579076464538154,-0.0371643993526704,-0.0144646019427747,8.33766544549521e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,37058,-0.021054649757042,0.00472452660725361,-0.0303147219072591,-0.0117945776068249,8.40438869481392e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39507,0.0119129723305212,0.00267388229777669,0.0066721630268789,0.0171537816341635,8.4376386881982e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,39095,0.0427692920145384,0.00960933496052387,0.0239349954919116,0.0616035885371652,8.61800973612914e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37203,-0.0241160656267873,0.00542154624969305,-0.0347422962761857,-0.0134898349773889,8.7330121377775e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39428,0.0269963904531416,0.00607783972386511,0.015083824594366,0.0389089563119172,8.98594314286322e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,39099,-0.0468574171974059,0.0105794172281987,-0.0675930749646753,-0.0261217594301365,9.53077661057839e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39431,-0.026189732032106,0.00592251569008658,-0.0377978627846757,-0.0145816012795363,9.84517753829405e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,37077,0.0409816027235421,0.00927434826798909,0.0228038801182834,0.0591593253288007,1.00072096356368e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,39485,0.0269725825405747,0.00611529257836972,0.01498660908697,0.0389585559941793,1.03763671736342e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",36916,0.00986464056334142,0.00223663991073002,0.00548082633831059,0.0142484547883723,1.04009530601885e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,37247,-0.0304402494205503,0.00690197379999297,-0.0439681180685365,-0.016912380772564,1.04037240046572e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,39485,0.0303679699954472,0.00689800003887369,0.0168478899192548,0.0438880500716397,1.07782949462281e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",36955,0.0339772978462981,0.00772473490474134,0.0188368174330051,0.0491177782595911,1.0989965660227e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,39564,0.0280728901061545,0.00638399266990524,0.0155602644731402,0.0405855157391687,1.10310072019619e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,36906,-0.010732940412598,0.00244194099225674,-0.0155191447574212,-0.00594673606777485,1.11561490348024e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,36955,0.0433979068473562,0.00988087225570449,0.0240313972261754,0.062764416468537,1.13177495307684e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,39251,0.0105534691807755,0.00240457158539694,0.00584050887339747,0.0152664294881535,1.14704522949086e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,36880,0.0122470029754956,0.00279106014831752,0.00677652508479329,0.017717480866198,1.15372891637211e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,39636,0.017421075477462,0.0039743651614782,0.00963131976096475,0.0252108311939593,1.17647357541124e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39458,-0.0279451151626417,0.00638132058824093,-0.0404525035155939,-0.0154377268096895,1.19919278581031e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,39485,0.0153103679612361,0.00349702295790549,0.00845620296374138,0.0221645329587309,1.20518699324997e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37247,0.0113344473516011,0.0025903594228209,0.00625734288287211,0.01641155182033,1.22042802208612e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,39654,-0.016446227158382,0.00376094555099626,-0.0238176804383347,-0.00907477387842938,1.2342365425311e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,39601,0.022054257160978,0.00504477943343069,0.0121664894714538,0.0319420248505021,1.24104935614688e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,39438,0.0177919570690951,0.00407071556481666,0.00981335456205446,0.0257705595761357,1.24671127771009e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39531,0.00956210541396026,0.00219027165447004,0.00526917297119899,0.0138550378567215,1.27550475115796e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,39436,0.0233033000902123,0.00533933103728021,0.0128382112571431,0.0337683889232815,1.28289942192541e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,36360,0.00940338448631144,0.00215743716327002,0.0051748076463022,0.0136319613263207,1.32000730384016e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37221,0.0430246129081403,0.00987757639482746,0.0236645631742785,0.0623846626420022,1.33624194017521e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,37247,0.0244706087622359,0.00562327143384696,0.0134489967518959,0.035492220772576,1.36153754885784e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,39420,-0.0112960112134909,0.00261311514737685,-0.0164177169023496,-0.00617430552463228,1.55046727213508e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,36955,-0.0143921598019377,0.00333028210205515,-0.0209195127219658,-0.00786480688190955,1.56096454651637e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,39123,-0.0207401981391761,0.00480553337256699,-0.0301590435494074,-0.0113213527289448,1.59995804128463e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39462,0.0304293899751785,0.00706069645151153,0.0165904249302159,0.0442683550201411,1.64527014219194e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,39531,0.020913849188355,0.00485459144119962,0.0113988499636037,0.0304288484131062,1.65738541375692e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,37164,-0.0349909285489609,0.00813080722079736,-0.0509273107017238,-0.0190545463961981,1.69378605731844e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,36992,0.0134887341862006,0.00313479588028922,0.00734453426083373,0.0196329341115675,1.69849625181956e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37203,-0.0112096052771813,0.002609848214851,-0.0163249077782893,-0.00609430277607335,1.7589320104289e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,37255,-0.027684046812903,0.0064639500048663,-0.0403533888224409,-0.015014704803365,1.85870648586166e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39337,0.0150036923651515,0.00350802670049115,0.00812796003218882,0.0218794246981141,1.90643942673704e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,36955,-0.0334238331793386,0.00782604843019978,-0.0487628881025302,-0.018084778256147,1.96173207451334e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37164,-0.0213728980083307,0.00500662503736482,-0.0311858830815658,-0.0115599129350957,1.9784365449668e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39428,-0.0207627831095879,0.00486490537078507,-0.0302979976363266,-0.0112275685828491,1.98561884447785e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,39104,0.0124340994441559,0.00291513507622047,0.0067204346947638,0.018147764193548,2.00832088133841e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39355,0.0187471749715629,0.00440284049700649,0.0101176075974302,0.0273767423456957,2.07552527132205e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,37164,-0.0114086075493313,0.00268204831092111,-0.0166654222387367,-0.00615179285992594,2.11779087073328e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,37247,-0.00953721404102442,0.00224216276290487,-0.013931853056318,-0.00514257502573086,2.11877143933145e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,37030,-0.0232102910132667,0.00545698540062984,-0.0339059823985012,-0.0125145996280323,2.12149442239686e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,37247,-0.0104056688869011,0.0024469584014382,-0.01520170735372,-0.00560963042008227,2.12906877364251e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,39582,0.0223207635527039,0.00525456757564428,0.0120218111044411,0.0326197160009667,2.17094697120615e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,39388,0.0155519173850285,0.0036626731281996,0.00837307805375726,0.0227307567162997,2.18881132871833e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,36955,-0.0138220176946271,0.00325632254386563,-0.0202044098806037,-0.00743962550865044,2.20494291033561e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,39636,-0.0180089458055919,0.00424363075068171,-0.0263264620769281,-0.00969142953425579,2.21111031350585e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,36916,-0.00861837569825997,0.00203071522562755,-0.01259857754049,-0.00463817385602997,2.21149128936696e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,39601,0.0119961161343125,0.00283804592926225,0.00643354611295852,0.0175586861556665,2.38328615860515e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,39401,0.0219301286672572,0.00519189988508801,0.0117540048924847,0.0321062524420297,2.4151949395619e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,39453,0.0331599110338946,0.0078756540666707,0.01772362906322,0.0485961930045691,2.56367933727341e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39516,0.0324779052824147,0.00771704615442654,0.0173524948197387,0.0476033157450907,2.58455153198168e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,39578,0.0110188300225599,0.00261901998860064,0.00588555084490265,0.0161521092002172,2.60005593333315e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39428,-0.0166112723111551,0.00395254853491319,-0.024358267439585,-0.00886427718272528,2.6531002237881e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,39428,0.0164889778228687,0.00393200532884511,0.00878224737833227,0.0241957082674051,2.76227448734965e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,37243,0.0235299016645849,0.00561152077509757,0.0125313209453936,0.0345284823837761,2.76969783589842e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,39601,0.02219943213447,0.00529935835386221,0.0118126897609001,0.0325861745080399,2.81674332972385e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,36880,0.00960983941161419,0.00229396552632365,0.00511366698001984,0.0141060118432085,2.81894754277624e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,39532,0.0411909793186672,0.0098398725535007,0.0219048291138058,0.0604771295235285,2.8536121847937e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,39104,0.0381757577352387,0.00912499457292634,0.0202907683723031,0.0560607470981743,2.88540300246107e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,39654,-0.0181753421879398,0.00434460743401273,-0.0266907727586047,-0.00965991161727483,2.88760762156912e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,39505,0.0205648442044424,0.00491985185799113,0.0109219345627798,0.0302077538461051,2.93192127071308e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37243,0.0261746903597479,0.00627623699249193,0.0138732658544637,0.0384761148650321,3.06012611399388e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,37269,-0.00674982393952499,0.0016200466482483,-0.00992511537009167,-0.00357453250895832,3.11424802381449e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,39633,0.0151669356740841,0.00364570874286603,0.00802134653806668,0.0223125248101015,3.19696419354714e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,39541,0.0171417182243283,0.00412106192195488,0.00906443685729671,0.0252189995913598,3.20654840835185e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39470,0.0179326899914017,0.00431337131877567,0.00947848220660139,0.026386897776202,3.23584206651151e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,39531,0.00998122901151322,0.00240130622662618,0.00527466880732591,0.0146877892157005,3.2482637177801e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,36955,-0.0266776887690729,0.00642218023645301,-0.0392651620325208,-0.014090215505625,3.28895340505988e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,39445,-0.0300067896157664,0.0072308611372472,-0.044179277444771,-0.0158343017867619,3.34569715600071e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39355,0.0147873730498345,0.00356353527070707,0.0078028439192486,0.0217719021804203,3.34853581141236e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,39455,0.0100828140097147,0.00243057333363308,0.00531889027579382,0.0148467377436355,3.36757838490342e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,37081,0.0359317825190595,0.00867180136006681,0.0189350518533285,0.0529285131847904,3.44244072411175e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39455,0.0131416902180079,0.00318362906086603,0.0069017772587105,0.0193816031773053,3.68076219881167e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,39462,0.0191529484128329,0.00464116912396422,0.010056256929863,0.0282496398958027,3.69910440180091e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,39541,0.0127332202550262,0.0030875800218861,0.00668156341212942,0.0187848770979229,3.74321724862588e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37255,0.00754328930375721,0.00183076278858017,0.00395499423814007,0.0111315843693744,3.80762530161827e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,39561,0.0132916118158449,0.00324053605050121,0.00694016115686254,0.0196430624748273,4.1232655336364e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37243,0.00789610109567351,0.00192706752494555,0.00411904874678023,0.0116731534445668,4.20266105327862e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,39554,0.0142393373632331,0.0034769183379851,0.00742457742078232,0.0210540973056839,4.23654021888089e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37203,-0.0252855661211724,0.00618608661776198,-0.0374102958919859,-0.0131608363503589,4.38738216837503e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,39589,-0.0130882855366602,0.00320684728800404,-0.0193737062211481,-0.0068028648521723,4.50034550289987e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37216,0.00521575460391428,0.00127849196616361,0.00270991035023361,0.00772159885759495,4.53845688732194e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39355,-0.0101004277855192,0.00247688598068218,-0.0149551243076563,-0.00524573126338217,4.56855921954205e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39462,-0.022091080837413,0.00542326455236733,-0.032720679360053,-0.011461482314773,4.65713942201471e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,39428,0.0264802983173166,0.00651397930337594,0.0137128988826998,0.0392476977519335,4.82469555515568e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,39282,-0.0130383900274316,0.0032153135025535,-0.0193404044924365,-0.00673637556242675,5.03708374798797e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,37221,-0.0153298313568612,0.00378597272569091,-0.0227503378992154,-0.00790932481450705,5.17156723747693e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39319,0.0336127567497446,0.00830210511005164,0.0173406307340433,0.0498848827654458,5.176327643268e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39455,0.0121787203136354,0.00300862047007612,0.00628182419228621,0.0180756164349846,5.19292899824203e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,39654,-0.0156739662081334,0.00387637818737217,-0.0232716674553829,-0.00807626496088399,5.29286864667223e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,38961,-0.0141530370656941,0.00350018878095793,-0.0210134070763716,-0.00729266705501658,5.29297493070323e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39462,-0.00858860580456543,0.00213162552910899,-0.0127665918416191,-0.00441061976751181,5.62584715920687e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,39485,0.015837676997095,0.0039329863864908,0.00812902367957301,0.023546330314617,5.67985880053714e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39434,-0.0307866967496542,0.00764578322677924,-0.0457724318741415,-0.0158009616251669,5.68620200558293e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,39460,0.0229756920896406,0.00570685175640441,0.011790262647088,0.0341611215321933,5.70164218858085e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,39621,-0.0214225265451788,0.00532430453897859,-0.0318581634415769,-0.0109868896487808,5.7609097052623e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,39214,0.0120092044266898,0.00298472551836669,0.00615914241069111,0.0178592664426885,5.76121623444462e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,39391,0.0130983874025737,0.00325982761521674,0.00670912527674887,0.0194876495283985,5.89511024754312e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,38992,0.0423781476178494,0.010550375556366,0.0216994115273722,0.0630568837083267,5.93047112190916e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,39453,0.0339849993559494,0.00847297770316906,0.017377963057738,0.0505920356541607,6.07586406080534e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36457,-0.0386348162418235,0.0096357591396329,-0.057520904155504,-0.0197487283281431,6.12091782641159e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,39485,0.0266462781447092,0.00665538114558674,0.0136017310993592,0.0396908251900592,6.26538577941674e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",36916,0.0300422465052899,0.00750696401895303,0.015328597028142,0.0447558959824378,6.3194882053919e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39531,0.0115262821466465,0.00288469365151714,0.00587228258967289,0.0171802817036201,6.48182963587254e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,39589,0.00780893588720144,0.00195473833045812,0.00397764875950353,0.0116402230148994,6.50345164433417e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,39280,-0.0125274887707827,0.00313597138550902,-0.0186739926863804,-0.00638098485518501,6.50694105725365e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39516,0.0180544675899048,0.00452196458275719,0.00919141700770067,0.0269175181721088,6.56583549168765e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,36880,0.0173558051589313,0.00434746237235666,0.00883477890911219,0.0258768314087503,6.58480464027996e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39043,0.0199622878974247,0.00500624061422344,0.0101500562935468,0.0297745195013027,6.71040834961981e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",36880,-0.0120730596069622,0.00302889859163423,-0.0180097008465653,-0.00613641836735916,6.75927916219273e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37203,0.0362145375042858,0.00913309174463082,0.0183136776848094,0.0541153973237622,7.37348408860383e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37221,0.0288667148341069,0.00728738516313324,0.0145834399143657,0.043149989753848,7.49823970600823e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,37243,0.00768711880323577,0.00194551401648771,0.00387391133091987,0.0115003262755517,7.81773473754135e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,37269,0.00654820485346503,0.0016609545286011,0.00329273397740687,0.00980367572952319,8.10873461388802e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37024,0.00463228033244019,0.00117709194616187,0.00232518011796292,0.00693938054691746,8.35192934572875e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39123,-0.0176638563250977,0.00449495586620381,-0.0264739698228572,-0.00885374282733826,8.54397458889248e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,37221,0.0234621598236516,0.00597273262947255,0.0117556038698854,0.0351687157774178,8.60301790884029e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39194,0.0142883166934964,0.0036376383118113,0.0071585456023463,0.0214180877846466,8.60775977729416e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,39589,0.0116127314978178,0.00297529740865373,0.00578114857685652,0.0174443144187792,9.53999484652651e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,39435,0.0227740178722784,0.00583621614716969,0.0113350342238258,0.034213001520731,9.57435598316812e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,39079,-0.0210874445958357,0.00540428500065849,-0.0316798431971264,-0.0104950459945451,9.58339426698421e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,37162,-0.0120762760686103,0.00309820806131006,-0.018148763868778,-0.00600378826844256,9.75584443767567e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37247,0.0303842926526935,0.0078172033433709,0.0150625740996865,0.0457060112057005,0.000102066140911974
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37221,0.0332781737589744,0.00858287314856902,0.0164557423877792,0.0501006051301697,0.00010616138383393
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,39104,0.0149993787644446,0.003872228851373,0.00740981021575355,0.0225889473131357,0.000107715685563193
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,39294,0.013109164378732,0.00338753113926009,0.00646960334578222,0.0197487254116818,0.000109377843230726
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37164,0.0344311227782929,0.00892391556161763,0.0169402482775224,0.0519219972790635,0.000114743521455896
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39526,0.009311128230514,0.00241388289816036,0.00457991775011969,0.0140423387109083,0.000115112142530621
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,37247,-0.00977391610358655,0.00253472627847413,-0.0147419796093958,-0.00480585259777726,0.000115819676863835
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39428,-0.0226996855250895,0.00589878328728875,-0.0342613007681754,-0.0111380702820035,0.000119483769919756
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,39654,-0.0188511494243725,0.00490132949789722,-0.028457755240251,-0.00924454360849391,0.000120487848553299
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,37269,-0.0248924826292375,0.00649528148906185,-0.0376232343477987,-0.0121617309106763,0.000127507977163265
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,39480,0.0192260987956001,0.00501749589275449,0.00939180684580127,0.0290603907453989,0.000127720864241624
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,36955,0.0393114748115906,0.0102707658728589,0.0191807737007872,0.0594421759223939,0.00013007605413196
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37221,0.0415131954743589,0.010866000402141,0.0202158346861625,0.0628105562625553,0.000133830328888056
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39428,-0.0257614988731302,0.00674904512866169,-0.0389896273253071,-0.0125333704209533,0.000135595852437233
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39432,0.00629407300058845,0.00164957730810287,0.00306090147670683,0.00952724452447007,0.000136416434796722
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,39145,-0.0208804173888256,0.00547388858109457,-0.0316092390077709,-0.0101515957698802,0.000136990102002323
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,36861,-0.0111145695192871,0.00292542048946405,-0.0168483936786366,-0.00538074535993754,0.00014579423924141
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,39194,-0.00999537486679361,0.00263577714179404,-0.0151614980647099,-0.00482925166887729,0.000149918689607975
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,36880,-0.0153319384462176,0.00404330864843042,-0.0232568233971412,-0.007407053495294,0.000150189175080319
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39410,0.00907173553543587,0.00239562331005053,0.00437631384773684,0.0137671572231349,0.000153199394071888
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,39654,-0.0174861791637541,0.00462021934159362,-0.0265418090732776,-0.00843054925423057,0.000154480339867127
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39459,-0.0245538541543446,0.00650137386739053,-0.03729654693443,-0.0118111613742591,0.000159521862922702
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37203,-0.0129217011762849,0.00342601886424523,-0.0196366981502056,-0.00620670420236424,0.000162912788966547
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,37255,-0.0114419456633636,0.0030365912822655,-0.017393664576604,-0.00549022675012323,0.000165283600691405
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,39589,0.00852082454206111,0.0022661651450381,0.00407914085778643,0.0129625082263358,0.000170539543174852
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,36916,-0.0239085234278359,0.00636050778066462,-0.0363751186779385,-0.0114419281777332,0.000171440036137868
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,37269,0.00608749905536894,0.00162370006294714,0.00290504693199255,0.00926995117874533,0.000178213279512858
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,36847,0.0106175713596855,0.0028360034114638,0.00505900467321647,0.0161761380461546,0.000182041380787785
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,37221,-0.014892977905779,0.00397894134384118,-0.0226917029397077,-0.00709425287185024,0.000182670143688678
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,39601,-0.0118844699220046,0.0031765917193361,-0.0181105896919033,-0.00565835015210584,0.000183772196644894
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,36916,0.0199172999410671,0.00533478744731324,0.00946111654433316,0.0303734833378011,0.000189695801518602
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,36847,-0.0205717305619966,0.00551133585692079,-0.0313739488415613,-0.00976951228243182,0.000190344557991546
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39458,0.0102567333420902,0.00275035597769966,0.00486603562579887,0.0156474310583816,0.000192766052983453
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37247,-0.0192627413310529,0.00516558131945542,-0.0293872807171856,-0.00913820194492029,0.000193028022199364
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,36916,-0.00949995386689359,0.00255062060427035,-0.0144991702512635,-0.00450073748252371,0.00019651472131693
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,39163,0.0182129054638094,0.00489080902448607,0.00862691977581668,0.0277988911518021,0.000196897578259988
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,39589,0.0217071682665397,0.0058479217789597,0.0102452415797787,0.0331690949533007,0.000206409356644717
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,39319,0.0259988365178324,0.00700671768943137,0.0122656698465469,0.0397320031891179,0.000207556159045277
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,37203,0.0148061815237392,0.0039914182308495,0.00698300179127421,0.0226293612562042,0.000208547471723189
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39428,0.0304362969654226,0.00821360120663096,0.0143376386004259,0.0465349553304193,0.000211652513590728
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,37114,0.0298542260313709,0.00805687652382952,0.014062748044665,0.0456457040180768,0.000211927476562078
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,39601,0.0355591717223234,0.00960111086036883,0.0167409944360005,0.0543773490086463,0.000213272720041324
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,39104,-0.0266281187498168,0.00719976057377866,-0.040739649474423,-0.0125165880252107,0.000217692950767826
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,39462,0.0215270855620072,0.00582767461169266,0.0101048433230896,0.0329493278009249,0.000221588904216643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,39636,-0.0169072982369608,0.00458018819661384,-0.025884467102324,-0.0079301293715977,0.000223805232852843
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,39636,-0.0120336621925651,0.00326358193688446,-0.0184302827888587,-0.0056370415962716,0.000227475249977512
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,39458,0.0123940565857562,0.00336368715025424,0.0058012297712579,0.0189868834002545,0.000229810064980056
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,36880,0.0192923408575102,0.00524981994552442,0.0090026937642823,0.029581987950738,0.000238982889582617
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39531,-0.0110558974734445,0.0030097075366014,-0.0169549242451832,-0.00515687070170573,0.000240160705863046
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,36955,0.0120733893138744,0.00328822139396661,0.00562847538169984,0.018518303246049,0.000241938619718485
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39439,0.0065009404422269,0.00177070127497798,0.00303036594327006,0.00997151494118374,0.00024207005254262
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,39636,0.0112465128251561,0.00307315037229122,0.00522313809546526,0.0172698875548469,0.000253461285880485
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,37162,-0.0130254054712464,0.00356088735173613,-0.0200047446806492,-0.00604606626184357,0.000255307882285617
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,39582,-0.019523175276464,0.00533856894767949,-0.0299867704139158,-0.00905958013901222,0.000256044334320324
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,39549,-0.0152472279070485,0.00416967106041002,-0.0234197831854521,-0.00707467262864486,0.000256353014266419
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39194,-0.0184583902760233,0.0050569655125388,-0.0283700426805994,-0.00854673787144727,0.000263052097143224
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,39462,0.00917300424662298,0.00251490545137357,0.00424378956193079,0.0141022189313152,0.000265747201188294
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,39344,0.00732213024346235,0.00201018207938172,0.00338217336787418,0.0112620871190505,0.000270897427479621
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37255,0.0191522195883332,0.00525787194465264,0.00884679057681406,0.0294576485998524,0.000270984888249642
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39123,0.0243144953671294,0.00667845575073855,0.0112247220956818,0.037404268638577,0.000272794565565179
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,39092,0.0275547591508509,0.00757426760463449,0.0127091946457673,0.0424003236559345,0.000275767900370098
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,39123,0.0257658252102645,0.00708659998921659,0.0118760892314,0.039655561189129,0.000278011976392394
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39428,0.0282862765332811,0.00779368029096415,0.0130106631629914,0.0435618899035709,0.00028504179066299
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,37247,0.031541170944636,0.00869564351773535,0.0144977096498747,0.0485846322393973,0.000287583115580079
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,39654,0.0126899700689811,0.00350066382204901,0.00582866897776502,0.0195512711601971,0.000289884616207988
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39499,0.0108565322474868,0.00299688856539142,0.00498263065931959,0.016730433835654,0.000292615042510957
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39453,0.00706503595078962,0.00195056519858408,0.00324192816156482,0.0108881437400144,0.000293246923173095
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,39462,0.0106181047632507,0.00293569543336745,0.00486414171385052,0.0163720678126509,0.000299134967073563
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,39541,-0.0184701186012328,0.00511075897581776,-0.0284872061938356,-0.00845303100862998,0.000302527244178479
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39526,-0.0144293773456429,0.00399312146706219,-0.0222558954210848,-0.00660285927020103,0.000303006249065605
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,37269,0.0103412586177458,0.00286407120071402,0.0047276790643463,0.0159548381711452,0.000306555087875599
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39428,-0.0324094197061165,0.00897787901562893,-0.0500060625767492,-0.0148127768354837,0.000307291675060736
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,39531,-0.0164740918670853,0.00456742515640722,-0.0254262451736435,-0.00752193856052719,0.000310918502174931
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,39462,0.0214801923029344,0.00597227776884302,0.00977452787600205,0.0331858567298667,0.000323376974866696
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,39485,-0.0177802761539975,0.00494650547997888,-0.0274754268947561,-0.00808512541323891,0.000326039193167207
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,39428,-0.0294930980785532,0.00820797786885778,-0.0455807347015145,-0.013405461455592,0.000327659820742259
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37162,0.0128282430593593,0.00357301759268256,0.00582512857770144,0.0198313575410171,0.000331528658773782
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,37247,-0.0134503282497022,0.0037515015196706,-0.0208032712282566,-0.0060973852711478,0.000337920534592342
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37247,0.0303699091815595,0.00847593150094688,0.0137570834397036,0.0469827349234154,0.000340832848396634
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,36861,0.0168644761832679,0.00470668772073658,0.00763936825062423,0.0260895841159116,0.000340856893810277
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,37247,0.0162697546313266,0.00454354978362138,0.00736439705542868,0.0251751122072245,0.000343752061512109
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,39330,0.0161919256750604,0.00453447997353309,0.00730434492693554,0.0250795064231852,0.000356953421162342
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,39387,0.0207786859810136,0.00582116619903809,0.00936920023089891,0.0321881717311282,0.000358777443054509
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,37255,0.0154797328957983,0.00433822092357403,0.00697681988559323,0.0239826459060034,0.000360726441711485
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,39636,-0.0121407450613987,0.00340394510870512,-0.0188124774744607,-0.00546901264833666,0.00036266015298003
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39498,0.00698499679771278,0.00195970699176778,0.00314397109384794,0.0108260225015776,0.000365949020868899
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,36916,0.0359316025360614,0.0101060747801934,0.0161236959668823,0.0557395091052405,0.000378736465985425
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,37203,-0.0219195780515555,0.00616847201274308,-0.034009783196532,-0.00982937290657908,0.000381535458789607
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,39270,-0.0235972465557752,0.00664513561695106,-0.0366217123649993,-0.0105727807465512,0.000384879149569999
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39485,-0.0238651500176105,0.00672176790381198,-0.037039815109082,-0.010690484926139,0.000385780864325775
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39462,0.0141389384665077,0.00398259550756241,0.00633305127168538,0.02194482566133,0.00038614256015802
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,37269,0.00637457094245474,0.00180112056526802,0.00284437463452943,0.00990476725038006,0.000402724849117931
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37221,-0.0133579472680814,0.00377523411088086,-0.0207574061254079,-0.00595848841075496,0.000404127646292001
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,39410,0.0221494730157161,0.00626097260426867,0.00987796671134954,0.0344209793200827,0.00040484364396004
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39123,0.0146313526475083,0.00413631695022922,0.006524171425059,0.0227385338699575,0.000405503505999665
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,39123,0.0522107215168927,0.0147643899765348,0.0232725171628844,0.0811489258709009,0.000407086602583019
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37203,-0.0263925175954676,0.00747926729574751,-0.0410518814951327,-0.0117331536958025,0.000418986077019834
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,37269,0.00470118945333195,0.00133429049298943,0.00208598008707266,0.00731639881959124,0.000427591609558242
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39187,-0.0175990349932161,0.00499837795052361,-0.0273958557762424,-0.00780221421018983,0.000431303992244713
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,39654,-0.0171511650216641,0.00487181488889969,-0.0266999222039075,-0.0076024078394207,0.000432014445285446
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,39355,0.0187194251389034,0.00532050857240168,0.00829122833699609,0.0291476219408107,0.000435528442485049
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,36916,0.0176719451676173,0.00502430727415719,0.00782430291026924,0.0275195874249654,0.00043752867115131
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,39526,0.0177881656546807,0.00506720867116257,0.00785643665920209,0.0277198946501594,0.000448660968367361
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39477,0.00852014555393294,0.00243740997843181,0.0037428219962066,0.0132974691116593,0.000474408395102613
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",36916,0.0195782761654454,0.00560085057371982,0.00860060904095453,0.0305559432899362,0.000474659890639259
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,39636,0.00800179396690136,0.00229223386281149,0.00350901559579085,0.0124945723380119,0.000482893362490771
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,39636,0.00806736460371156,0.0023130337445197,0.00353381846445294,0.0126009107429702,0.000488417619703426
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39499,0.0101614437184335,0.00291424795229575,0.00444951773193385,0.0158733697049332,0.000490203607649407
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37235,0.00740252639699872,0.00212483240768483,0.00323785487793644,0.011567197916061,0.000495972908777893
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,36847,0.0123588035094016,0.00354772674764217,0.00540525908402297,0.0193123479347803,0.000496455883836126
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,37203,-0.0111658356603153,0.00320644263856025,-0.0174504632318934,-0.00488120808873721,0.000498768610030136
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,39322,-0.00865985286374627,0.00248714958463768,-0.0135346660496361,-0.00378503967785641,0.000499414026691054
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,39344,-0.0113953476199806,0.00327782682484973,-0.0178198881966861,-0.00497080704327517,0.000509462426766384
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39123,-0.0177803835630263,0.00511677229029734,-0.0278092572520091,-0.00775150987404353,0.000512478463867008
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,39531,0.00884757437273589,0.00255422332594052,0.00384129665389247,0.0138538520915793,0.000533882958093283
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,39654,0.00954213206114047,0.00275707583107861,0.0041382634322264,0.0149460006900545,0.000539728849300686
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,37203,-0.0122133576242368,0.00352905597070002,-0.0191303073268089,-0.00529640792166478,0.000540335702769066
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39289,-0.0138381915172058,0.00400396817851057,-0.0216859691470865,-0.00599041388732507,0.000549546813111474
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,37187,0.00573393867925753,0.00166043307963469,0.00247948984317355,0.00898838751534152,0.000555616754803023
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39455,-0.0130206260080677,0.003780231026074,-0.0204298788191727,-0.00561137319696264,0.00057389367919449
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37203,0.0158968359103567,0.0046169322500526,0.00684764870025359,0.0249460231204598,0.000576806247324948
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39497,0.00804819506368225,0.00233801211155109,0.00346569132504211,0.0126306988023224,0.000578307676631825
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,36916,0.0111817731381079,0.00325096029844979,0.00480989095314636,0.0175536553230695,0.000584634286642809
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,39187,0.0253853651811194,0.00738971949214582,0.0109015149765136,0.0398692153857252,0.000593688790967407
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,39589,0.008987617798173,0.00261646319318519,0.00385934993953004,0.014115885656816,0.0005940870357312
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,37255,-0.0269944094886008,0.00788589676758368,-0.0424507671530648,-0.0115380518241367,0.000620994223597328
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,36847,0.0200510271773879,0.00586737140374237,0.00855097922605285,0.0315510751287229,0.000634305553282155
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39462,-0.0182473375963202,0.00534113647900428,-0.0287159650951686,-0.0077787100974718,0.000636284341069184
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36823,0.0183868280061988,0.00538264158979751,0.00783685049019566,0.0289368055222019,0.000637645259884347
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,36955,0.0125161115056831,0.0036674501426768,0.00532790922603657,0.0197043137853296,0.000645133961376864
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39194,0.0251736691465775,0.00737665412471776,0.0107154270621307,0.0396319112310243,0.000645160550455544
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,37269,0.00435925404597329,0.00128115094209729,0.00184819819946261,0.00687030989248398,0.000669501462078261
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,39428,0.0243871584032192,0.00716886935574761,0.0103361744659539,0.0384381423404845,0.000671152484063551
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37164,0.0287801752131558,0.00846538626724251,0.0121880181293605,0.0453723322969511,0.000676554271695122
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,37247,0.0211031565180317,0.00621233419218927,0.0089269815013407,0.0332793315347226,0.000683421111618543
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,37183,-0.00937116002740887,0.00276227474698939,-0.0147852185315081,-0.00395710152330967,0.000694556901529952
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,39390,0.0213830839722517,0.00630490161312695,0.00902547681052284,0.0337406911339805,0.000696909015249196
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39104,-0.0121541822758758,0.00358371352669407,-0.0191782607881962,-0.00513010376355543,0.000696935641483609
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,37221,0.0131055320383563,0.00386583020018114,0.00552850484600124,0.0206825592307113,0.000700799139877069
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,36847,-0.0108310538318103,0.00319538231765863,-0.0170940031744213,-0.00456810448919942,0.000702139993643833
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39462,-0.0151050062747847,0.00446038500842089,-0.0238473608912897,-0.00636265165827977,0.000709769333131998
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,39455,0.0120623458358828,0.00356468729427692,0.00507555873910009,0.0190491329326656,0.000716614944952984
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37247,0.0180732813944603,0.00534972281996688,0.00758782466732517,0.0285587381215953,0.000731374590180433
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,36975,0.00659394340804918,0.00195280398736897,0.002766447592806,0.0104214392232924,0.000735964758063578
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39440,0.0321599401647098,0.00952858764343454,0.0134839083835781,0.0508359719458415,0.000739759523645268
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39541,0.0256267126307141,0.00759343445748104,0.0107435810940513,0.0405098441673769,0.000740416243153862
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,37195,0.0284317863017752,0.00842951504264931,0.0119099368181825,0.0449536357853678,0.00074606405785044
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,39482,-0.0132990892498923,0.00394318405847065,-0.0210277300044947,-0.0055704484952898,0.000746288296549081
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39462,0.0162104058551205,0.0048097049646265,0.00678338412445254,0.0256374275857884,0.000752609936432078
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,37255,0.0110343246327219,0.00327507857401034,0.00461517062766167,0.0174534786377822,0.000756150360059547
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39428,-0.0108981453259022,0.00323633433911695,-0.0172413606305715,-0.00455493002123302,0.000760619348158816
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,37162,-0.00601581352309424,0.00178695702763354,-0.00951824929725598,-0.00251337774893249,0.000763506951717313
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,39654,-0.00759361517558394,0.00225900577023123,-0.0120212664852372,-0.00316596386593072,0.000777154316399868
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,39601,0.00956245647998663,0.00284619606885927,0.00398391218502246,0.0151410007749508,0.000782105932883777
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,39516,-0.0165976784610214,0.00494181002574682,-0.0262836261114851,-0.00691173081055758,0.000785259103868829
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37019,0.0162029477661247,0.00483313913483603,0.00672999506184609,0.0256759004704033,0.000803306783297044
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,36880,0.0082974814325541,0.00247900953158971,0.00343862275063826,0.0131563401144699,0.000819053651530233
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,39187,-0.0155954988145833,0.00466291885148031,-0.0247348197634847,-0.00645617786568187,0.000826132581436459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,36955,0.00773855723094636,0.00231660303242806,0.00319801528738735,0.0122790991745054,0.00083879679392719
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,36861,-0.0228807874714865,0.00685325855617832,-0.036313174241596,-0.009448400701377,0.000844274639270231
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39194,0.0110355158838752,0.00331225243221611,0.00454350111673166,0.0175275306510188,0.000865215193764721
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",36847,0.0128198241697633,0.00384852097652539,0.00527672305577353,0.020362925283753,0.000867550092715251
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37221,-0.0165670643346718,0.00497620026169098,-0.0263204168475862,-0.00681371182175753,0.00087323573571243
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,39636,-0.00869978220961874,0.00261360206343054,-0.0138224422539426,-0.00357712216529489,0.000874736826977648
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37203,-0.0219245677822602,0.00659784116485612,-0.0348563364653782,-0.00899279909914219,0.000893084343503172
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,39433,0.0193696734884567,0.00583422432685761,0.00793459380781584,0.0308047531690977,0.000902296808996277
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37247,-0.00836071387179856,0.00252243583762132,-0.0133046881135363,-0.00341673963006078,0.000920492121671793
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,39473,-0.0123082524424981,0.00371418049118183,-0.0195880462052145,-0.00502845867978174,0.00092237117083826
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,39654,0.00674584683352639,0.0020358597030203,0.00275556181560661,0.0107361318514462,0.000923471593938036
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39123,-0.0159210376987898,0.00481261948284761,-0.0253537718851711,-0.00648830351240851,0.000941285511005948
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39187,-0.0156361989238492,0.00473231799400717,-0.0249115421921033,-0.00636085565559517,0.000954984830108801
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37221,0.0229514089850018,0.00694920536041833,0.00933096647858186,0.0365718514914217,0.000960086942730754
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,36955,0.0250532973950316,0.00758666541956031,0.0101834331726934,0.0399231616173698,0.000961711217849192
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,39396,0.011137952399924,0.00337514356088183,0.00452267102059562,0.0177532337792524,0.000969133088178914
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,39636,-0.00946935580193463,0.00287581487523932,-0.0151059529574037,-0.00383275864646557,0.000994373252512637
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37255,0.00741185351118427,0.00225126965401816,0.00299936498930867,0.0118243420330599,0.000996409685535933
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39545,0.0132172195847097,0.00401723122857503,0.00534344637670265,0.0210909927927168,0.00100370031299667
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,39123,-0.0217379580681747,0.0066075268068078,-0.034688710609518,-0.00878720552683144,0.00100467039096559
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,37162,0.015037541414687,0.00457203393802249,0.00607635489616292,0.0239987279332111,0.00100807816887065
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39428,0.00995230512985146,0.00302788972645565,0.00401764126599838,0.0158869689937045,0.00101537731205661
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,37247,-0.010512289253306,0.00320068334352136,-0.0167856286066079,-0.00423894990000417,0.00102478300088669
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,36916,-0.0116639059600002,0.0035540392697674,-0.0186298229287443,-0.00469798899125613,0.00103403572945244
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39428,0.0331711772186779,0.0101133161058765,0.0133490776511599,0.0529932767861959,0.00104062345582757
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,39636,0.0215101921856459,0.00655976409145928,0.00865305456638567,0.0343673298049061,0.00104369108191882
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,36919,-0.0137875624466035,0.00420530488563972,-0.0220299600224574,-0.00554516487074967,0.00104604767496613
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,39462,0.0106337977436568,0.00324407007625662,0.00427542039419382,0.0169921750931198,0.0010481324269278
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39531,0.0207266468918644,0.00633331245477568,0.00831335448050402,0.0331399393032247,0.00106788024014934
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,39492,0.0105710115137946,0.00323095202347327,0.00423834554778703,0.0169036774798023,0.00107107929063038
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,39601,0.00974291162273684,0.00298100267065836,0.00390014638824645,0.0155856768572272,0.00108423737636146
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37164,-0.0223558664355679,0.00684413289233065,-0.035770366904536,-0.00894136596659981,0.00109202132127915
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,36916,0.0252385964532638,0.00773127312338808,0.0100853011314232,0.0403918917751044,0.00109960412349818
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,39462,0.0121556328771919,0.00372611235127634,0.00485245266869029,0.0194588130856935,0.00110765573616416
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,36955,0.0191159141165171,0.0058626557852578,0.00762510877741184,0.0306067194556224,0.00111465002805122
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39187,0.0313614347391026,0.0096275879081966,0.0124913624390372,0.0502315070391679,0.00112670406424196
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,39485,0.0110571390445989,0.00339459292619641,0.00440373690925389,0.0177105411799438,0.00112734885701448
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,37247,-0.00861117281143009,0.0026456518464975,-0.0137966504305652,-0.00342569519229498,0.00113751130047623
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,39526,0.0134428936229566,0.00413507556827719,0.00533814550913332,0.0215476417367799,0.00115275555755877
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39194,0.0101970423125227,0.00313719244520105,0.00404814511992866,0.0163459395051168,0.00115512709617536
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39456,-0.00499277566514643,0.00153907506909388,-0.00800936280057044,-0.00197618852972243,0.0011811730642198
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,36955,-0.00808693883875973,0.00249439123128072,-0.0129759456520699,-0.00319793202544952,0.0011898454597684
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39355,0.022391519292529,0.00691134807065251,0.00884527707405012,0.035937761511008,0.00119867684121404
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,39654,0.00462623275734406,0.00142798548962272,0.00182738119768353,0.00742508431700459,0.00119916152442882
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37255,0.017508549936837,0.00540824749670483,0.00690838484329555,0.0281087150303785,0.00120939897019086
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39355,0.0116258071384716,0.00359430927573777,0.0045809609580256,0.0186706533189177,0.00122119838736994
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39123,-0.0145049678951802,0.00448622612805868,-0.0232979711061753,-0.00571196468418522,0.00122672701628065
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37221,0.012069270652394,0.0037328184233412,0.00475294654264527,0.0193855947621428,0.00122685715871432
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37221,0.0202866287152204,0.00627434914999362,0.00798890438123287,0.0325843530492079,0.00122695182505222
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,37162,-0.0134971560232542,0.00417472178859771,-0.0216796107289057,-0.00531470131760268,0.00122781222053654
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,37247,0.0180127617085041,0.00557368725042094,0.00708833469767903,0.0289371887193291,0.00123346159419427
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,39654,0.00825854896482018,0.00255786605178348,0.00324513150332455,0.0132719664263158,0.00124623828668217
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39549,0.00952351092194958,0.00295176970110338,0.00373804230778696,0.0153089795361122,0.00125636937009312
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,37203,0.0110704164496398,0.00343356401365338,0.00434063098287918,0.0178002019164004,0.00126653544382084
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,39104,-0.0129231274199809,0.00400878231289596,-0.020780340753257,-0.0050659140867048,0.0012682120580974
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,36823,0.02561361190745,0.00794929306870534,0.0100329974927875,0.0411942263221124,0.00127573235298081
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39455,0.0118533526456296,0.00368071191108228,0.00463915729990837,0.0190675479913509,0.00128285979799627
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,39104,0.0206591390597717,0.00641583974725575,0.00808409315515039,0.0332341849643929,0.00128460644915326
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,39390,0.0238184014107439,0.00739916394705435,0.00931604007451736,0.0383207627469704,0.00128883339840431
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37162,-0.0160913886562041,0.00500460456645359,-0.0259004136064532,-0.00628236370595512,0.00130626437199145
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,36880,0.0164787997068021,0.0051322456175356,0.0064195982964323,0.0265380011171719,0.00132686035487171
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",39636,0.0192850726609555,0.00601016404059296,0.00750515114139332,0.0310649941805177,0.00133593393296324
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,39319,-0.0153466409946204,0.00478595089395236,-0.024727104746767,-0.00596617724247378,0.00134596733590836
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39526,0.0117562031591423,0.00366654885094712,0.00456976741128591,0.0189426389069986,0.00134715371689869
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,39499,-0.00826568575131988,0.00258123777979685,-0.0133249117997217,-0.00320645970291806,0.0013665746350833
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37162,-0.0168405054839356,0.0052611573449901,-0.0271523738801162,-0.00652863708775504,0.00137329882445312
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,39589,0.0201161788740335,0.00629682053349726,0.00777441062837885,0.0324579471196881,0.00140284284870308
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,39552,0.0166243466353505,0.005205072032985,0.00642240545069988,0.0268262878200011,0.00140665315619005
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,39455,0.0205739755858582,0.00644812344909094,0.00793565362563994,0.0332122975460764,0.00142224693277504
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,39485,0.0238852942951487,0.00750310579023853,0.00917920694628121,0.0385913816440162,0.00145859120310845
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39355,0.0162240741352237,0.00509729779386371,0.00623337045925085,0.0262147778111966,0.00146118792491506
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39531,-0.00675672292801283,0.00212742985384149,-0.0109264854415421,-0.00258696041448352,0.00149620238945537
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,39589,0.0362484951668332,0.0114156496422591,0.0138738218680053,0.0586231684656612,0.00149964339512509
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39502,-0.0131311748813684,0.00414168684317649,-0.0212488810939943,-0.00501346866874248,0.00152487369897468
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,39308,0.0193795592758081,0.00611899527194794,0.00738632854279017,0.0313727900088261,0.00154271070314234
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,39654,0.0185892659849972,0.0058765015273818,0.00707132299132889,0.0301072089786656,0.00156286738837266
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,39123,0.0208123610947607,0.00658066428769735,0.00791425909087395,0.0337104630986475,0.00156656860444499
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,37221,-0.0120032636012225,0.00379836325701873,-0.0194480555849792,-0.00455847161746582,0.00158075218610822
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,36955,0.02587441677164,0.00818944594343797,0.00982310272250159,0.0419257308207784,0.00158425779365755
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,39589,0.0123199826244361,0.00390432351547848,0.00466750853409831,0.0199724567147739,0.00160552609214268
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39151,0.0142394145095255,0.00451354144650441,0.00539287327437683,0.0230859557446741,0.0016092037325402
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,36690,0.0217247362477548,0.0068884465777913,0.00822338095528389,0.0352260915402258,0.00161552929494375
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37164,0.0380466287362626,0.0120744826415251,0.0143806427588733,0.0617126147136518,0.00163093081440421
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,39622,0.0149034499443845,0.00473055130743479,0.00563156938181235,0.0241753305069567,0.001633258920351
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,37164,0.0209588887957097,0.00665863016601915,0.0079079736703122,0.0340098039211073,0.00164981606382511
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,36847,0.00703488413093481,0.00223502352567616,0.00265423802060954,0.0114155302412601,0.00165026124550921
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,38859,-0.0102335391543349,0.00325275427080527,-0.0166089375251132,-0.00385814078355658,0.00165791689759644
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,39104,-0.0108087680209463,0.00344066387135156,-0.0175524692087954,-0.00406506683309725,0.00168432358833039
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,37146,0.0241283522899471,0.00768054348940756,0.00907448705070826,0.0391822175291859,0.00168476670909027
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,39623,0.0139212076874942,0.00444041841629054,0.00521798759156476,0.0226244277834237,0.00172116495496137
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39462,0.0274169163737792,0.00874844363061969,0.0102699668577646,0.0445638658897938,0.00172820490102573
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,39601,-0.0356717280141683,0.011383600369616,-0.0579835847386156,-0.0133598712897211,0.00173001428915849
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36763,0.0387124102319535,0.0123876411471473,0.0144326335835449,0.0629921868803622,0.00178167870265875
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,36955,0.0154137775383801,0.00493230348564992,0.00574646270650623,0.0250810923702539,0.00178171536746035
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39526,-0.0112728107538157,0.00360937558058189,-0.0183471868917562,-0.00419843461587516,0.00179233420649884
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,38967,-0.0211511697913981,0.00678000710963186,-0.0344399837262765,-0.00786235585651965,0.00181427878083456
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39428,0.00836773309281381,0.00268375652006575,0.00310757031348494,0.0136278958721427,0.001824784207353
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37221,-0.0107892149725664,0.00346048486329084,-0.0175717653046164,-0.00400666464051633,0.00182590587410681
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39123,-0.0119444964982525,0.00383680763978792,-0.0194646394722368,-0.00442435352426814,0.00185467870008372
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,39428,-0.0138498906978717,0.00445890893314462,-0.0225893522068351,-0.00511042918890821,0.00189916136643151
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39123,0.0344369512164759,0.011088356019319,0.0127037734186107,0.0561701290143411,0.00190200075953221
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36533,0.0289282393653956,0.00933685278318716,0.0106280079103487,0.0472284708204424,0.00195090211738263
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,39485,-0.0094731231025361,0.0030636288302141,-0.0154778356097557,-0.00346841059531645,0.00199092961936078
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39485,-0.0106772519849525,0.00345408167057377,-0.0174472520592771,-0.0039072519106279,0.00199714845208776
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39427,-0.0185770928145199,0.006012426778051,-0.0303614492994998,-0.00679273632953989,0.00200669971792221
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39497,0.0107069230338631,0.0034746103169301,0.00389668681268006,0.0175171592550461,0.00206350132810934
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37221,-0.0100389919899771,0.00325811910945417,-0.0164249054445072,-0.00365307853544691,0.00206590682425711
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39477,0.00904042921319192,0.00293862965379427,0.00328071509175516,0.0148001433346287,0.00209886252828731
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39462,0.0125641568529433,0.00408647921842218,0.00455465758483586,0.0205736561210508,0.0021118638584734
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,39516,0.00787019608810401,0.00256035525493666,0.00285189978842815,0.0128884923877799,0.002116800493242
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,39415,-0.0189068809060954,0.00616486311784606,-0.0309900126170737,-0.00682374919511716,0.00216693398699098
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39541,0.00754976983595854,0.00246600586860005,0.00271639833350244,0.0123831413384146,0.002205905016087
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,37243,0.0240512387791167,0.0078563729660693,0.00865274776562086,0.0394497297926125,0.0022078603902195
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37247,0.0187818254056471,0.00614606454997363,0.0067355388876988,0.0308281119235954,0.0022484015930109
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,39462,-0.0141223934268753,0.00463422804523128,-0.0232054803955286,-0.00503930645822202,0.00231223716701556
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,36916,0.0200972967314303,0.00660375953312119,0.00715392804651272,0.0330406654163478,0.00234477440614419
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39455,0.0072468945599004,0.00238210093429569,0.00257797672868085,0.01191581239112,0.00235239611713469
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39520,-0.0169821960094153,0.00558304510438964,-0.027924964414019,-0.00603942760481161,0.00235616014977929
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39418,0.0114535370141546,0.00377058242927086,0.00406319545278377,0.0188438785755255,0.00238877746441396
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37164,-0.0136970838570681,0.00451068273127251,-0.0225380220103622,-0.00485614570377393,0.00239757185891777
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,39601,-0.0120273034331679,0.00396111104360168,-0.0197910810786272,-0.00426352578770859,0.00239871363947601
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,39462,-0.0187808978334424,0.00618560023605654,-0.0309046742961132,-0.00665712137077156,0.00239968261311415
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,39485,-0.00683054115202302,0.00225057750821031,-0.0112416730681152,-0.0024194092359308,0.00240933284468352
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,39589,-0.0081769056221947,0.00269687384572405,-0.0134627783598138,-0.00289103288457555,0.00243354937142177
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,39654,0.00596592366527299,0.00196899090568372,0.0021067014901329,0.00982514584041308,0.00245013599579576
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37164,0.0305807516719126,0.0101042547681576,0.0107764123263237,0.0503850910175015,0.00247879734989921
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,39213,-0.0145546585352725,0.00480994368649055,-0.023982148160794,-0.00512716890975105,0.00248278534300878
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,36847,-0.014435048889866,0.00477211275490258,-0.0237883898894751,-0.00508170789025698,0.00249244692013622
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,39166,-0.0114046649760339,0.00377412120135409,-0.0188019425306879,-0.00400738742137984,0.00251702853689941
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37229,0.012690161953342,0.00420854292148217,0.00444141782723695,0.0209389060794471,0.00257200784071786
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39428,-0.0142709760257182,0.00474877603826483,-0.0235785770607172,-0.00496337499071909,0.00265854017111396
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37164,0.0153418922425965,0.00510602178600185,0.00533408954203287,0.0253496949431601,0.00266390453000508
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,36847,0.00987388833847277,0.00329180969436458,0.0034219413375182,0.0163258353394273,0.00270931895959473
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,39319,0.00815273608649707,0.0027184666892386,0.00282454137558941,0.0134809307974047,0.0027129774152316
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,39654,0.00717766554450882,0.00239362162682134,0.00248616715593898,0.0118691639330787,0.00271605407586146
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39455,0.0312568420295218,0.0104396693469089,0.0107950901095803,0.0517185939494633,0.0027575391170137
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,37162,0.0182295790405784,0.00608890187097998,0.00629533137345765,0.0301638267076992,0.00275963796448625
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,39104,-0.013464892672814,0.00449796376413475,-0.0222809016505181,-0.00464888369510994,0.00276209648275491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,39066,0.0197728640074502,0.00661817719012995,0.00680123671479549,0.0327444913001049,0.00281588800145146
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,37162,-0.0103000347354224,0.00345451389999424,-0.0170708819794111,-0.00352918749143372,0.00287274618876558
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,39636,0.0105916402557138,0.00355758256728047,0.0036187784238441,0.0175645020875836,0.00291351704295244
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,37203,0.0238590659988196,0.00801904375584088,0.00814174023737149,0.0395763917602677,0.00293250249660607
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,37203,0.0257057449133004,0.00864485092856301,0.00876183709331691,0.0426496527332839,0.00294943949730861
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39433,0.022914022385279,0.00770627644583762,0.00780972055143727,0.0380183242191207,0.00294966730517973
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,37164,-0.0144640995053855,0.0048651477641724,-0.0239997891231634,-0.00492840988760757,0.00295454423989457
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,37241,0.00578015968585925,0.00194507347987594,0.00196781566530241,0.00959250370641609,0.00296714545756439
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,39477,0.00601558189496955,0.00202747271440494,0.00204173537473586,0.00998942841520324,0.0030116053127759
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39485,-0.00736061590910852,0.00248334262256322,-0.0122279674493324,-0.0024932643688846,0.00304149080236572
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,36992,0.0164126881797045,0.0055390588744808,0.00555613278572215,0.0272692435736869,0.00305146906669738
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39428,0.00581666618516667,0.00196325242561477,0.00196869143096172,0.00966464093937161,0.00305363057965129
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,39636,-0.00879297131013032,0.00296829375216203,-0.0146108270643679,-0.00297511555589274,0.00305824927622104
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,39510,-0.00722796983769968,0.00244136710404229,-0.0120130493616226,-0.00244289031377678,0.00307495215206982
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,39423,-0.0164660118268139,0.00556281853508394,-0.0273691361555784,-0.0055628874980494,0.0030810866782061
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,37197,0.0215930173396824,0.00729473616435521,0.00729533445754614,0.0358907002218186,0.00308123302771294
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39428,0.00528243751633723,0.00178582190299757,0.00178222658646199,0.00878264844621246,0.00310139253188041
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37164,0.037722249546283,0.0127546437523231,0.0127231477917298,0.0627213513008363,0.00310684483712432
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37221,0.0245736062782933,0.00831222649763382,0.00828164234293106,0.0408655702136556,0.00311902687848638
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,39636,0.00878977696568719,0.00297459973941488,0.00295956147643403,0.0146199924549404,0.00313205472345688
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,36763,0.0244285683060193,0.00827423370722644,0.0082110702398555,0.0406460663721831,0.00315943936459832
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",39104,-0.0128615615838464,0.00435852764097418,-0.0214042757601558,-0.00431884740753699,0.00317355239111413
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,39531,0.00705998465607591,0.00239374865593737,0.00236823729043867,0.0117517320217132,0.00318939754188448
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39420,0.00747994307749535,0.00253631646986198,0.00250876279656588,0.0124511233584248,0.00319156104231916
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,39654,0.00709627548853161,0.0024088625661155,0.00237490485894523,0.011817646118118,0.00322501657611254
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,39601,0.0156548080646235,0.00531823404918582,0.00523106932821927,0.0260785468010277,0.00324900552939765
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39516,0.0195720995662718,0.00665069933566201,0.00653672886837426,0.0326074702641693,0.00325687663800857
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37247,0.0229373183696111,0.00780150227349066,0.00764637391356942,0.0382282628256528,0.00328676778210633
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37162,0.0240366172077827,0.00817630373382207,0.00801106188949145,0.040062172526074,0.00329025848295455
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,39485,-0.0137181281105726,0.00466690345023817,-0.0228652588730394,-0.00457099734810578,0.0032929578478679
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39104,0.0286686625237284,0.00978565475698661,0.00948877920003468,0.0478485458474222,0.00339853955347125
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,39355,0.00871942180966137,0.00297793571719334,0.00288266780396242,0.0145561758153603,0.00341656575867035
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,36893,0.00868311801663138,0.00296675410685684,0.00286827996719197,0.0144979560660708,0.00343080606626435
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,39187,-0.00919087712378492,0.00314213880312538,-0.0153494691779107,-0.00303228506965918,0.00344938631015863
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,37162,0.00856401048660239,0.00293007085292767,0.00282107161486416,0.0143069493583406,0.00347510948142773
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,37255,0.0230740454883755,0.00789531387040646,0.00759923030237889,0.0385488606743722,0.00347842308669509
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39462,0.0244686390171256,0.00837704814775612,0.00804962464752363,0.0408876533867276,0.00349525562852239
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,36990,-0.0106482547120716,0.00364658054180814,-0.0177955525740156,-0.00350095685012764,0.00350580804868304
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37164,0.0221465889928345,0.00758782460774511,0.00727445276165407,0.0370187252240149,0.00352109832603888
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,37162,-0.0101966461901139,0.00349502532963188,-0.0170468958361924,-0.00334639654403543,0.0035349673993231
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,36861,0.0166278735822044,0.00570007843284176,0.00545571985383452,0.0278000273105742,0.00353901057594447
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39079,0.0136735803858547,0.00469623368019218,0.00446896237267799,0.0228781983990314,0.00360119391817534
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,39424,0.0200556896980813,0.00689847875673108,0.0065346713348884,0.0335767080612742,0.00365141978955017
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37221,0.0159242958357226,0.00547964405771194,0.00518419348260721,0.026664398188838,0.0036661420735458
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,39462,0.0123469974701576,0.00425052496333072,0.00401596854202936,0.0206780263982858,0.00368004060742243
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39564,0.0070639565078966,0.00243216096308312,0.00229692102025368,0.0118309919955395,0.00368496504002744
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39123,0.0213856337951081,0.00736324582920497,0.00695367196986633,0.0358175956203498,0.00368535173222061
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,37117,0.00731188524469671,0.00251774018352155,0.00237711448499447,0.012246656004399,0.00368892739953624
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,36928,0.0257927552535725,0.00888178216509833,0.0083844622099798,0.0432010482971652,0.00369066478505797
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,39601,-0.0166960903624571,0.00575122055163077,-0.0279684826436535,-0.00542369808126083,0.00370078840090972
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37203,0.00777933450129001,0.00268336414943281,0.0025199407684017,0.0130387282341783,0.00374876763239283
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39123,0.0147862925359268,0.00510073147509906,0.0047888588447326,0.0247837262271209,0.00375080379871117
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39104,0.00699220506579757,0.00241438453260733,0.00226001138188721,0.0117243987497079,0.00378437623130546
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39123,-0.010280232285877,0.00355020845656882,-0.0172386408607518,-0.00332182371100207,0.00378908454872881
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,36880,0.0260199627157086,0.00900045357400619,0.00837907371065649,0.0436608517207608,0.00384730773329118
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39485,0.0211342012735092,0.00731303541685528,0.0068006518564728,0.0354677506905455,0.00385871856649142
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37221,0.0213559380579737,0.00739325393309331,0.00686516034911077,0.0358467157668365,0.00387647331026351
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,39654,0.0221330877712264,0.00766262018983459,0.00711435219915057,0.0371518233433021,0.00387693295094776
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,39541,0.0109001663872404,0.00377662034680919,0.0034979905074944,0.0183023422669864,0.00390449455268041
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,39354,0.00720846172511681,0.00249767708735232,0.00231301463390625,0.0121039088163274,0.00390650024039042
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37164,0.0227028182903381,0.00786614793159357,0.00728516834441466,0.0381204682362615,0.00390652925542005
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,36880,0.0229878028399867,0.00796760091688498,0.00737130504289219,0.0386043006370813,0.00391887667303953
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,36955,-0.0104376284879256,0.00361834463290695,-0.0175295839684232,-0.00334567300742797,0.00392528550747393
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,36955,0.0313040318638043,0.0108539988722026,0.0100301940742871,0.0525778696533214,0.00393202619286534
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,39194,0.0084614854196321,0.00293724488851595,0.00270448543814083,0.0142184854011234,0.00397294762471892
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,39552,0.0172258360165831,0.00601428686313542,0.00543783376483768,0.0290138382683285,0.00418702687145199
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39426,0.0144576255421205,0.00504793518670518,0.00456367257617835,0.0243515785080627,0.00418820540073167
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37162,-0.0163048077621706,0.00569672688852575,-0.027470392463681,-0.0051392230606601,0.00421483487268833
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,36992,0.0102392409480123,0.0035795686772792,0.00322328634054511,0.0172551955554796,0.00423715363159075
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39462,-0.0199930935348478,0.00699064288947848,-0.0336947535982257,-0.00629143347147001,0.00424253097293902
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,39654,-0.0142203795619948,0.00497487872886567,-0.0239711418705715,-0.0044696172534181,0.00426311714456005
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,39608,0.00798578597647696,0.00279627794305987,0.0025050812080796,0.0134664907448743,0.00429783874918429
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,39414,0.0218638084118933,0.00765700542014966,0.00685607778839997,0.0368715390353866,0.00430418733173099
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,39428,-0.0170966444878987,0.0059893611971795,-0.0288357924343705,-0.00535749654142687,0.00431635136884743
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,39455,0.00589087177503333,0.00206730079991723,0.00183896220719557,0.0099427813428711,0.00438410917279466
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,39463,0.0128474327999126,0.00450948919740095,0.00400883397300675,0.0216860316268185,0.00439196486327543
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39068,0.011703750806686,0.00410888454838837,0.00365033709184483,0.0197571645215272,0.00440008545754323
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,36861,-0.0150477341920921,0.00529180048641388,-0.0254196631454633,-0.00467580523872092,0.00446806894489855
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37221,0.017671023537058,0.00621878521370587,0.00548220451819446,0.0298598425559215,0.00449651414668494
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",36847,0.0122428525883263,0.00430911557506165,0.00379698606120552,0.0206887191154472,0.00450241842377537
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,39458,-0.00735107139493782,0.00259226707039295,-0.012431914852908,-0.00227022793696763,0.00457766138215114
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37203,0.00872981145396341,0.00308016399187636,0.00269269002988574,0.0147669328780411,0.00460122611607806
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,39636,0.0101909181389133,0.00360451891007785,0.00312606107516068,0.0172557752026658,0.00470093492312991
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39418,0.00705565274918045,0.00249576638785043,0.00216395062899361,0.0119473548693673,0.0047041524824795
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,37203,-0.0157291786438387,0.00557259433981529,-0.0266514635498767,-0.00480689373780076,0.00477104126332011
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,39485,0.0162575664773683,0.00576203640766819,0.00496397511833863,0.0275511578363979,0.00478628148138712
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,36955,-0.0133494691063889,0.00473200325959497,-0.0226241954951951,-0.00407474271758277,0.00479342397111449
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37162,-0.011702387255551,0.00414842980432532,-0.0198333096720286,-0.00357146483907336,0.00479604099133239
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,36955,-0.00645327450388681,0.00228918445451532,-0.0109400760347368,-0.00196647297303679,0.00482450633245596
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,37243,-0.00890495010011979,0.00316328090128549,-0.0151049806666393,-0.00270491953360023,0.0048836690979942
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39485,0.0189743939861285,0.00674615002862607,0.00575193993002137,0.0321968480422356,0.00492025410605209
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,36916,-0.00546673157885546,0.00194383000275372,-0.00927663838425275,-0.00165682477345816,0.00492577362825912
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39428,0.00952600356296842,0.00339199473201209,0.00287769388822472,0.0161743132377121,0.00498561815744529
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,39564,0.0170683648264123,0.00608397405741433,0.00514377567388021,0.0289929539789444,0.00503085357354502
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,37203,0.00893638143468528,0.00319142770985354,0.00268118312337234,0.0151915797459982,0.00511604068307269
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39123,0.00983308908809907,0.00351497918168119,0.00294372989200395,0.0167224482841942,0.00515698210336001
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,39531,0.0167119462364298,0.00598188979000225,0.00498744224802543,0.0284364502248342,0.00521653401780642
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,39654,-0.00713672550743835,0.00255643555802615,-0.0121473392011696,-0.0021261118137071,0.00525021726628737
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,39526,0.0140667871991688,0.0050389708051314,0.00419040442111122,0.0239431699772263,0.0052514266534741
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39123,0.0131959936142134,0.00472893888521138,0.00392727339919906,0.0224647138292277,0.00526984434040806
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,36880,-0.0136862124902507,0.00490846913419733,-0.0233068119932775,-0.00406561298722395,0.00530683853368728
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39428,0.00578775511279556,0.00207583565324412,0.00171911723243709,0.00985639299315404,0.00530757374968253
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39291,-0.0142929164256162,0.00512925171419284,-0.0243462497854341,-0.00423958306579819,0.00533400520825338
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37221,0.0114687670530148,0.00412126335045105,0.00339109088613074,0.0195464432198989,0.00539665169339072
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39485,-0.00674102745368315,0.00242470882897545,-0.011493456758475,-0.00198859814889128,0.00544031950678006
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,36992,0.0176738985926785,0.00635869683449313,0.00521085279707196,0.030136944388285,0.00545263501384868
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,37085,-0.00648410961834345,0.00233376547906317,-0.0110582899573073,-0.00190992927937964,0.00547097219971809
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,39636,0.0141245915845133,0.00509467755133413,0.00413902358389843,0.0241101595851282,0.00557088079098422
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,39636,0.00209234102542786,0.000755152691013525,0.000612241751041351,0.00357244029981437,0.00559949644657093
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,39462,0.0163362625518479,0.00590281469265101,0.00476674575425194,0.0279057793494439,0.00565506867728568
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,37221,0.0246791621670672,0.00892276122929371,0.0071905501576515,0.0421677741764828,0.00568534241699509
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,39104,0.0171120953493773,0.00618718695747752,0.00498520891272131,0.0292389817860332,0.00568664494370263
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,39636,0.0134312601217446,0.00485654178448355,0.00391243822415686,0.0229500820193324,0.00568865144120051
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,39390,-0.0186869704393427,0.00676868045363119,-0.0319535841284598,-0.00542035675022554,0.00577303897201209
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,39428,0.0132082926953295,0.00479516796177702,0.00380976349024651,0.0226068219004124,0.00588527440577921
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,39208,0.012837157076692,0.00466690158487888,0.00369002997032934,0.0219842841830546,0.00595440330570788
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,36775,0.0130561614895737,0.004752305255279,0.00374164318922682,0.0223706797899205,0.0060169549587726
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36642,-0.0117503326191992,0.00427786735298057,-0.0201349526310411,-0.00336571260735725,0.00602730381375295
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37247,0.00646656459789634,0.00235521465173256,0.00185034388050052,0.0110827853152922,0.00604778780280038
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,36823,0.0115599224876769,0.00421292238063436,0.00330259462163351,0.0198172503537202,0.00607978013421061
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,39509,0.00928250543120266,0.00338392698463942,0.00265000854130941,0.0159150023210959,0.00609310988454187
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39455,0.0185214534170444,0.00675426375670351,0.00528309645390554,0.0317598103801833,0.00611039652657477
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,37243,0.00671660520080349,0.00245471744967052,0.00190535899944926,0.0115278514021577,0.00622384315885567
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,39485,0.00851687146776469,0.00311367160565746,0.00241407512067607,0.0146196678148533,0.00623937534392408
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,39104,-0.00848149410521403,0.00310372428332763,-0.0145647937005362,-0.00239819450989187,0.00628961083568198
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,37055,0.0146369268469521,0.00535644521504917,0.00413829422545576,0.0251355594684485,0.00629275695520567
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37164,0.015208574300989,0.0055730830273295,0.00428533156742316,0.0261318170345548,0.00636268452372963
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39123,-0.0137392052259027,0.00503858717181367,-0.0236148360826575,-0.00386357436914792,0.00640283206561507
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,36847,0.00869744848835375,0.00318978528101881,0.00244546933755688,0.0149494276391506,0.00640695829213879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,36992,0.0174588348296441,0.00641505611595989,0.00488532484236271,0.0300323448169255,0.00650681304007324
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,36847,0.00878712331078245,0.00323078221892914,0.00245479016168132,0.0151194564598836,0.00654098732876945
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,39462,0.0211621435417144,0.00778144221767338,0.00591051679507457,0.0364137702883542,0.00654428925734407
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,39319,-0.00814075648463936,0.00299614348466185,-0.0140131977145766,-0.00226831525470214,0.00659372569982727
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,39516,0.0203754563916866,0.00751318073184671,0.00564962215726705,0.0351012906261062,0.00669622682075599
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,36916,0.0148624215426318,0.00548152286196753,0.00411863673317548,0.0256062063520882,0.00670981894389317
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,39601,-0.0155235313990701,0.00573035558523765,-0.0267550283461358,-0.00429203445200428,0.00675622535558743
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39477,0.0118843214708529,0.00439524545520593,0.00326964037864924,0.0204990025630565,0.00686072318286678
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,39123,0.0173671288546187,0.00642817688673415,0.00476790215661972,0.0299663555526176,0.00690612805643906
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,37269,0.00588325284503911,0.00217987321788167,0.00161070133799104,0.0101558043520872,0.00696609354336423
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,39623,0.0089294920590511,0.00330880850119787,0.00244422739670327,0.0154147567213989,0.0069687289794142
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,39182,0.00977701628901611,0.00362458630277289,0.00267282713558124,0.016881205442451,0.00699594984120393
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39428,-0.0186146881661942,0.00690795481692344,-0.0321542796073642,-0.0050750967250243,0.00705360618699361
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37247,-0.0152163064350898,0.00564705713307901,-0.0262845384159246,-0.00414807445425489,0.00705746894401956
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39531,-0.0105286360069032,0.0039109194192151,-0.0181940380685647,-0.00286323394524157,0.00710793287021726
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37162,0.0115099095455313,0.00427810982360514,0.00312481429126519,0.0198950047997973,0.00714555450344122
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,36955,0.0260182709381925,0.0096742039245549,0.0070568312460649,0.0449797106303201,0.00716652062039605
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,36847,0.00756131962629625,0.00281775894826739,0.00203851208769217,0.0130841271649003,0.00729632834802345
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37057,-0.0130319130209602,0.00486387620758038,-0.0225651103878177,-0.00349871565410264,0.00738661856435832
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,39601,0.013169614083173,0.00491542927479126,0.00353537270458215,0.0228038554617639,0.00738692246595569
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37203,-0.00509690601091646,0.00190395348478013,-0.00882865484108552,-0.00136515718074741,0.00743770665358173
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37221,0.0155749544836422,0.00581844662383258,0.00417079910093031,0.026979109866354,0.00744187339572024
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,37141,-0.00968741544313319,0.00362324813317417,-0.0167889817841546,-0.00258584910211182,0.0075119467863744
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,37243,-0.0159134100127076,0.00595849870090817,-0.0275920674664876,-0.00423475255892757,0.0075787209541695
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37164,-0.0111144045413747,0.00416875369963782,-0.0192851617926649,-0.0029436472900846,0.00768289843263232
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,39194,0.0214032403936114,0.00803845912417625,0.005647860510226,0.0371586202769969,0.0077622582074958
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39123,0.0111544233160273,0.00419496082691285,0.00293230009527811,0.0193765465367765,0.00784567979139036
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,39485,0.0293700620120459,0.0110535559050909,0.00770509243806776,0.051035031586024,0.00789065744019729
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,36823,0.0174191894718589,0.00656177382464623,0.00455811277555228,0.0302802661681655,0.00794931927285751
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,36928,-0.0083339478941711,0.00314018430622208,-0.0144887091343664,-0.00217918665397583,0.00796523027031236
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39104,0.0129166918303273,0.00487020300200447,0.00337109394639849,0.022462289714256,0.0080058240572899
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,39485,-0.0148132915792224,0.00558731442751789,-0.0257644278571575,-0.00386215530128736,0.0080281761491762
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,36847,-0.00825749270847115,0.00311519981136516,-0.0143632843387469,-0.00215170107819543,0.00804247370823279
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,36916,-0.0123962364573348,0.00468572423480889,-0.0215802559575602,-0.00321221695710935,0.00816647682584696
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,36847,0.0111344170584718,0.00421106404667269,0.00288073152699335,0.0193881025899503,0.00820149135243684
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,39474,0.017838564336302,0.00674937534339753,0.00460978866324287,0.0310673400093612,0.00822615494277103
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37209,0.0156638254933898,0.00592812985614565,0.00404469097534431,0.0272829600114353,0.0082448559782502
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,39428,-0.0128265755395188,0.00485569671536627,-0.0223437411016367,-0.00330940997740096,0.00826128553037892
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,39516,0.0119135446044623,0.00451698250552013,0.00306025889364287,0.0207668303152818,0.00836052273584883
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39428,-0.00487008615963903,0.00184824297354444,-0.00849264238778614,-0.00124752993149192,0.00842284832684557
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,39477,0.00587238438427785,0.00222987815701045,0.00150182319653737,0.0102429455720183,0.00845963580054864
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,36847,0.0165943686850347,0.00630323201714978,0.00424003393142111,0.0289487034386483,0.00848201356426068
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,39608,0.00478235025131221,0.00181956856921486,0.00121599585565108,0.00834870464697334,0.0085902340056813
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,37221,0.0074787902573074,0.00284700463844434,0.00189866116595649,0.0130589193486583,0.00862701243961017
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,37221,-0.005845877304234,0.00222554050161007,-0.0102079366873897,-0.00148381792107827,0.00863145562387605
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37164,0.00959615137954904,0.00365401277378844,0.0024342863429237,0.0167580164161744,0.00864487399105509
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,39608,-0.0103566565197554,0.00394900867020045,-0.0180967135133483,-0.0026165995261625,0.00873498344768386
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,36861,0.00827047040517339,0.00315672320910162,0.00208329291533422,0.0144576478950126,0.0088048632513517
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39485,-0.0165444318992386,0.00632092838812328,-0.0289334515399603,-0.00415541225851699,0.00886897828752279
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37221,0.0157275289603064,0.00601018830561907,0.00394755988129304,0.0275074980393198,0.00888599446312892
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39355,0.0238859400990972,0.00913708761370052,0.00597724837624421,0.0417946318219502,0.00895333394220889
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,39568,0.0117438249099236,0.00450282481055944,0.0029182882812271,0.0205693615386201,0.00911354433717309
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39104,-0.0119640320629106,0.00459090650150732,-0.020962208805865,-0.00296585531995627,0.00916915747815665
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37221,0.0167254197164124,0.00642401223972197,0.00413435572655733,0.0293164837062674,0.00923628998314376
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,36847,0.0264156212108724,0.0101632307455389,0.00649568894961618,0.0463355534721287,0.00935693997467002
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,39455,0.00563182554178071,0.00216812411020903,0.001382302285771,0.00988134879779041,0.0093981283972863
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,39432,0.0155525983028741,0.00599130608485703,0.00380963837655434,0.0272955582291939,0.00944462808628354
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39499,-0.00599950302031518,0.00231157190163287,-0.0105301839475156,-0.00146882209311475,0.00945667562165545
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,37203,0.0188207424051361,0.00725238996900023,0.00460605806589563,0.0330354267443765,0.00946692295359227
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,39568,0.0149834081049203,0.00577844738368551,0.00365765123289673,0.0263091649769439,0.00952394962616952
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,36861,-0.0101950855604155,0.00393457458124832,-0.0179068517396622,-0.00248331938116879,0.00957668600862091
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,39355,0.00753831583231531,0.0029093504590337,0.00183598893260927,0.0132406427320214,0.00957726845947459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,39636,0.0103050250093272,0.0039776070521348,0.00250891518714304,0.0181011348315114,0.00958558216697048
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39123,-0.00757796059908734,0.0029287335792987,-0.0133182784145128,-0.00183764278366188,0.00967836107163946
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,39531,0.0158800610194213,0.00614238474418368,0.00384098692082133,0.0279191351180214,0.00973801978656446
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,36847,0.0189426977877418,0.0073301207523226,0.00457566111318946,0.0333097344622941,0.00977107490773459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,37255,0.0185567632298421,0.00719063460673108,0.00446311940064922,0.0326504070590351,0.00987147598971033
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,39187,-0.0115005690582276,0.00445953641791928,-0.0202412604373494,-0.00275987767910579,0.0099219870228458
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,36992,0.0288332586075929,0.0111996304540848,0.00688198291758666,0.0507845342975991,0.0100503651168972
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,39428,0.0203113267616554,0.00789280722994562,0.00484142459096203,0.0357812289323488,0.0100800914745582
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37143,0.0156895819455844,0.0061043421009483,0.0037250714277257,0.027654092463443,0.0101743124949776
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39194,0.0109264464401429,0.00425494241204443,0.00258675931253578,0.0192661335677499,0.0102401815413493
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,36823,0.0257216047466809,0.0100166960634244,0.00608888046236915,0.0453543290309927,0.0102440943378975
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,36847,0.0147269355542504,0.00573536600137766,0.00348561819155017,0.0259682529169506,0.0102479693320337
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,36847,-0.00794540490175595,0.00309691842524568,-0.0140153650152375,-0.00187544478827443,0.0103118747202693
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39485,0.00692380523963348,0.00270636997856609,0.00161932008164395,0.012228290397623,0.0105271364803135
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39531,-0.00477620760400216,0.00186982293007295,-0.00844106054694515,-0.00111135466105917,0.0106479498725914
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39485,0.0176783721835898,0.00692147630552997,0.00411227862475105,0.0312444657424285,0.0106550259321501
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39123,0.0242381846831628,0.0095041232736456,0.00561010306681746,0.0428662662995082,0.0107736844140019
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39541,0.00574976774849684,0.00225473023007431,0.00133049649755119,0.0101690389994425,0.0107792684460552
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,39636,-0.00895672209651731,0.00351361889663762,-0.015843415133927,-0.00207002905910757,0.0108085031748172
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,39436,0.00765063298076374,0.00300519380579675,0.00176045312140212,0.0135408128401254,0.0109125792221561
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,39428,0.00629978294182238,0.00247623204043898,0.00144636814256198,0.0111531977410828,0.0109659146610399
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39194,-0.00968532749254326,0.00380733723235573,-0.0171477084679605,-0.00222294651712603,0.0109736638582951
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,36916,-0.0112331370924097,0.00442018313506524,-0.0198966960371375,-0.00256957814768179,0.0110552246387684
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,36648,0.0103826289310952,0.00409262119414936,0.00236109139056242,0.0184041664716279,0.0111957904018724
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,39355,0.0179183015468415,0.007069573400311,0.00406193768223196,0.0317746654114511,0.0112688116308093
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,37221,0.0164517408657732,0.00649908680535254,0.00371353072728219,0.0291899510042642,0.0113729533701681
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39462,0.0221249675975303,0.00874189008234392,0.00499086303613624,0.0392590721589244,0.0113867168506272
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,39636,0.00970623796013207,0.00383884387936457,0.00218210395657751,0.0172303719636866,0.0114675254946476
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,36847,0.0147490742293225,0.00583882193855077,0.00330498322976303,0.0261931652288821,0.0115481175215696
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37255,-0.0108888137919668,0.00431248943965387,-0.0193412930936884,-0.00243633449024522,0.0115834998110338
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39401,0.0229890546488275,0.00910588989187858,0.00514151046074545,0.0408365988369095,0.0115920890713692
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39433,0.0085820327315644,0.00340044518251754,0.00191716017383002,0.0152469052892988,0.0116197520208968
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,39654,0.00711578913955244,0.00282053638597959,0.00158753782303244,0.0126440404560724,0.0116509331343509
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,36880,0.0202400888149889,0.00802476783440017,0.00451154385956454,0.0359686337704132,0.0116746439325294
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39104,0.00665518417265813,0.00264658568171181,0.00146787623650299,0.0118424921088133,0.011926351382955
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39123,0.0108860799480068,0.00432983018923385,0.00239961277710849,0.0193725471189052,0.0119407255068295
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,39194,-0.0104568436420715,0.00416248590736587,-0.0186153160205086,-0.00229837126363434,0.0120099533266727
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39428,0.0124792109042354,0.00496904895417528,0.0027398749540518,0.0222185468544189,0.0120361759674293
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,39485,0.006068759691424,0.00241669524845319,0.00133203700445576,0.0108054823783922,0.0120431935763451
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39526,0.024117565037773,0.00961282653173427,0.0052764250355738,0.0429587050399721,0.0121213819738104
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39456,0.00982738217131969,0.0039183254837342,0.00214746422320065,0.0175073001194387,0.0121501901400138
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37247,0.016155033967384,0.00644720862824431,0.0035185050560252,0.0287915628787429,0.0122318317306444
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,36992,0.0165270987142277,0.00660094357993611,0.00358924929755292,0.0294649481309025,0.0123011585347735
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,39589,0.0209795326563524,0.00838195787793273,0.00455089521560428,0.0374081700971006,0.0123271153607856
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39104,-0.00583543059740735,0.00233351873906899,-0.0104091273259826,-0.00126173386883212,0.0124056408364463
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,36880,0.0257794704530151,0.010309518048154,0.00557281507863325,0.0459861258273969,0.0124128196903937
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,39440,0.00880337364713435,0.00352530052499505,0.00189378461814406,0.0157129626761246,0.0125285438213414
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39392,0.0134345030184833,0.00538027399855182,0.0028891659813217,0.0239798400556448,0.0125358452613014
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39309,0.00889765164123076,0.00356933804157265,0.00190174907974836,0.0158935542027132,0.0126847660252969
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39428,0.00918233705653458,0.0036843867534428,0.00196093901978668,0.0164037350932825,0.0127051263845295
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,39531,0.00665557525227707,0.00267058883509476,0.00142122113549134,0.0118899293690628,0.0127069921593681
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,39541,0.0199572160699148,0.00802918256034831,0.00422001825163214,0.0356944138881975,0.012944611968297
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,37164,0.0220981034315374,0.00889603709536153,0.00466187072462877,0.039534336138446,0.0130029373628273
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39462,0.022543013431273,0.0090800233277045,0.00474616770897219,0.0403398591535738,0.0130497693349871
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,36955,0.0177455971350756,0.00714788515536809,0.00373574223055412,0.031755452039597,0.0130544465478002
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36823,0.0132906294686896,0.00536045296301795,0.00278414166117442,0.0237971172762048,0.0131741149534719
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,39551,-0.00554853118699006,0.00223980093329735,-0.00993854101625287,-0.00115852135772726,0.0132510338507319
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37162,0.0204158218006114,0.0082517853476628,0.00424232251919233,0.0365893210820305,0.0133698285850225
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,39455,-0.00961941947898675,0.00389501723442468,-0.0172536532584591,-0.00198518569951437,0.0135347006756029
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,39541,0.0224915988820803,0.00911373457176898,0.00462867912141307,0.0403545186427475,0.0136026151081515
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",36847,0.0190234883842841,0.00771805036383394,0.0038961096711696,0.0341508670973986,0.0137222461326702
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",36916,0.0107255002467822,0.00435319832086865,0.00219323153787962,0.0192577689556847,0.0137598871644837
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,36823,0.00948934706849926,0.00385181388543183,0.00193979185305287,0.0170389022839457,0.0137682759690135
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37255,-0.00858849158809655,0.00348936251010065,-0.0154276421078938,-0.00174934106829928,0.0138551799204513
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",36847,0.00839533065612934,0.00341146892397168,0.00170885156514486,0.0150818097471138,0.013871899453967
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,36992,0.0149327379185968,0.00607389568547284,0.00302790237507006,0.0268375734621236,0.0139648768842848
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,39455,-0.00906074764802741,0.00368988931910453,-0.0162929307134723,-0.00182856458258253,0.0140777539190158
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39123,-0.0135319852882431,0.00551287023370242,-0.0243372109462999,-0.0027267596301864,0.0141150027287345
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36823,-0.0133414976726374,0.00543667941919468,-0.023997389334259,-0.00268560601101586,0.0141422034878769
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,39462,-0.0114387631474405,0.00467065644511036,-0.0205932497798568,-0.0022842765150242,0.0143339258438804
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,36916,-0.0127312093078348,0.00519836673310616,-0.0229200081047229,-0.0025424105109467,0.014335886400643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,39497,0.00599505780438899,0.00244850454462116,0.00119598889693153,0.0107941267118465,0.0143582955816006
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39355,-0.0102928576544663,0.0042053669136687,-0.018535376805257,-0.00205033850367567,0.014394461525087
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,39601,-0.00722402595954397,0.00295274199178283,-0.0130114002634383,-0.00143665165564962,0.0144344327591566
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37203,-0.0137415454859598,0.00562005409588172,-0.024756851513888,-0.00272623945803164,0.0144949824610792
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,36916,-0.0067381067022,0.00275580075540175,-0.0121394761827874,-0.00133673722161257,0.0144964261036901
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39462,0.00715106325215517,0.00292762904312,0.00141291032763997,0.0128892161766704,0.0145928357945606
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,36916,0.0118157097205616,0.00483881744216536,0.00233162753391747,0.0212997919072057,0.0146256582677089
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,36992,-0.00714390765652536,0.00292790120604297,-0.0128825940203696,-0.00140522129268113,0.0147033962017497
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,36595,0.00489885519216665,0.00200870169993046,0.000961799860302951,0.00883591052403035,0.0147496683716339
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37221,0.0083248788181533,0.00341487725003596,0.00163171940808282,0.0150180382282238,0.0147894040521097
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,39355,0.0213268822018356,0.00877484597662094,0.00412818408765855,0.0385255803160126,0.0150915327414528
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39541,0.00572719918760274,0.00236009164522194,0.00110141956296775,0.0103529788122377,0.01524910914125
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,36861,0.0129421000274131,0.00534236117556794,0.00247107212329994,0.0234131279315263,0.0154265216113266
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39123,-0.0129161054579855,0.00533474095140958,-0.0233721977227483,-0.00246001319322274,0.0154843620584851
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39487,0.0103930454928801,0.00431705268888331,0.00193162222266878,0.0188544687630914,0.0160767699539433
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,36880,-0.0074929291530494,0.00311613348520752,-0.0136005507840561,-0.00138530752204266,0.01620649382804
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39462,0.0110414255512212,0.00459691682993103,0.00203146856455634,0.020051382537886,0.0163213585203517
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,37122,0.0149371572156717,0.00622555516464466,0.00273506909296811,0.0271392453383752,0.0164394864505893
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,39485,0.0142103933239442,0.00592415267004625,0.00259905409065356,0.0258217325572349,0.0164645210010193
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39355,-0.0127034895613795,0.00529945723470018,-0.0230904257413918,-0.00231655338136711,0.0165362819364672
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39187,0.00436514585262481,0.00182489298860989,0.000788355594949435,0.00794193611030019,0.0167692527531777
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,36880,-0.00705635174471187,0.0029506548864377,-0.0128396353221298,-0.00127306816729397,0.0167966226391782
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,36916,-0.00680116757143542,0.00284990096758459,-0.0123869734679012,-0.00121536167496963,0.0170264019136007
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,37247,-0.00604922427494379,0.00253759650545697,-0.0110229134256395,-0.00107553512424812,0.01714753825922
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36763,-0.0114147912738458,0.00478902547453655,-0.0208012812039374,-0.00202830134375414,0.0171625027527483
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,39123,0.00645000204758859,0.00270742248802647,0.0011434539710567,0.0117565501241205,0.0172156489041969
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,39428,0.00586692631593175,0.00246270327624429,0.00104002789449294,0.0106938247373706,0.0172167433755366
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,37164,-0.0087985019562313,0.00369594347408145,-0.0160425511654309,-0.00155445274703167,0.0172998910644892
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39289,-0.0072857369162987,0.00306648460783446,-0.0132960467476542,-0.00127542708494316,0.0175176502005237
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37235,0.00992268180362901,0.00417925916101515,0.00173133384803932,0.0181140297592187,0.0175984567210152
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39462,0.0126688812827764,0.00533652516343199,0.00220929196244966,0.023128470603103,0.0176093195187864
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,39516,0.0171393474617679,0.00722421889265483,0.0029798784321644,0.0312988164913713,0.0176813881319249
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,39319,0.0157655973412096,0.00665786760070918,0.00271617684381965,0.0288150178385996,0.0178989491596198
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37203,0.0197984785649554,0.00837041851372635,0.0033924582780517,0.036204498851859,0.0180307718167032
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,36916,-0.0128847394824913,0.00546262007487812,-0.0235914748292524,-0.00217800413573015,0.0183539003095967
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,39462,0.0181863660181915,0.00771373161993481,0.00306745204311928,0.0333052799932637,0.0184032258501653
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,36847,0.0127685709876522,0.00542096967268934,0.00214347042918113,0.0233936715461233,0.0185180950343877
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,36992,0.0107585039764623,0.00457057332155473,0.00180018026621499,0.0197168276867095,0.0185947940473993
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36668,-0.00654348631343118,0.00278186096455878,-0.0119959338039664,-0.00109103882289596,0.0186786458834743
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39428,0.0150330862389808,0.00639375174997373,0.00250133280903232,0.0275648396689293,0.0187250965639071
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,39194,0.0298081881273757,0.0126817971531579,0.00495186570718627,0.0546645105475651,0.0187628059394368
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,39355,0.0114560272818901,0.00487907526301284,0.00189303976638494,0.0210190147973953,0.0188879530530947
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,36880,0.0154744252462594,0.00659376546550345,0.00255064493387261,0.0283982055586461,0.0189496686720504
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39194,-0.00651333970185456,0.00277568827893863,-0.0119536887285743,-0.00107299067513484,0.018960403533095
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,36861,-0.0143287414569899,0.0061148569368154,-0.026313861053148,-0.00234362186083167,0.0191314097082582
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,37203,-0.0126455836701866,0.00540029925131998,-0.0232301702027738,-0.00206099713759944,0.0192142790786789
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39428,0.00658197649547923,0.00281109255701994,0.00107223508372014,0.0120917179072383,0.0192230669576494
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,39531,0.0145424157900046,0.00622700641386438,0.00233748321883037,0.0267473483611787,0.0195367101419593
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,36894,-0.00836933953913196,0.00358654022644727,-0.0153989583829686,-0.00133972069529531,0.0196355999619096
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,38915,-0.0133110301225856,0.00570775231282918,-0.0244982246557308,-0.00212383558944042,0.0197092592816104
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,39391,-0.0114936906057161,0.0049370537840228,-0.0211703160224008,-0.00181706518903142,0.019922917312883
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,36993,0.00775335764853371,0.00333138112033887,0.00122385065266954,0.0142828646443979,0.0199613954221293
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,36637,0.00897441528779755,0.00385664728205335,0.00141538661497299,0.0165334439606221,0.0199816085826622
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,36823,0.0192860043641494,0.00829827486173166,0.00302138563515537,0.0355506230931435,0.0201363521515634
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,39123,-0.00933550712264837,0.00401974185654848,-0.0172142011614834,-0.00145681308381334,0.0202242353795376
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,39428,-0.0108593632001835,0.00467650259609421,-0.0200253082885281,-0.00169341811183879,0.020240241195076
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,36847,-0.0162184541296812,0.0069844115084174,-0.0299079006861793,-0.0025290075731831,0.0202440390286549
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36823,0.0200987517029593,0.00866181864250966,0.00312158716364041,0.0370759162422783,0.0203362563054181
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37162,-0.0102778518245926,0.00443006510164293,-0.0189607794238128,-0.00159492422537249,0.0203554036455585
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,39636,-0.00899479787152166,0.00387966682487554,-0.0165989448482777,-0.0013906508947656,0.0204383103145409
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39413,0.0179499173572946,0.00774223229146552,0.00277514206602216,0.033124692648567,0.0204387163935186
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,39455,0.0108210438812162,0.004667568984995,0.00167260867062599,0.0199694790918064,0.0204438523414163
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39104,0.00986795957612641,0.00425735238691286,0.00152354889777721,0.0182123702544756,0.0204704705004675
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36763,0.0129129292636664,0.00557836808783795,0.00197932781150402,0.0238465307158288,0.0206390405846748
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37221,0.0229573158985643,0.00991773106259244,0.00351856301588317,0.0423960687812455,0.0206410287091837
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37203,0.0215036174025038,0.00929185498689898,0.00329158162818178,0.0397156531768258,0.020670166714632
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,39455,0.00392295607404586,0.00169738651542035,0.000596078503821968,0.00724983364426975,0.0208367155963923
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,39589,-0.0131244742404234,0.00570661709379406,-0.0243094437442597,-0.00193950473658702,0.0214691580094781
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,38998,-0.0178168762719592,0.00775296640842199,-0.0330126904324663,-0.00262106211145213,0.021571801170026
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37164,0.0153282307642707,0.00667275076681312,0.00224963926131702,0.0284068222672245,0.0216270595823175
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,36823,0.00943529908153029,0.00410748851260123,0.00138462159683188,0.0174859765662287,0.0216298629113737
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,37255,-0.00815465022297674,0.00355539110618936,-0.0151232167911079,-0.00118608365484559,0.0218295238162491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,39582,-0.00399518952015888,0.00174231573510364,-0.00741012836096202,-0.000580250679355734,0.0218596887132269
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,36955,-0.0139636637579219,0.00610597760909346,-0.0259313798717451,-0.00199594764409871,0.022219216465429
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36823,0.0157647059060946,0.00689722505236148,0.00224614480346607,0.0292832670087231,0.0222910380310401
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39549,-0.014676055344246,0.0064240917423586,-0.0272672751592688,-0.00208483552922313,0.022353984326805
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37203,0.00950409089252074,0.00416142253640866,0.00134770272115976,0.0176604790638817,0.0223963454731409
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,39526,0.00607518510582694,0.00266614331859158,0.000849544201387453,0.0113008260102664,0.0227023014724291
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37164,0.00924911982865072,0.00405904336458549,0.00129339483406316,0.0172048448232383,0.0227046730060383
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39428,0.0166512865207757,0.00731158469564127,0.00232058051731881,0.0309819925242326,0.0227773342206106
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,39256,0.0133778136314879,0.00587718185699877,0.00185853719177029,0.0248970900712055,0.0228465031104064
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,39312,0.0131374265478553,0.00578292064391901,0.001802902085774,0.0244719510099365,0.0231150449965772
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,36880,0.0065597882779411,0.00288803339441741,0.000899242824882974,0.0122203337309992,0.0231416987787953
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,36861,0.011917534172595,0.00524780810892962,0.00163183027909294,0.022203238066097,0.0231667811214421
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,39299,0.0115586847170834,0.00509242594745481,0.00157752986007194,0.0215398395740948,0.0232352309076605
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39123,0.0134627514674111,0.00593260286144495,0.00183484985897897,0.0250906530758432,0.0232656093044039
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,36847,0.012291503998271,0.00542302653582319,0.00166237198805757,0.0229206360084845,0.0234355285913934
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,39462,0.0120046571648714,0.00530045856039322,0.00161575838650072,0.0223935559432421,0.0235370819949308
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,39477,0.0364370365602337,0.0160890075892435,0.00490258168531647,0.0679714914351508,0.0235442820372679
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39401,0.00535474215132934,0.00236462607520773,0.000720075043922184,0.00998940925873649,0.023556432287733
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37164,0.00997334868060534,0.00440598231652392,0.00133762334021846,0.0186090740209922,0.0236159717215181
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,36823,0.0143286455323979,0.00633158397940236,0.00191874093276924,0.0267385501320265,0.0236503083526389
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39365,0.00586232948570651,0.00259278501417085,0.000780470857931636,0.0109441881134814,0.0237725871907787
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37162,0.0155936496942657,0.00691414452223254,0.00204192643068995,0.0291453729578415,0.0241298127389752
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,39187,0.00652504983853632,0.00289420765710217,0.000852402830616062,0.0121976968464566,0.0241780785000419
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,37221,0.00596682912477842,0.00264966839705632,0.000773479066548033,0.0111601791830088,0.0243445376449395
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39531,0.0172717423362747,0.00768222722999727,0.00221457696548005,0.0323289077070694,0.0245731851487891
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,36916,-0.0081142181282775,0.00362342687042454,-0.0152161347943096,-0.00101230146224541,0.0251489741063558
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,36847,0.00558149815909842,0.00249363251440846,0.000693978430857832,0.010469017887339,0.0252191682715241
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,37224,-0.0109276242701077,0.00488508120739075,-0.0205023834365936,-0.00135286510362181,0.0253075717409821
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,39434,0.0133501291019583,0.00597394281369658,0.001641201187113,0.0250590570168036,0.0254499853676507
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39428,-0.0107059789093754,0.00479438506795871,-0.0201029736425744,-0.00130898417617629,0.0255620505779746
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,39019,0.0136014952997721,0.00609714153913025,0.0016510978830768,0.0255518927164674,0.0257096317757243
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37102,-0.00637316925087703,0.00286024467528607,-0.0119792488144377,-0.000767089687316333,0.0258853418434039
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,37247,0.0089975616611085,0.00404020385647064,0.00107876210242605,0.0169163612197909,0.0259641484912316
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,36847,0.00777205351417575,0.00349530368496455,0.000921258291645227,0.0146228487367063,0.0261953228317866
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,36955,-0.00542430687929994,0.00244303978462221,-0.0102126648571595,-0.00063594890144042,0.0264155573557715
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,36861,0.0076641930159208,0.00345316367634492,0.00089599221028476,0.0144323938215568,0.0264727795698629
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,39526,-0.00970109254852675,0.00437206354870841,-0.0182703371039952,-0.00113184799305827,0.0265095969475339
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,36847,0.0039052040445449,0.00176117878157281,0.000453293632662191,0.0073571144564276,0.0266151484788129
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39428,0.0108822340762238,0.00490863328597902,0.00126131283570492,0.0205031553167427,0.0266409194590498
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36823,0.00552494611218145,0.00249266430796916,0.000639324068561892,0.010410568155801,0.0266766150144866
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,39428,0.00566821960306564,0.00255764220305268,0.000655240885082386,0.0106811983210489,0.026693504635823
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,36992,0.00672024226084551,0.0030325106331531,0.000776521419865433,0.0126639631018256,0.0267048989737289
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39187,0.00662791405054996,0.00299623700549071,0.000755289519788176,0.0125005385813117,0.0269764628275929
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,39123,-0.0114813860991693,0.00519724024152914,-0.0216679769725665,-0.00129479522577223,0.0271809029391056
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,36847,-0.0090930609254725,0.00411615882077103,-0.0171607322141837,-0.00102538963676127,0.0271849864342148
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,39485,0.0232017332537125,0.0105218682602795,0.00257887146356471,0.0438245950438603,0.0274624180378505
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",36992,0.00946623996011635,0.00429393554650021,0.00105012628897593,0.0178823536312568,0.0275030543726827
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39433,-0.010529286531749,0.00478270801892594,-0.0199033942488438,-0.00115517881465411,0.0277135473494363
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,36955,-0.00623258128283929,0.00283303969753718,-0.0117853390900122,-0.00067982347566642,0.0278277799955611
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,39532,-0.0128429568714827,0.00584055808518601,-0.0242904507184473,-0.00139546302451815,0.0278982912268457
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39531,0.0182852161888098,0.00832292878999346,0.00197227576042257,0.0345981566171969,0.0280378227428867
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,36847,0.0210674580533973,0.00959812552889183,0.00225513201676931,0.0398797840900253,0.0281852717527653
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,36992,0.0166005714859348,0.00756540043122881,0.00177238664072632,0.0314287563311433,0.0282338998189788
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37203,-0.00509826233350734,0.00232363482360254,-0.00965258658776833,-0.000543938079246352,0.0282469677725777
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,36880,0.0146502838728196,0.00667797554839803,0.0015614517979595,0.0277391159476798,0.0282667215598104
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39123,-0.0133851172020183,0.00611515604581902,-0.0253708230518236,-0.00139941135221299,0.0286239507282891
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,39428,0.0149671675032845,0.00685000699568869,0.00154115379173462,0.0283931812148343,0.0289053370785442
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,37164,0.012751632457726,0.00583983954898472,0.00130554694171597,0.0241977179737361,0.0290129108641439
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,36861,0.00612726839150095,0.00280743552764672,0.000624694757313368,0.0116298420256885,0.0290902751813491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,39495,0.0202247038389769,0.00926693103833694,0.00206151900383647,0.0383878886741173,0.0290910326817735
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37162,0.0156208119364893,0.00716422100358775,0.00157893876945734,0.0296626851035213,0.02924667675367
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39123,-0.0100426485645666,0.0046099580001476,-0.0190781662448559,-0.00100713088427731,0.0293870349211158
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37247,-0.00500080194816375,0.00229698028561575,-0.00950288330797061,-0.000498720588356881,0.0294898219740399
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37203,-0.00597872651065477,0.00275158757581572,-0.0113718381592536,-0.000585614862055966,0.0298116177963699
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,38827,0.00429016582995959,0.00197490109307028,0.00041935968754184,0.00816097197237734,0.0298459625672995
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,39123,0.0107066959298328,0.00492901438421806,0.00104582773676544,0.0203675641229002,0.0298582099449017
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36823,0.0117056253919863,0.00538940596951832,0.00114238969173035,0.0222688610922422,0.0298768949356576
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,39654,0.00785708232476928,0.00361782911807686,0.000766137253338642,0.0149480273961999,0.0298886415801953
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,36955,-0.0118232176623687,0.00544631821488717,-0.0224980013635476,-0.00114843396118988,0.0299601845282636
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36823,0.010812796169442,0.00500155741376274,0.00100974363846701,0.020615848700417,0.0306460889913126
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,37255,0.00979866562126424,0.00453403683260762,0.000911953429353306,0.0186853778131752,0.0307033944246658
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,36948,-0.00593660981004249,0.00274807101737297,-0.0113228290040935,-0.000550390615991476,0.0307697543198367
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37162,0.00847543246470147,0.00392582877681038,0.000780808062153123,0.0161700568672498,0.0308773572568014
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37221,-0.00906912095171193,0.00420746564801312,-0.0173157536218177,-0.00082248828160621,0.0311426800975071
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,39428,-0.00608416533527251,0.00282402966464141,-0.0116192634779697,-0.000549067192575349,0.0312226107272744
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,37269,0.00570810378890108,0.00265220997046397,0.000509772246791702,0.0109064353310105,0.0313997007341986
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,38989,-0.0110653587628908,0.00514195438463952,-0.0211435893567842,-0.000987128168997318,0.0314157160306006
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,39589,0.00849172225700145,0.00394948118762318,0.000750739129260011,0.0162327053847429,0.0315642438651243
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,37165,0.00527983850693417,0.0024578354250411,0.000462481073853624,0.0100971959400147,0.0317194066581791
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,37162,0.0202222852548809,0.0094221099078306,0.00175494983553296,0.0386896206742289,0.0318712193931993
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,36916,-0.0488943659308545,0.0227872419348232,-0.0935573601231079,-0.00423137173860098,0.0319169451351244
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,36916,0.00524002869382142,0.00244607203381779,0.000445727507538542,0.0100343298801043,0.0321949600382498
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,39462,-0.0171131176184572,0.00799874275285603,-0.032790653414055,-0.00143558182285941,0.0324132234896792
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37162,-0.00847645722923222,0.00396702807961541,-0.0162518322652784,-0.00070108219318602,0.0326392153556576
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39309,-0.00554729345729472,0.00260031119728396,-0.0106439034039713,-0.000450683510618151,0.0329148975442874
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,39636,0.0067722678244194,0.00317767684231587,0.000544021213480296,0.0130005144353585,0.0330886077557067
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,37221,0.01014151175119,0.00476041582131686,0.000811096741408938,0.019471926760971,0.0331590152558131
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,36955,0.0112840439798966,0.0052980351847806,0.000899895017726679,0.0216681929420666,0.0332031016346353
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,36916,-0.0112481234022587,0.00528308713873899,-0.0216029741941872,-0.00089327261033032,0.0332670600779584
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,39623,-0.00375173280180135,0.00176515238661897,-0.00721143147957453,-0.000292034124028168,0.0335656809967645
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37203,0.00736854336403093,0.00346860842586823,0.000570070849329194,0.0141670158787327,0.0336599530381693
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,37162,-0.00813899268932724,0.0038351474504152,-0.015655881692141,-0.000622103686513453,0.033839295850637
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,39601,-0.0109001041442268,0.00513813082481174,-0.0209708405608578,-0.000829367727595839,0.0339031455364872
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,37221,0.00694222161708788,0.0032729072939225,0.000527323320999782,0.013357119913176,0.0339311128539028
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39554,0.00517559059058307,0.00244072268968734,0.000391774118795872,0.00995940706237026,0.0339788403823946
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,39654,0.00358962797924054,0.00169289184609577,0.000271559960892842,0.00690769599758825,0.0339874751887926
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,36823,-0.00724583709442558,0.00341806469541934,-0.0139452438974475,-0.000546430291403686,0.0340372524803453
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39537,-0.0191531945712296,0.00904856568533046,-0.0368883833144773,-0.00141800582798189,0.0343007471197229
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39485,-0.00650419525103641,0.00307743976683157,-0.0125359771940263,-0.000472413308046526,0.0345736937263489
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,39601,-0.00579239348000022,0.00274344283034703,-0.0111695414274804,-0.000415245532520029,0.0347577763080773
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,36955,-0.00575433654938182,0.00272723028569844,-0.0110997079093508,-0.000408965189412876,0.0348819406165998
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,39541,0.00610251541134577,0.00289765287338231,0.000423115779516445,0.0117819150431751,0.035219074374645
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,39495,0.0169650305217648,0.00805872457582923,0.00116993035313953,0.0327601306903901,0.0352925602586574
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,39428,0.0035061747802808,0.00166675169266695,0.000239341462653567,0.00677300809790803,0.0354302008639921
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39194,0.00804273425261695,0.0038272212465475,0.000541380609383839,0.0155440878958501,0.0356179487269825
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,36880,0.0161409075999874,0.00769263867486748,0.00106333579724717,0.0312184794027277,0.0359051703164075
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,36847,0.00622146074658316,0.00297123205360306,0.000397845921521159,0.0120450755716452,0.0362892131114076
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,39457,0.0039976314892053,0.00191171243618019,0.000250675114292127,0.00774458786411847,0.0365335513969792
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,39329,-0.00617799403977001,0.00295704270131376,-0.011973797734345,-0.000382190345195049,0.0367023979799769
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36763,-0.00753442585816005,0.00360847398765421,-0.0146070348739623,-0.00046181684235781,0.0368200318449844
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,36847,0.0107740801042978,0.00516759831783845,0.000645587401334448,0.0209025728072612,0.0370960806485811
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,39482,0.00689915725837595,0.00332072369716236,0.00039053881193772,0.0134077757048142,0.0377625500565524
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,39462,0.0101755011300152,0.00490281040615602,0.000565992733949435,0.019785009526081,0.0379625307316292
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,39104,0.0130874538657491,0.00631377274476165,0.000712459286016251,0.0254624484454819,0.0382044188670922
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",36847,0.00950733616996582,0.00459399734736566,0.000503101369129124,0.0185115709708025,0.0385186662199874
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,39123,0.00878403255029014,0.00424766049402928,0.000458617981992758,0.0171094471185875,0.0386603731071254
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,36861,0.0214175764475922,0.0103735268737831,0.00108546377497731,0.0417496891202072,0.0389780061925233
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,36847,0.0127582876135315,0.00619875221860374,0.000608733265068181,0.0249078419619948,0.0395915524831478
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,36847,0.0129986868952979,0.00632095944834446,0.000609606376542718,0.025387767414053,0.0397608125050305
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39462,-0.0152581272656257,0.00742010832647115,-0.0298015395855092,-0.000714714945742235,0.0397688002753487
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,39581,-0.00614283260968224,0.00298736744888145,-0.0119980728094899,-0.000287592409874598,0.0397736599992967
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37164,0.00986013002729666,0.00479706988727603,0.000457873048235646,0.0192623870063577,0.0398560888130039
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37164,0.0087408995308879,0.00425501123867443,0.000401077503086019,0.0170807215586898,0.0399709318195233
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,36861,-0.0109559395849311,0.00533367733345425,-0.0214099471585014,-0.000501932011360715,0.0399863176266154
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,36955,0.00526493535995364,0.00256405726257936,0.000239383125298088,0.0102904875946092,0.0400583288531868
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,36880,-0.0100069682970773,0.00487874358713035,-0.0195693057278528,-0.000444630866301848,0.0402745887053055
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,36955,-0.00378480998366022,0.00184551603405925,-0.00740202141041635,-0.000167598556904085,0.040305868652457
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39485,0.0102973861333032,0.00502126458906577,0.000455707538734303,0.0201390647278721,0.0403080582849949
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,36955,-0.00445259233061261,0.00217210627542774,-0.00870992063045099,-0.000195264030774227,0.0403953768266384
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,37162,0.0109328119020887,0.00533703646116983,0.000472220438195838,0.0213934033659816,0.0405334959109179
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,36861,0.0233371225001439,0.0113972923066558,0.000998429579098511,0.0456758154211893,0.040619986429049
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,36916,0.0120795634963576,0.00590130879531043,0.000512998257549123,0.023646128735166,0.0406859254582378
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,39455,0.00835741831503891,0.00408479007704159,0.00035122976403739,0.0163636068660404,0.0407752651972926
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39428,0.00959025417226792,0.00469360523222044,0.000390787917115857,0.01878972042742,0.0410442064473014
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,39428,0.0159641478833106,0.00782844839365318,0.000620389031750417,0.0313079067348709,0.0414427985287589
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,39194,0.0105633886199714,0.00518079864205922,0.000409023281535279,0.0207177539584074,0.0414728328836596
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,39499,-0.00866277709204414,0.00425306889749368,-0.0169987921311317,-0.000326762052956529,0.0416845770539732
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,36916,0.0168340014819544,0.00826633886247436,0.000631977311504626,0.0330360256524041,0.041726091635682
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39485,-0.00563107922072054,0.00276728113512,-0.0110549502455557,-0.000207208195885348,0.0418806695523849
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",36916,0.0170908082891913,0.00842689262143562,0.000574098751177497,0.0336075178272051,0.0425685148128688
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39485,0.00557679658305268,0.00275153509593867,0.00018378779501289,0.0109698053710925,0.0427010339351765
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,39592,-0.00410010340229261,0.00203158957893293,-0.00808201897700115,-0.000118187827584072,0.0435906349581906
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39485,0.00858735259148469,0.00426014669668758,0.000237465065977027,0.0169372401169924,0.0438448183373619
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,36880,0.00733842130741996,0.00364076265750947,0.000202526498701398,0.0144743161161385,0.0438604248447561
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,36847,0.0171050748558003,0.00848722434787909,0.000470115133957328,0.0337400345776434,0.0438852485006887
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,37243,0.00422016238470158,0.0020956505557286,0.00011268729547352,0.00832763747392964,0.0440543784968229
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,36992,0.00602257415170446,0.00299245943101876,0.00015735366690769,0.0118877946365012,0.0441798126720782
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39330,0.00425461715515202,0.00211431583884101,0.000110558111023644,0.00839867619928039,0.0442073369772013
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,36992,0.00613654305098352,0.00305212603480822,0.000154376022759402,0.0121187100792076,0.0443912237925293
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",36916,0.00805905171213351,0.004008513970871,0.000202364329226356,0.0159157390950407,0.0444015267680803
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,36955,0.0146480867944753,0.0072956828985298,0.000348548313356935,0.0289476252755937,0.0446887233002267
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,36992,0.00725855340687964,0.00361537244964013,0.000172423405584995,0.0143446834081743,0.0446974706461427
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,35538,-0.0181992290445689,0.00906878934143867,-0.0359740561537887,-0.000424401935349126,0.0447954029315204
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36823,0.00745128795968272,0.00371926643785675,0.000161525741483482,0.014741050177882,0.0451529816738369
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,36992,0.0128660156368336,0.00642437692699717,0.000274236859919133,0.025457794413748,0.0452323914368298
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,39194,0.0107367601466318,0.00536184828198,0.000227537513951008,0.0212459827793126,0.0452560986761926
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39258,0.0305348370567411,0.0152535574265107,0.000637864500780225,0.060431809612702,0.0453225812888201
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,36823,0.00956724405908937,0.00477939717208678,0.000199625601799275,0.0189348625163795,0.0453314903001669
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,36861,0.00719429677568323,0.00359572519661538,0.00014667539031709,0.0142419181610494,0.0454365963797108
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,36955,0.0151222459120821,0.00755881137287749,0.000306975621242192,0.029937516202922,0.0454558424887886
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,36823,0.00867266532836648,0.00433788075108696,0.000170419056236033,0.0171749116004969,0.04559922463311
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,39355,0.022729414318182,0.0114111347474349,0.000363590213209624,0.0450952384231543,0.0464043355104505
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39485,0.00466205907923032,0.0023421566430857,7.14320587823425e-05,0.0092526860996783,0.046554135370858
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,36861,-0.00513319429218384,0.00257995717640007,-0.010189910357928,-7.64782264396921e-05,0.04665216415175
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,39104,0.0107055661435721,0.00538854495839195,0.000144018025123833,0.0212671142620203,0.0469712858619537
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36763,0.00523877359647959,0.00263840225496807,6.75051767421797e-05,0.010410042016217,0.0471015013357241
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39531,0.0144850202706119,0.00730119378149005,0.000174680458891404,0.0287953600823324,0.0472823130000518
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39462,0.00650274447936185,0.00328085644884522,7.22658396252168e-05,0.0129332231190985,0.0474944817583636
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,36847,-0.0116743789571318,0.00590068926740575,-0.0232397299212471,-0.000109027993016583,0.0478970055309
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,39654,0.00395043459239935,0.00199693809616035,3.64359239250663e-05,0.00786443326087364,0.0479189979279612
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,36968,-0.0110310898591921,0.00558227276378593,-0.0219723444762125,-8.98352421716819e-05,0.048166174792958
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,36835,-0.0118189463501072,0.00598394643671213,-0.023547481366063,-9.04113341514533e-05,0.0482779559515573
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",36992,0.0122829051180589,0.00621976101420575,9.21735302155877e-05,0.0244736367059021,0.0483105399662104
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,36763,0.0126933521593697,0.00643837347558527,7.41401472225747e-05,0.0253125641715168,0.0486873153374477
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,39513,0.00678161426619181,0.00344360346012072,3.2151484355202e-05,0.0135310770480284,0.048932753674813
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,36968,0.0087163135933376,0.00443150602194252,3.05617903302614e-05,0.0174020653963449,0.0492172035619357
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,39541,0.0107054280458533,0.00545452322931545,1.45625163950145e-05,0.0213962935753116,0.0497028996571672
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,37255,0.00421832649303477,0.00215189648471489,6.09382993597279e-07,0.00843604360307595,0.0499843552094489
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39194,-0.0119338699684827,0.00608931157027343,-0.0238689206462186,1.18070925326022e-06,0.0500372701032224
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,37162,0.00979758733820136,0.00500487217179017,-1.19621185073818e-05,0.0196071367949101,0.0502976547173074
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,39104,0.0114970427199767,0.00587323338329677,-1.44947112850208e-05,0.0230085801512383,0.0503039000475088
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,37196,-0.00437406383281942,0.00223649898985183,-0.00875760185292901,9.47418729016752e-06,0.050514799235109
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39431,-0.0107915326674354,0.00552495806640083,-0.021620450477581,3.73851427102109e-05,0.0508105362575516
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39187,-0.0156730377722832,0.0080242922291138,-0.0314006505413462,5.45749967798895e-05,0.0508149461871354
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,37241,0.00611084965094777,0.00313031675365775,-2.45711862214126e-05,0.012246270488117,0.0509421208222798
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,36972,0.00519807418989836,0.00267046650641504,-3.6040162675127e-05,0.0104321885424718,0.0516165449576014
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39386,0.00451920708774217,0.00232230300329571,-3.2506798717421e-05,0.00907092097420177,0.0516731904729559
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,39355,0.00722053188890904,0.00371173519058029,-5.44690846283188e-05,0.0144955328624464,0.0517546339274017
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,37162,-0.0109642303513252,0.00563712855185545,-0.0220130023129619,8.45416103114963e-05,0.0517966751830326
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,36955,0.0143834158832867,0.00739654444078366,-0.000113811220649252,0.0288806429872227,0.0518439770677081
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,37269,0.00441685029239161,0.00227193084551785,-3.61341648233695e-05,0.00886983474960659,0.0519058008781626
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39287,0.00641558737928821,0.00330542203536896,-6.30398100349566e-05,0.0128942145686114,0.0522858835752974
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,39123,0.0124919823428763,0.00643871766923948,-0.00012790428883311,0.0251118689745857,0.0523824067345246
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37164,0.0128603905292962,0.0066340491407085,-0.00014234578649249,0.0258631268450848,0.052579099282815
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,39462,0.00655746484275768,0.00338513000730946,-7.73899715688659e-05,0.0131923196570842,0.0527471841766889
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,36847,0.00833675249966095,0.00430697344739106,-0.000104915457225529,0.0167784204565474,0.0529344520368114
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,36955,0.00365698663126701,0.00188948827871504,-4.6410395014468e-05,0.00736038365754848,0.0529591404729691
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39123,-0.00908881134117446,0.00469632120766797,-0.0182936009082037,0.000115978225854765,0.0529721396045991
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,39589,0.00583916768166005,0.00302232239012673,-8.45842029883392e-05,0.0117629195663084,0.0533764778628076
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37162,-0.00807705358261704,0.00418143815102332,-0.0162726723586227,0.000118565193388678,0.0534255560993474
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,39355,-0.00880005432593844,0.00455610101838999,-0.0177300123219828,0.000129903670105937,0.0534416728580997
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,36757,-0.0104156272090496,0.0053981303817983,-0.0209959627573743,0.000164708339275043,0.053693285438154
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,39418,0.00687847838017107,0.00356722404040308,-0.000113280739018972,0.0138702374993611,0.0538436771595703
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,37255,0.00786833683628198,0.00408217570284535,-0.000132727541294909,0.0158694012138589,0.0539411779464614
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39462,0.0187323531573741,0.00972094156680616,-0.000320692313566014,0.0377853986283141,0.0539972166690087
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,36861,0.0134258939170158,0.00696999885262303,-0.000235303834125315,0.0270870916681569,0.0540971687379541
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,36847,0.00812029161737571,0.0042233810826475,-0.000157535304613392,0.0163981185393648,0.0545407199485421
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,36861,0.00651988980270243,0.00339742069435625,-0.000139054758235824,0.0131788343636407,0.0549983239066311
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,39654,0.00494758448569361,0.00258071343059644,-0.000110613838275404,0.0100057828096626,0.0552390897554908
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,36880,0.00674996073388042,0.00352403886400641,-0.000157155439572143,0.013657076907333,0.0554638313741963
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,36880,-0.00728078017371115,0.00380440519711185,-0.0147374143600504,0.000175854012628075,0.0556717012402536
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,39641,0.00565602202752308,0.00295817348270407,-0.000141997998576898,0.0114540420536231,0.0558952332047988
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39531,0.01518220966736,0.00794163979087156,-0.000383404322748238,0.0307478236574683,0.0559307593179145
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,36992,0.0121635827347888,0.00636663822939946,-0.000315028194834172,0.0246421936644117,0.0560892162758584
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,37162,0.0128768585557281,0.00674055170523528,-0.000334622786533064,0.0260883398979892,0.0561097731652287
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,36880,0.00576099659051748,0.0030175511968321,-0.000153403755273437,0.0116753969363084,0.0562640945744641
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,36992,0.0175572959646923,0.00920555339278506,-0.000485588685166443,0.035600180614551,0.0565109860193674
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,39477,-0.00597602513302274,0.0031346702066805,-0.0121199787381165,0.000167928472071052,0.0566136708730555
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,39455,-0.0042421870549226,0.00222700511867401,-0.00860711708752367,0.000122742977678461,0.0568142168300754
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,36847,0.0111105049253617,0.00583942612428511,-0.000334770278237089,0.0225557801289605,0.0571066792178283
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,36847,0.00671871062226897,0.00353226840037164,-0.000204535442459452,0.0136419566869974,0.0571818729762434
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,36992,0.0104462262277448,0.00549906791288311,-0.000331946881506085,0.0212243993369957,0.0575038527189736
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39455,0.00438897655034109,0.00231127043947224,-0.000141113511024493,0.00891906661170667,0.0575908101392049
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,39507,0.00504446312095007,0.00265944930133693,-0.000168057509670314,0.0102569837515704,0.0578724833308013
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,39589,0.00861267716089375,0.00454591614597781,-0.000297318485222764,0.0175226728070103,0.0581649094618652
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39427,0.00369689599981355,0.0019539307586747,-0.000132808287188863,0.00752660028681597,0.0585062306501718
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,37269,0.00515568160463341,0.00272629049682725,-0.000187847769148005,0.0104992109784148,0.0586338371503839
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37164,0.00473494830773525,0.00250914409227152,-0.000182974113116942,0.00965287072858743,0.0591727232989862
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,39374,0.00837598204031502,0.00444265676631255,-0.000331625221657583,0.0170835893022876,0.0594014300223632
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,36861,-0.00759467999539217,0.00403043384750856,-0.0154943303365089,0.000304970345724598,0.0595432838331209
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37164,-0.00536253993832341,0.0028524095928095,-0.01095326274023,0.000228182863583207,0.0601304536331181
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39187,0.005425871473616,0.00288972176787575,-0.000237983191420474,0.0110897261386525,0.0604494886602188
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,36916,0.0165981261432534,0.0088508565296656,-0.00074955265489118,0.033945804941398,0.0607730384914882
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39123,-0.00810964761119902,0.00433841162545824,-0.0166129343970972,0.000393639174699126,0.0616056500133374
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37247,-0.0120345859563872,0.00644863441004082,-0.0246739094000672,0.000604737487292813,0.0620331172437042
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,39455,0.00435557213755951,0.00233481165931316,-0.000220658714694288,0.0089318029898133,0.0621319954837789
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39187,0.012175731452606,0.00653579959889064,-0.000634435761219626,0.0249858986664317,0.0624921207844551
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,36861,-0.0117934095463609,0.00635056998016553,-0.0242405267074854,0.000653707614763495,0.0633258464144056
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39477,0.00614732913767311,0.00331152445708893,-0.000343258798221184,0.0126379170735674,0.0634240780233384
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,39104,-0.00526801635073544,0.00283914614679622,-0.010832742798456,0.000296710096985147,0.0635458982806453
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,36847,0.00828173721832821,0.00446510258524232,-0.000469863848746735,0.0170333382854031,0.0636528435526609
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,39423,-0.00459858772728773,0.00248076631862086,-0.00946088971178462,0.000263714257209168,0.0638022566665184
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,36992,0.0179808946579955,0.00970975307131471,-0.00105022136178133,0.0370120106777723,0.0640725048328818
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,37203,0.0218189267661815,0.0117833601408222,-0.00127645910982991,0.0449143126421929,0.0640959327116857
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,36847,0.00694642934447118,0.00375331686634385,-0.000410071713562763,0.0143029304025051,0.0642301410362055
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,36880,0.00713774711438765,0.00386615984163624,-0.000439926175219375,0.0147154204039947,0.0648853271428089
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,39355,0.0154767632664856,0.00840838059712269,-0.00100366270387492,0.031957189236846,0.0656948696876498
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,37162,-0.00931260323305769,0.00506456103124066,-0.0192391428542894,0.000613936388174001,0.065971166392116
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,36880,0.0149231792412772,0.00812062775185331,-0.000993251152355266,0.0308396096349097,0.0661322669684348
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39449,0.00581062694823394,0.00316215405656145,-0.000387195002626503,0.0120084488990944,0.0661480117990141
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,37255,0.00490242733698983,0.00267039004429462,-0.000331537149827615,0.0101363918238073,0.0664034774131652
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,39499,0.00536736182051686,0.0029253073759966,-0.000366240636436481,0.0111009642774702,0.0665546612041288
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,36880,0.0145399528592115,0.00792941470967094,-0.00100169997174354,0.0300816056901666,0.0667264639560551
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,39589,0.0105088451461013,0.00573787690913567,-0.000737393595804662,0.0217550838880072,0.0670475755728477
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39187,-0.0134894941617837,0.00737162950687715,-0.0279378879952629,0.000958899671695566,0.0672820556981744
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,36861,0.0127012438830192,0.00694570905716775,-0.000912345869029623,0.026314833635068,0.0674766298036431
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,36880,-0.0043335128858983,0.00236988880165078,-0.00897849493713383,0.000311469165337225,0.0674876680395059
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,36992,0.0106580388939946,0.00582869850404741,-0.000766210173938298,0.0220822879619275,0.0674915034079985
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,39636,-0.0097001177423374,0.00531256572862195,-0.0201127465704364,0.000712511085761623,0.0678876787653631
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,39654,0.00498296743874297,0.0027292751019138,-0.000366411761008084,0.010332346638494,0.067907898527975
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,39601,-0.00713583101708628,0.00391275888105274,-0.0148048384239496,0.000533176389777081,0.0682120042293384
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,39617,0.00756564376999164,0.00414902396792486,-0.000566443207141078,0.0156977307471244,0.0682510711797059
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,36847,-0.00625317618645606,0.0034419319153606,-0.0129993627405628,0.000493010367650712,0.0692774782385281
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39571,0.00548848059990619,0.00302219212735634,-0.000435015969712231,0.0114119771695246,0.0693810486103146
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,39404,-0.00773550816577678,0.00426746641854514,-0.0160997423461252,0.000628726014571688,0.0699027873238347
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,36823,0.012453388406241,0.00687873706587459,-0.00102893624287316,0.0259357130553552,0.0702552637088868
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,39104,0.00596401262005858,0.00330029050946547,-0.000504556778493748,0.0124325820186109,0.0707644695382985
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,37241,0.00230477523158195,0.00127566848007239,-0.000195534989359934,0.00480508545252383,0.0708295059736187
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37221,0.010890264128777,0.00603726077326206,-0.000942766986816647,0.0227232952443706,0.0712796486881824
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39455,0.00587031262852476,0.00325872707055086,-0.000516792429754931,0.0122574176868044,0.0716579112862837
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,36853,0.00425894875352721,0.00237021251458506,-0.000386667775059499,0.00890456528211392,0.0723815901424976
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,36861,0.00501445295916135,0.00279081720730958,-0.000455548767165433,0.0104844546854881,0.0723966596266296
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39355,-0.00848358083682871,0.00472793204233603,-0.0177503276398073,0.000783165966149909,0.0727770435857609
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,39654,-0.00827424990005054,0.00461313100164644,-0.0173159866632776,0.000767486863176479,0.0728921213209324
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,37221,-0.00463644091005453,0.00258821303472926,-0.00970933845812389,0.000436456638014832,0.0732580021313102
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",36957,-0.0102476715689751,0.00573001951397053,-0.0214785098163573,0.000983166678407135,0.0737327518064471
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37221,0.0182666981237461,0.0102298500601304,-0.00178380799410951,0.0383172042416018,0.0741833710057285
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,36880,0.00539587606108937,0.00302697718053587,-0.000536999212760941,0.0113287513349397,0.0746765675478093
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39485,-0.00996307669685172,0.00559087452084258,-0.0209211907577032,0.00099503736399973,0.0747653766658048
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,39462,0.00404781653661693,0.00227178893119675,-0.000404889768528692,0.00850052284176256,0.0748061555843603
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',36847,0.00669852700850027,0.0037632672698151,-0.000677476840337324,0.0140745308573379,0.0751043112464901
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,37241,0.00422853408759242,0.00237727193811677,-0.000430918911116458,0.00888798708630129,0.075307153281008
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37203,0.0139883965101489,0.00787697611232871,-0.00145047667001538,0.0294272696903132,0.075780053996431
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,39415,0.00731903903832491,0.00412770001870974,-0.000771252998346171,0.015409331074996,0.0762238817132966
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,39194,-0.0049718102015746,0.00280701807446411,-0.0104735656275243,0.000529945224375064,0.0765469345327662
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,37203,0.0107754085334955,0.00609239903815098,-0.0011656935812804,0.0227165106482714,0.0769738211088056
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,36916,0.0110501926191526,0.00625676995107909,-0.00121307648496241,0.0233134617232676,0.0774005677637934
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39428,0.0211587763805068,0.0120017841360179,-0.00236472052608829,0.044682273287102,0.0779260680386391
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37269,0.00292058474534529,0.00165920906880702,-0.00033146502951648,0.00617263452020705,0.0783931600428917
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,39636,0.00829708569985216,0.004718912548346,-0.000951982894906001,0.0175461542946103,0.0787230454079452
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,36916,0.00458633166709147,0.00261086484634844,-0.000530963431751481,0.00970362676593441,0.0790049169903499
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,39608,0.00747863730223233,0.00425889270250485,-0.000868792394677183,0.0158260669991418,0.0791077343505658
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39104,0.00761288851685054,0.00433612026449127,-0.000885907201552362,0.0161116842352534,0.0791620306755718
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,36861,0.0106048592592036,0.00604127733023776,-0.0012360443080624,0.0224457628264696,0.079215555082556
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37162,0.00880084890751728,0.00502158802347068,-0.00104146361848525,0.0186431614335198,0.0796943311260536
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39403,-0.0115516212093637,0.00659252921807324,-0.0244729784767873,0.00136973605805982,0.079754928737986
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,36763,-0.00787323771105772,0.00449335388321589,-0.0166802113221609,0.000933735900045423,0.0797649669761925
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,36847,-0.00707043321628503,0.00403796949950323,-0.0149848534353114,0.000843987002741289,0.0799728369482892
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37162,0.00839282126076149,0.00480476188195504,-0.00102451202787039,0.0178101545493934,0.0807011313078442
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,37709,-0.00479443917812633,0.00274504541360551,-0.0101747281887931,0.000585849832540461,0.080733519652578
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39531,0.00528198317215612,0.00302769987924871,-0.000652308591171348,0.0112162749354836,0.0810830664063188
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,36847,0.0128393436090285,0.0073679622145374,-0.00160186233146482,0.0272805495495218,0.0814299078767163
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37203,0.0360766195551763,0.0207044926936682,-0.00450418612441339,0.0766574252347661,0.0814531980056142
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,39194,0.00714278552754028,0.00409970706675062,-0.000892640323290933,0.0151782113783715,0.0814825378350449
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39415,0.00522254767414335,0.00300144225047576,-0.000660279136789139,0.0111053744850758,0.0818773455037122
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,36916,0.0116242852535542,0.00668117949590945,-0.00147082655842834,0.0247193970655367,0.0819091205538793
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39531,0.00933464567810344,0.0053670024594247,-0.00118467914236897,0.0198539704985758,0.0820083657099472
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,37203,-0.010091977246322,0.00580628288952368,-0.0214722917097884,0.00128833721714444,0.0822150002339397
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39123,0.00764687137306416,0.00440029524401913,-0.000977707305213341,0.0162714500513417,0.0822655095028877
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,36955,0.0107289593576145,0.00618087923350286,-0.00138556394005114,0.0228434826552801,0.0826184261464894
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,39194,-0.00625928306680365,0.00360937830687461,-0.0133336645482779,0.000815098414670585,0.0829084604878804
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,36992,0.00558353413522428,0.0032234591233858,-0.000734445746611891,0.0119015140170605,0.0832703760758318
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,39187,0.0109440978227396,0.0063312636706288,-0.00146517897169282,0.0233533746171721,0.0839051810605744
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,36847,0.00586586607317202,0.00339440494897737,-0.000787167626823613,0.0125188997731677,0.0839954737562068
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,39187,0.00675355088843636,0.00391064820564964,-0.000911319594636946,0.0144184213715097,0.0841949844821995
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,37243,-0.0108634921224195,0.00629081237654903,-0.0231934843804555,0.00146650013561663,0.0842129590427941
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37203,0.00980494774816195,0.0056811818883783,-0.00133016875305951,0.0209400642493834,0.0843960941119062
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,39079,0.0134512948865063,0.00780637587964026,-0.00184920183758861,0.0287517916106012,0.0848885988271484
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,37269,0.00297203816710676,0.00172938492676936,-0.000417556289361196,0.00636163262357471,0.0857201018151046
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,36847,0.00979789744249846,0.00570734264659174,-0.00138849414482136,0.0209842890298183,0.0860557063337329
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39104,0.0112696332135365,0.00656724715240764,-0.00160217120518249,0.0241414376322555,0.086176573543335
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,39589,0.0053024504093711,0.00309061593512708,-0.000755156823477967,0.0113600576422202,0.0862445001794594
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,36880,0.0160015158397126,0.00933136666920871,-0.00228796283193651,0.0342909945113616,0.0864050961964772
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,36916,0.00620248317178649,0.00361899621760602,-0.000890749414721311,0.0132957157582943,0.0865777658284287
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37269,-0.00291808398954392,0.00170269022098222,-0.00625535682266906,0.000419188843581222,0.086588187327377
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,39589,0.00960683247005595,0.0056067448757655,-0.00138238748644443,0.0205960524265563,0.0866517200961421
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39103,-0.00421966100323898,0.00246321101485132,-0.00904755459234757,0.000608232585869603,0.086720213351009
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,39194,0.0118525125865759,0.00692026098263189,-0.00171119893938259,0.0254162241125344,0.0867839429020349
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,37269,0.00410589071634737,0.00240075578476566,-0.00059959062179332,0.00881137205448805,0.0872439983604109
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37247,0.0131282883279383,0.00767666497174557,-0.00191797501668297,0.0281745516725597,0.0872614258026137
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,36823,0.00686469395993291,0.00401426248468487,-0.00100326051004944,0.0147326484299153,0.0872768939766929
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,39462,0.0124334324198392,0.00727626377294726,-0.0018280445751374,0.0266949094148158,0.0875149692920335
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39104,0.0126770413875171,0.0074197035283039,-0.00186557752795854,0.0272196603029927,0.0875528452224335
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,36848,-0.00424387734460353,0.00248389592897746,-0.00911231336539936,0.000624558676192294,0.0875581058341306
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,39123,0.0102402842727264,0.00599399209237021,-0.0015079402283192,0.021988508773772,0.0875787161504633
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,36880,0.00751815848147942,0.00440551729065368,-0.00111665540820178,0.0161529723711606,0.0879339609174735
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,36861,0.0129861134229047,0.00762165446455108,-0.00195232932761546,0.0279245561734248,0.0884351940840448
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39194,0.00596075362575246,0.00350098051676164,-0.000901168187100355,0.0128226754386053,0.0886648765447788
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,36861,0.0151990770514748,0.00892709322647271,-0.0022980256724117,0.0326961797753613,0.0886720199743112
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,36847,0.00779751728869669,0.00458388529982591,-0.0011868978989621,0.0167819324763555,0.0889546174986525
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39123,0.0113554203765897,0.00667847637762997,-0.00173439332356507,0.0244452340767444,0.0890955085274041
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37203,0.00801249310878185,0.00471676891063481,-0.00123237395606238,0.0172573601736261,0.0893954124848004
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,36847,0.00584131887329816,0.00344044663731277,-0.00090195653583487,0.0125845942824312,0.0895635617686226
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39355,-0.0103437996943843,0.00609592066290325,-0.0222918041936747,0.00160420480490609,0.0897478681081392
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39506,0.0176992677844787,0.0104331767580649,-0.00274975866132857,0.0381482942302859,0.0898230877350092
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39068,0.00709424114594065,0.00418261811050468,-0.00110369035064853,0.0152921726425298,0.089883595970349
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,39636,-0.00749494674943348,0.00442241744798407,-0.0161628849474823,0.0011729914486153,0.0901410107655994
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36823,0.0134628345975482,0.00794812655819498,-0.00211549345651396,0.0290411626516104,0.090321344633029
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39123,-0.00780829287239148,0.00461199121275927,-0.0168477956493996,0.00123120990461669,0.0904687843171064
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",36847,0.00721737828430435,0.00426539076682966,-0.00114278761868178,0.0155775441872905,0.0906560401267265
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,36916,0.0150271537083453,0.00888661943149396,-0.00239062037738282,0.0324449277940735,0.0908643778627152
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39247,0.00306278716954756,0.00181252050067822,-0.000489753011781749,0.00661532735087686,0.0910883448410355
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,36880,0.0117205482589825,0.00693631651167224,-0.00187463210389506,0.0253157286218601,0.0911034282796508
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36823,0.0159848486392489,0.00946215792409622,-0.00256098089197964,0.0345306781704775,0.0911785439769109
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,37247,-0.00516019769566153,0.00305542042160454,-0.0111488217220064,0.000828426330683367,0.0912693510710518
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,39104,0.00907897029894584,0.00537767741642459,-0.00146127743724636,0.019619218035138,0.0913807332338434
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39123,0.0118432570341716,0.00701695414047535,-0.00190997308116013,0.0255964871495032,0.0914697381344744
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,39309,0.0102000128268386,0.00604740658021013,-0.00165290407037329,0.0220529297240504,0.0916867501748209
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,37243,0.00686470451507458,0.00407354112113063,-0.00111943608234145,0.0148488451124906,0.091975661844035
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,36880,0.00564032643783258,0.0033470272869588,-0.000919847044606659,0.0122004999202718,0.091979934317957
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,39496,0.00688445898278834,0.00408646470880867,-0.00112501184647666,0.0148939298120533,0.0920675920079626
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39123,-0.00667295492879243,0.00396379148190607,-0.0144419862333283,0.00109607637574347,0.0923039102986413
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,36823,0.0109983164617771,0.00653922174935633,-0.00181855816696126,0.0238151910905156,0.0926134893959264
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,36992,0.012531571485643,0.00745616063631954,-0.00208250336154331,0.0271456463328293,0.0928460455722593
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39498,0.00397809211389186,0.00236790213550529,-0.000662996071698506,0.00861918029948223,0.0929767177380108
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39455,0.00855886347547803,0.00509687486264316,-0.00143101125530257,0.0185487382062586,0.0931265861407208
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,36861,0.00730392733242803,0.00435222972273154,-0.00122644292412579,0.0158342975889819,0.0933325515130533
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37162,0.0124550380162299,0.00743744412435064,-0.00212235246749735,0.0270324284999571,0.0940295782142707
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,39321,-0.00683450091669494,0.00410880708537568,-0.0148877628040313,0.0012187609706414,0.0962577902832467
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39123,0.00484090295960515,0.00291047576022533,-0.000863629530436488,0.0105454354496468,0.0962800392057283
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,39485,-0.00505812923748447,0.00304555018735645,-0.0110274076047031,0.000911149129734162,0.096769231662651
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,37203,-0.00543334694880497,0.00327154140555046,-0.0118455681036839,0.000978874206073927,0.0967799892666568
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,39589,0.00315086563324529,0.00189774066389165,-0.000568706067982346,0.00687043733447294,0.0968698686343571
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36823,0.0117279974543641,0.00706637743312452,-0.00212210231456001,0.0255780972232881,0.0970021357866367
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,39455,-0.00664424910996701,0.00400562118755728,-0.0144952666375793,0.00120676841764526,0.0971908589200724
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,39342,0.00650070343830428,0.00392913943743682,-0.00120040985907188,0.0142018167356804,0.0980500245970481
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37255,0.00511244268193172,0.00309346688632873,-0.000950752415272591,0.011175637779136,0.0984250141236732
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,36916,0.0132963542785537,0.00805415069880242,-0.00248978109109908,0.0290824896482064,0.0987903543308016
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39428,0.00314173691509262,0.00190372990085105,-0.000589573690575441,0.00687304752076069,0.0989013316044561
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37162,0.00979317264741093,0.00594167299661999,-0.00185250642596426,0.0214388517207861,0.0993326518218704
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,37162,-0.00556585928950208,0.00337722839914578,-0.0121852269518278,0.00105350837282365,0.0993660332685903
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39440,0.00405738094200822,0.00246283977169146,-0.000769785010507046,0.00888454689452348,0.0994885860146684
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,36880,0.00892412795795233,0.00542037937898572,-0.00169981562485969,0.0195480715407643,0.0997061348815999
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,37196,0.010782253922517,0.00655174336792198,-0.00205916307861007,0.0236236709236441,0.0998486314264404
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37203,-0.0040382855278529,0.00245533492028199,-0.0088507419716056,0.000774170915899804,0.100056663659108
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,39636,-0.00780878912119312,0.0047481028649852,-0.0171150707365641,0.00149749249417786,0.100070456883466
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,37243,-0.003644240567547,0.00222033485435587,-0.00799609688208451,0.000707615746990504,0.100759276897826
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,37143,-0.00728959520944915,0.00444424962639573,-0.0160003244771848,0.00142113405828649,0.10098196622249
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,39462,-0.0142134792203401,0.00867260612526599,-0.0312117872258614,0.00278482878518123,0.101256365630008
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37164,-0.0055821852590366,0.00341921611122133,-0.0122838488370304,0.00111947831895721,0.102579578386255
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,36861,0.00880705255684189,0.00540303965638849,-0.00178290516967954,0.0193970102833633,0.103123047371276
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,36861,0.00715150605535187,0.00438747650519596,-0.00144794789483222,0.015750960005536,0.103130762596556
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39455,0.00409986488539173,0.00252348009814756,-0.000846156106977487,0.00904588587776095,0.104250310449842
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,39654,-0.0041893404510442,0.00257906570740801,-0.0092443092375639,0.000865628335475497,0.104318962989187
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,36955,0.00435547705394036,0.00268256538038143,-0.000902351091607242,0.00961330519948796,0.104481327257464
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39104,-0.0071361528964803,0.00440073867350005,-0.0157616006965404,0.0014892949035798,0.104914674597031
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,39462,0.00753767305091531,0.00464865203107123,-0.00157368492998431,0.0166490310318149,0.104936811094218
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39355,0.01339215813432,0.00826535295372735,-0.00280793365498561,0.0295922499236256,0.105194026491937
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,38760,-0.00394548168184017,0.00243508916823104,-0.008718256451573,0.000827293087892654,0.105198112576696
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39355,-0.0104511714529932,0.00645443222703719,-0.0231018586179861,0.00219951571199972,0.105420239478262
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",36861,0.0118462022718018,0.00731659077773586,-0.00249431565256046,0.0261867201961641,0.105453803611651
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37164,0.00743941704722696,0.00461025164611187,-0.00159667617915231,0.0164755102736062,0.106624209044873
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39187,0.013613769597129,0.00844078804690022,-0.00293017497479541,0.0301577141690534,0.106797366996364
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,39636,0.0124141446761055,0.00770180940135618,-0.00268140175055263,0.0275096911027636,0.107015843409844
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39578,0.005694796888431,0.00353901959229663,-0.0012416815124704,0.0126312752893324,0.107605433522081
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39123,0.00434417366701742,0.00270128105764776,-0.000950337205972189,0.00963868454000702,0.107815051150862
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,36823,0.00822616773948142,0.00511599428473688,-0.00180118105860286,0.0182535165375657,0.10787572750329
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36742,0.00687993788910429,0.00428205319475995,-0.00151288637262523,0.0152727621508338,0.108147778687291
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,37255,-0.00607398394999991,0.00378151925575273,-0.0134857616912753,0.00133779379127543,0.108248377944921
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36688,0.00481289613332694,0.00299978556654107,-0.00106668357709355,0.0106924758437474,0.108648769334747
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,36823,0.00898401395169617,0.00560304392462689,-0.00199795214057253,0.0199659800439649,0.108868224800872
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39123,-0.00828253650711034,0.00517280782999062,-0.018421239853892,0.00185616683967127,0.109361153078739
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,39623,0.00524458795359854,0.00329316412124738,-0.00121001372404633,0.0116991896312434,0.111277959866298
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,36880,-0.00620642865832926,0.00389786717930925,-0.0138462483297754,0.00143339101311686,0.11135111426605
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,36992,0.00411178965214078,0.00258822206913238,-0.00096112560335869,0.00918470490764025,0.112163712995972
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,37247,0.00690006626752834,0.00434628246070194,-0.00161864735544746,0.0154187798905041,0.112406305220026
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,36880,-0.00421022193694826,0.00265362492728597,-0.00941132679442877,0.000990882920532243,0.11263036248224
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37162,0.00752130525238634,0.00475555517901535,-0.00179958289848375,0.0168421934032564,0.11376967848421
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,39050,0.00587539471185262,0.0037192783731638,-0.00141439089954843,0.0131651803232537,0.11419413055444
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,39045,0.00645227197557477,0.00409036052626316,-0.00156483465590102,0.0144693786070506,0.114717473452826
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,36916,-0.00778874154011789,0.00494145794914922,-0.0174739991204504,0.00189651604021457,0.115004373971812
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37162,-0.0106628781188062,0.00677282904472382,-0.0239376230464649,0.00261186680885249,0.115428896999044
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,39169,0.00580107086118364,0.00368661358973332,-0.00142469177469366,0.0130268334970609,0.115613013227101
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,36861,0.00589982362969153,0.00375311429633477,-0.00145628039112461,0.0132559276505077,0.115980498237026
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,39123,0.00558325912409766,0.0035569595420674,-0.00138838157835445,0.0125548998265498,0.116513048330062
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,39416,-0.00427011202920982,0.00272443346721833,-0.00961000162495775,0.0010697775665381,0.117056515479988
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37255,0.00402227257136626,0.00257012566737226,-0.00101517373668336,0.00905971887941588,0.11760526101802
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,36955,0.00344292429052642,0.00220071818494952,-0.000870483351974639,0.00775633193302748,0.117736090608297
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37255,-0.00446927844450988,0.00286151055204334,-0.0100778391265148,0.00113928223749507,0.118345724477372
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",36955,0.01403298377816,0.00899215065600718,-0.00359163150761404,0.0316575990639341,0.118647840743937
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,37221,0.00653107056579169,0.00418838935077622,-0.00167817256172971,0.0147403136933131,0.118943675958158
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,36861,0.00668540938546492,0.00428864665721397,-0.00172033806267446,0.0150911568336043,0.119054487936871
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,39531,0.00866091076146691,0.00555671039896057,-0.00223024162049581,0.0195520631434296,0.119102610531513
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39526,0.00452174959243847,0.00290624849912454,-0.00117449746584562,0.0102179966507226,0.119759613979038
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,37136,0.00343281499516502,0.00220852655679312,-0.000895897056149503,0.00776152704647953,0.120126793599162
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39104,0.0109948458966353,0.007076680725591,-0.00287544832552307,0.0248651401187936,0.120284098050285
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,36847,0.00692450888185177,0.00446095170588448,-0.0018189564616818,0.0156679742253853,0.120628129913358
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39187,0.00988496371858313,0.00636954646387461,-0.0025993473506111,0.0223692747877774,0.120705203745423
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,39462,0.0111334756330939,0.00717704349373611,-0.00293352961462892,0.0252004808808166,0.120859966025017
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,36916,-0.011450527352829,0.00739095860391855,-0.0259368062165093,0.00303575151085141,0.121344268379179
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39194,0.00774945466931963,0.00500464569945185,-0.00205965090160599,0.0175585602402452,0.121534926270308
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37162,0.00496418208291895,0.00320853779995988,-0.00132455200500242,0.0112529161708403,0.121845002292652
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36823,0.00987720227062561,0.00638685707897762,-0.00264103760417052,0.0223954421454217,0.122012167512962
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,36847,0.0118904039199605,0.00770095393452062,-0.00320346579169992,0.0269842736316209,0.122609739154842
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37255,0.00297747333102722,0.00192848428278665,-0.000802355863234618,0.00675730252528906,0.122626414687949
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,39455,0.00362178335688083,0.00234663432799976,-0.000977619925998694,0.00822118663976035,0.122756091369732
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,39462,0.00911001257044509,0.00591026249656621,-0.00247410192282469,0.0206941270637149,0.123243262284604
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,36955,0.00407149119173337,0.00264369804236137,-0.00111015697129491,0.00925313935476166,0.123567570192297
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,39355,-0.0016445827680461,0.00106822423936026,-0.00373830227719221,0.000449136741100013,0.12369173669889
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36823,0.00772901622834881,0.00503128786325773,-0.00213230798363633,0.017590340440334,0.124517258154071
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,39566,0.00649831176198004,0.00423042637348857,-0.00179332393005756,0.0147899474540176,0.124537466322579
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37162,0.00676052325658137,0.00440950270385839,-0.00188210204298108,0.0154031485561438,0.125258528331581
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37135,0.00360091502952602,0.00235053230207345,-0.00100612828253793,0.00820795834158998,0.125557922823891
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,39462,0.00885625547785776,0.00578403629401695,-0.00248045565841547,0.020192966614131,0.125752189700835
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,39428,-0.0117485479300223,0.00768477035176849,-0.0268106978194886,0.00331360195944391,0.126332860733841
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,36847,0.00545786149494071,0.00357202848181269,-0.00154331432941216,0.0124590373192936,0.126551819574661
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,39433,0.00361278232319615,0.00236755262456707,-0.00102762082095531,0.00825318546734761,0.127041807787616
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,39462,0.00743065223895053,0.00487618904046245,-0.00212667828035587,0.0169879827582569,0.127563586143163
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39462,0.00624752313455751,0.00410013677419741,-0.00178874494286942,0.0142837912119844,0.12759591501228
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,39104,0.0049652312450012,0.00325896077329904,-0.00142233187066491,0.0113527943606673,0.127639555541412
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37221,0.00626874061676602,0.00411516344679384,-0.0017969797389499,0.014334460972482,0.127701616902157
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39531,0.00316989404203435,0.00208173742695654,-0.000910311314800463,0.00725009939886917,0.127850844670248
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,37164,0.00943590107545482,0.00620126994102183,-0.00271858800894796,0.0215903901598576,0.128132240110791
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39455,0.00503161886401498,0.00330725246043844,-0.00145059595844436,0.0115138336864743,0.128183219717579
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37125,0.0143022670300285,0.00940155363661904,-0.0041247780977448,0.0327293121578019,0.128217964063909
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39194,0.00794040657185259,0.00523207063054658,-0.00231445186401871,0.0181952650077239,0.129126287650679
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,39194,0.00589518055084833,0.00388801853679657,-0.00172533578127294,0.0135156968829696,0.129479381974774
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,36992,0.00599005284999054,0.00395307655608436,-0.0017579771999348,0.0137380828999159,0.129724473978761
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37162,-0.00574645689520276,0.00379490993771066,-0.0131844803731157,0.00169156658271014,0.129986340292296
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,39522,0.0197547435764093,0.0130504614493089,-0.00582416086423624,0.0453336480170548,0.13011785932437
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,36823,0.00367758251258024,0.00243106498367468,-0.00108730485542214,0.00844246988058261,0.130369872466491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,37221,0.021125840349974,0.0139749746929942,-0.00626511004829455,0.0485167907482426,0.130637292666207
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39479,-0.00767113105884227,0.00507587461733127,-0.0176198453088116,0.00227758319112702,0.13073498063452
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37164,-0.0169231817009529,0.011202389755242,-0.0388798656212272,0.00503350221932128,0.130895867752086
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,36847,0.00662360940401016,0.00438512317868122,-0.00197123202620504,0.0152184508342254,0.13094830902214
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,39589,-0.00344339210001624,0.00227985580035529,-0.00791190946871261,0.00102512526868014,0.130973682816141
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,36847,0.00829033919655397,0.00549795789682307,-0.00248565828121924,0.0190663366743272,0.131607076198112
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,39428,0.013444805155959,0.00893309804410987,-0.00406406701049637,0.0309536773224143,0.132330989378699
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,36763,0.00492319533865643,0.00327617531312549,-0.00149810827506954,0.0113444989523824,0.132935245260634
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,37221,-0.00467313357311338,0.00311425213316615,-0.010777067754119,0.00143080060789227,0.133493181707099
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,39436,0.00512455237241566,0.00341537323406322,-0.00156957916634825,0.0118186839111796,0.133522310638003
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,36880,-0.00565484174969117,0.00377123027800762,-0.0130464530945861,0.00173676959520377,0.133777484278181
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,36955,0.0100239042991535,0.00668823792091841,-0.00308504202584657,0.0231328506241536,0.133967327689406
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39485,-0.0128777545858985,0.00859264853393971,-0.0297193457124203,0.00396383654062335,0.133973917325908
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39187,-0.00533106821087719,0.00357020332625105,-0.0123286667303292,0.00166653030857487,0.135403276937574
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,36852,0.00765197860287404,0.00513095324294813,-0.00240468975330431,0.0177086469590524,0.135898569938773
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,39161,-0.00939322618414434,0.0062996303092517,-0.0217405015902777,0.00295404922198899,0.135963044134201
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,36847,-0.00814346637793912,0.00546958002663295,-0.0188638432301397,0.00257691047426146,0.136548357686276
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,36880,0.0035143169666458,0.00236482173069712,-0.00112073362552055,0.00814936755881216,0.137283026973977
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,37162,-0.0047905788848653,0.00322569071608479,-0.0111129326883915,0.00153177491866089,0.137533465836582
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,37203,-0.00693342728134355,0.0046720582264784,-0.0160906614052412,0.00222380684255411,0.137828364629045
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39194,0.00769311767474803,0.00519545515382878,-0.00248997442675637,0.0178762097762524,0.138697271780874
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,36992,0.00743600032339123,0.00502203367192771,-0.00240718567358709,0.0172791863203695,0.138718289682601
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,36992,0.00542575224637706,0.00366786603599451,-0.00176326518417218,0.0126147696769263,0.139094156551746
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37221,-0.00377724285508575,0.00255398486734657,-0.00878305319508502,0.00122856748491352,0.139175527328195
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,36763,0.00617828926973454,0.00418294571940267,-0.00202028434029469,0.0143768628797638,0.139696189523924
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,37162,-0.00812296165773668,0.00550109181786934,-0.0189051016207606,0.00265917830528721,0.139805254012175
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36763,-0.00341256000533255,0.00231417396282055,-0.00794834097246083,0.00112322096179574,0.140336493674974
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,39123,0.00680238864561779,0.00461309658423801,-0.0022392806594887,0.0158440579507243,0.140346446278348
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,39187,0.00784360016999615,0.00533154099977611,-0.00260622018956503,0.0182934205295573,0.141266654886363
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,39194,0.0062607593481744,0.0042620720211489,-0.00209290181327744,0.0146144205096262,0.141868411316823
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,36847,-0.00598410796471482,0.00407534555424786,-0.0139717852510406,0.00200356932161098,0.142029600569497
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39304,0.00360818696193464,0.00245750535422824,-0.00120852353235271,0.00842489745622199,0.142062507108511
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,39589,0.00773962475927191,0.00527435916461748,-0.00259811920337836,0.0180773687219222,0.14228649817567
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,39485,0.00388567549353768,0.00264928778938785,-0.00130692857366252,0.00907827956073787,0.142482186640291
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,39601,0.00322869873664227,0.0022099270681337,-0.00110275831689979,0.00756015579018433,0.144036766170337
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39194,-0.00766621782185018,0.00525151491343271,-0.0179591870521783,0.00262675140847793,0.144363407121608
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36763,0.00722725344827732,0.00495428451794527,-0.00248314420689542,0.0169376511034501,0.144648831400082
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,37203,0.00579250908457523,0.00397251799901175,-0.00199362619348779,0.0135786443626383,0.144825082348889
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",36880,0.00563656688698455,0.00386795120722823,-0.00194461747918278,0.0132177512531519,0.145073006148673
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,36847,0.00511970300436931,0.00351789362029875,-0.00177536849141624,0.0120147745001549,0.145602708688572
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,37247,0.00346165475992415,0.00238382570190638,-0.00121064361581235,0.00813395313566065,0.146486489805324
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,39389,-0.00376774811661536,0.00259676266354165,-0.008857402937157,0.00132190670392628,0.146817428693691
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39455,-0.00399195425257373,0.00275234069281144,-0.00938654201048416,0.0014026335053367,0.146972032317018
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39541,0.0157984301819824,0.0108946714386757,-0.00555512583782192,0.0371519862017866,0.147049702098743
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,36763,0.00788661701767876,0.00544971802077307,-0.00279483030303646,0.018568064338394,0.14787741983452
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37221,0.00476549095368859,0.0032940739642236,-0.00169089401618966,0.0112218759235668,0.148009411015498
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39355,-0.00478599023552328,0.00331020883807007,-0.0112739995581406,0.00170201908709404,0.148246681313766
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,36847,0.00645265309367627,0.00446641731364295,-0.00230152484106392,0.0152068310284165,0.14856618951779
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39541,0.00399769260877625,0.00276800261803034,-0.00142759252256321,0.00942297774011572,0.14868893757205
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,36880,-0.00444684375492134,0.00308553323683909,-0.010494488899126,0.00160080138928327,0.149555830908878
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,39123,0.00541426927894905,0.00375702912651281,-0.00194950780901606,0.0127780463669142,0.149576677662037
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36763,0.00514220585207489,0.00357657771106091,-0.0018678864616045,0.0121522981657543,0.150531905799487
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,39351,-0.00905635002343841,0.00631419067417778,-0.0214321637448269,0.00331946369795004,0.15151188910796
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36823,0.00708070554515338,0.00493737554110434,-0.00259655051541112,0.0167579616057179,0.151568120154236
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39516,-0.010597805000331,0.00741461116483666,-0.0251304428834109,0.00393483288274886,0.15293483890272
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,39462,0.00753110312807682,0.0052775870620167,-0.00281296751347591,0.0178751737696296,0.15360143881927
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,37031,0.00408376594125837,0.00286184431182681,-0.00152544890992218,0.00969298079243893,0.153613366357296
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,39312,-0.0082598654537576,0.00579211805684347,-0.0196124168451708,0.00309268593765561,0.153874144179209
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39355,-0.0036448472846535,0.00255972900098742,-0.00866191612658885,0.00137222155728185,0.154490797935762
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39104,0.00636791063541225,0.00448851455858283,-0.0024295778994101,0.0151653991702346,0.156004191471454
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39428,-0.00757713748976232,0.00534173049637074,-0.018046929262649,0.00289265428312432,0.156071503657
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39194,0.00570223080115102,0.00402227295562915,-0.00218142419188212,0.0135858857941842,0.156310076128186
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37127,0.0053383927021718,0.00376626650546868,-0.00204348964854683,0.0127202750528904,0.156383877780735
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,39104,0.00608740086790668,0.00429680333059188,-0.00233433366005339,0.0145091353958668,0.156583776939858
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36763,0.0110292619929471,0.00779620988625233,-0.00425130938410745,0.0263098333700017,0.157183125064227
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,36823,0.00429176203907112,0.00303853492142845,-0.00166376640692865,0.0102472904850709,0.157844266807562
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39187,-0.00612963704037845,0.00434845539047983,-0.0146526096057189,0.00239333552496201,0.158675241321362
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39187,-0.00373136492443485,0.00264787923142898,-0.00892120821803565,0.00145847836916596,0.158800097818282
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,39582,-0.00360940694885908,0.00256143137011498,-0.00862981243428444,0.00141099853656627,0.158815302297879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,39370,0.00849572165277816,0.00603428078165695,-0.00333146867926946,0.0203229119848258,0.159178686760394
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36823,0.00872769217572592,0.00620108680360582,-0.00342643795934149,0.0208818223107933,0.159320429888605
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39194,0.004366097735029,0.00310729254221815,-0.00172419564771857,0.0104563911177766,0.160008694140506
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39123,-0.0101030714470609,0.00719124752657381,-0.0241979165991456,0.00399177370502374,0.160068558081599
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,36992,0.00832901807786528,0.00593099452210185,-0.00329573118545434,0.0199537673411849,0.160248154654935
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,36992,0.00729478720281316,0.00519716987728731,-0.00289166575666996,0.0174812401622963,0.160460489184103
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,39194,0.0102123211986047,0.00727801202138752,-0.00405258236331481,0.0244772247605243,0.160585857768004
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,39455,-0.00484293617477504,0.0034525390009271,-0.0116099126165922,0.00192404026704209,0.160721849695784
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,39499,0.00361013825572561,0.00257487581797536,-0.0014366183475061,0.00865689485895733,0.160917046634086
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,36880,0.0109211193475323,0.00780314613883239,-0.00437304708457916,0.0262152857796438,0.161664390233601
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37203,-0.00681400500913523,0.00487133220292609,-0.0163618161268704,0.00273380610859991,0.161898179884176
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,39485,0.013135307518326,0.00939372968704178,-0.00527640266827594,0.0315470177049279,0.162041858401809
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,36763,0.00765712077938635,0.00548251032277752,-0.00308859945325759,0.0184028410120303,0.16254551994343
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37243,0.00310274045872168,0.002223884781435,-0.00125607371289093,0.00746155463033429,0.162982957601792
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,36861,-0.00539811696400026,0.0038701355256492,-0.0129835825942727,0.00218734866627217,0.163097077344767
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39378,-0.00540370243130368,0.00387992125992472,-0.0130083481007561,0.00220094323814878,0.163720661894404
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,37203,0.00264538927548792,0.00190391887488808,-0.00108629171929272,0.00637707027026855,0.164721940493456
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37203,-0.00751927458191831,0.00541425025147909,-0.0181312050748173,0.00309265591098071,0.164919863443681
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39428,-0.00544961727011664,0.00392640810577226,-0.0131453771574303,0.002246142617197,0.165176087704753
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,36926,0.0100107755154736,0.00722106063053723,-0.00414250332037941,0.0241640543513265,0.165670831045554
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,39549,-0.00727881606439255,0.00525155982597869,-0.0175718733233108,0.00301424119452567,0.165758411970588
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,36916,0.00567509500547723,0.00409795890825721,-0.00235690445470691,0.0137070944656614,0.166120393320611
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,38999,0.00801698900794104,0.00580122418866466,-0.00335341040184169,0.0193873884177238,0.167008949500887
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,39654,0.00374977178814975,0.00271426794079135,-0.00157019337580129,0.00906973695210079,0.167144377919991
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,39532,-0.00403991843859844,0.0029246085883043,-0.00977215127167487,0.00169231439447799,0.167190748892492
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,39428,0.00182436313526307,0.00132512486208936,-0.000772881594432088,0.00442160786495822,0.168610722654865
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39455,0.00390697089454489,0.0028379935579353,-0.0016554964790083,0.00946943826809809,0.168635897820515
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,36880,0.00676025248112211,0.00491667982379935,-0.00287643997352462,0.0163969449357688,0.16916772509797
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,37203,0.00971671798281839,0.00707834222468868,-0.00415683277757141,0.0235902687432082,0.169857574209096
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36763,0.0115172575891488,0.00839400616591164,-0.00493499449603798,0.0279695096743357,0.170063178501036
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39440,0.002940302526045,0.00214422692308173,-0.0012623822431952,0.00714298729528519,0.170313008840248
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,39123,-0.00497872341109277,0.0036310662479806,-0.0120956132571347,0.00213816643494921,0.170350295801193
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39541,0.0124793188755423,0.0091033648234458,-0.00536327617841147,0.030321913929496,0.170443096395267
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,39462,-0.00865105897067097,0.00632358017336954,-0.0210452761104753,0.00374315816913332,0.171312692112032
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,36847,0.00437143156083999,0.00319605145805798,-0.00189282929695366,0.0106356924186336,0.171411987778675
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,36955,0.00797717091971274,0.005833141425981,-0.00345578627521003,0.0194101281146355,0.171474423941224
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,36847,0.00381393361808215,0.00279275086698017,-0.00165985808119898,0.00928772531736328,0.172072119081508
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,36916,0.00502252100480114,0.00367800443207928,-0.00218636768207425,0.0122314096916765,0.172103008764358
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39485,-0.00762124767955708,0.00558490994909006,-0.0185676711797736,0.00332517582065944,0.172394750069879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,39104,0.00375909332264936,0.00275725359906599,-0.00164512373151998,0.00916331037681871,0.172794135260814
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,39455,0.00349670464889379,0.00256533153015625,-0.00153134515021245,0.00852475444800004,0.17288358426205
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,39589,-0.00348509394045969,0.00255719553362767,-0.00849719718636992,0.00152700930545054,0.172947596500548
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,36847,0.00794895301145139,0.00583590357555337,-0.00348941799663323,0.019387324019536,0.173198176905661
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,39123,0.00451038815215516,0.00331499576527725,-0.00198700354778826,0.0110077798520986,0.173660564824012
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,36880,0.00687365796580215,0.00506544627943491,-0.00305461674189028,0.0168019326734946,0.174815429607717
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39104,0.00642712663265832,0.0047413397716372,-0.0028658993197506,0.0157201525850672,0.175263048152152
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,36847,0.00728604103690865,0.0053826571311485,-0.00326396694014241,0.0178360490139597,0.175884181589239
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39541,0.00493958943586961,0.00365153035239836,-0.00221741005483118,0.0120965889265704,0.176157377523406
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,36847,-0.0113803974204388,0.00841793431772059,-0.0278795486831712,0.00511875384229354,0.176424677401861
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,37162,0.00964980261349917,0.00713961813685663,-0.00434384893473981,0.0236434541617382,0.176532082916789
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39485,0.00799672648725717,0.00592081932975518,-0.00360807939906299,0.0196015323735773,0.176840255183175
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,39355,-0.00571381958508933,0.00424193686937519,-0.0140280158490647,0.00260037667888604,0.178005981518503
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36741,-0.0104654245345507,0.00777176580452139,-0.0256980855114127,0.00476723644231117,0.178135392110302
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37044,0.000951495292446072,0.000706829025589443,-0.000433889597709236,0.00233688018260138,0.17827956550115
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,36847,-0.00793888756445717,0.00589779298567706,-0.0194985618163842,0.00362078668746987,0.178302079958334
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,36847,0.00611640732830998,0.00454601216012809,-0.00279377650554108,0.015026591162161,0.178506325579021
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36763,0.00382934147411458,0.00284936082032568,-0.00175540573372376,0.00941408868195292,0.178995791846952
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36823,0.00596204722352294,0.00443732338632461,-0.0027351066136733,0.0146592010607192,0.179098073186858
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,39485,0.00745853995193013,0.00555641406352853,-0.0034320316125858,0.0183491115164461,0.179509368908525
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,36880,0.0077434301815503,0.00577727221058521,-0.00358002335119672,0.0190668837142973,0.180163769522902
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39462,-0.00641558693518372,0.00479115426434579,-0.0158062492933015,0.00297507542293403,0.180575229440307
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,36916,-0.00448454023423887,0.00335724900533408,-0.0110647482846937,0.00209566781621592,0.181646150652522
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,36880,0.0121781007970717,0.00911813272231242,-0.00569343933866059,0.0300496409328041,0.181707280138246
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,39617,0.00347182516156623,0.00260124271075293,-0.00162661055150952,0.00857026087464198,0.182001323492029
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39455,0.00607704047790171,0.00455515279395263,-0.00285105899824545,0.0150051399540489,0.182190534415158
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39123,0.00531427296721809,0.00398353664760214,-0.00249345886208209,0.0131220047965183,0.18220522464828
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37164,0.00798830198688049,0.00598982855005606,-0.00375176197122938,0.0197283659449904,0.182344281912008
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36823,0.00822982172506875,0.00619636266779461,-0.00391504910380868,0.0203746925539462,0.184146523234889
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,37221,-0.00636572877827321,0.00479429100436524,-0.0157625391468291,0.00303108159028267,0.184276938661846
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,37221,0.00777913921445242,0.00586032411403994,-0.00370709604906585,0.0192653744779707,0.18439195207453
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,36861,0.00791643063998847,0.00597504876322032,-0.00379466493592335,0.0196275262159003,0.185223802238912
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,39330,0.00359719995827775,0.00272021971358688,-0.00173443068035254,0.00892883059690804,0.18605759121386
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39194,0.0138475377997285,0.0104895495986,-0.00671197941352757,0.0344070550129846,0.186813111314783
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,39355,0.00496757927330033,0.00376792322201844,-0.0024175502418558,0.0123527087884565,0.187394544252023
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,36847,0.0115116549641834,0.00873517914402033,-0.00560929615809645,0.0286326060864632,0.187578255110608
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37203,-0.00535561926408257,0.00406654318225046,-0.0133260439012935,0.00261480537312832,0.187863784383154
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39428,-0.0111830745260449,0.00849183695076867,-0.0278270749495515,0.00546092589746165,0.187885410287987
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39530,0.00278005808240425,0.00211454215418431,-0.001364444539797,0.0069245607046055,0.188619690648972
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36741,0.00587822665575129,0.00447780463827802,-0.00289827043527363,0.0146547237467762,0.189292574544531
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,36992,0.00852806454631818,0.00650088041615406,-0.00421366106934378,0.0212697901619801,0.189600757445385
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,36847,-0.00711740872591388,0.00542722855961371,-0.0177547767027568,0.00351995925092899,0.189738165644603
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,36861,0.00882277577748599,0.0067297372428078,-0.00436750921841729,0.0220130607733893,0.189877492619723
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,37255,-0.0127863324484387,0.00975494468116354,-0.0319060240235192,0.00633335912664185,0.189964409812137
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37221,0.00352071588849382,0.00268784989698122,-0.00174746990958938,0.00878890168657702,0.190265655035162
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36823,0.00381217106472366,0.00291484667829774,-0.00190092842473992,0.00952527055418724,0.190949792712434
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,36916,0.00478036754470868,0.00366661231600426,-0.00240619259465966,0.011966927684077,0.19234089229169
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,36861,0.00398088191479655,0.00305497309679195,-0.00200686535491568,0.00996862918450877,0.192570783348822
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39187,0.00639246090460161,0.00490678859319363,-0.00322484473805791,0.0160097665472611,0.192670597584847
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37162,-0.0040095708051472,0.00307920723626782,-0.0100448169882321,0.00202567537793773,0.192890807622376
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39123,-0.0112173724012019,0.00862160500375408,-0.0281157182085599,0.00568097340615613,0.193252515632212
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,39383,-0.00659110282490104,0.00507264589942481,-0.0165334887877737,0.00335128313797158,0.193846584079243
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,37162,0.00504447554854392,0.00388501484239728,-0.00257015354255475,0.0126591046396426,0.194158248074122
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,36880,0.00659670472616392,0.00508667812062184,-0.00337318439025488,0.0165665938425827,0.194703753235374
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,37203,0.00308250725097267,0.00238005345924482,-0.00158239752914718,0.00774741203109252,0.195294689268578
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,36880,0.00473466925110046,0.00365676594310873,-0.00243259199739266,0.0119019304995936,0.195423787796479
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,39187,-0.0026615159269288,0.00205885901633189,-0.00669687959893931,0.00137384774508172,0.196130254393867
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37203,-0.00990165018289033,0.00767387891376029,-0.0249424528538605,0.00513915248807983,0.196967914599438
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,36955,0.00597823722734844,0.00464204619076562,-0.00312017330655218,0.0150766477612491,0.197823665407611
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,39104,0.00589248716772951,0.00457680839954117,-0.0030780572953712,0.0148630316308302,0.197952099072503
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,36847,0.00533252559381043,0.00414779716093024,-0.00279715684161284,0.0134622080292337,0.198596818201684
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39194,0.00614671392372014,0.00478260508905167,-0.00322719205082113,0.0155206198982614,0.198734569233897
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,37162,0.0131297983854524,0.0102210382346558,-0.00690343655447292,0.0331630333253778,0.198960550111872
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39485,-0.00195378393150068,0.00152294337616331,-0.00493875294878077,0.00103118508577941,0.199546920325397
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,36916,-0.00619234192045663,0.00483096461928278,-0.0156610325742509,0.00327634873333762,0.199935823846425
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39485,0.00315675585392151,0.00246313246925146,-0.00167098378581136,0.00798449549365438,0.200002014182488
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,36823,0.00502519485327697,0.00392608285128581,-0.00266992753524322,0.0127203172417972,0.200586264813662
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39123,0.00630588547227112,0.00492824664633285,-0.00335347795454128,0.0159652488990835,0.200727429242976
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,39455,0.00352472472264239,0.00275738536244974,-0.00187975058775909,0.00892920003304388,0.201168682016413
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,39079,-0.00399838770730548,0.00313669157514029,-0.0101463031945804,0.00214952777996948,0.202430395089746
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37203,0.00416100395871815,0.00326900800874803,-0.00224625173842799,0.0105682596558643,0.203089366589411
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,36847,0.00410169373882218,0.00322998776300679,-0.00222908227667112,0.0104324697543155,0.20415156165272
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39123,-0.00740861355670395,0.00583715922572274,-0.0188494456391205,0.00403221852571262,0.204384312407977
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,39187,0.0067443131632353,0.00531717052051952,-0.00367734105698295,0.0171659673834536,0.204674235585124
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36823,0.00547765701331957,0.00432601692902144,-0.00300133616756245,0.0139566501942016,0.20546083054506
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,36880,0.0040430916097585,0.00320266549105608,-0.00223413275271143,0.0103203159722284,0.206823333435693
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39104,0.00538287183331799,0.00427131131127482,-0.00298889833678065,0.0137546420034166,0.207603334625314
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37247,0.00704367776448658,0.00559960054030125,-0.00393153929450386,0.018018894823477,0.208454739111371
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37203,0.00819939874025054,0.00652085074016411,-0.00458146871047111,0.0209802661909722,0.20862736165134
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39104,0.00801294499023096,0.00637653435291962,-0.0044850623414915,0.0205109523219534,0.208907644014952
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37241,0.00203052131219766,0.00161626768197332,-0.00113736334447005,0.00519840596886537,0.209029222588266
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,36880,0.00568316960309568,0.00455270922473374,-0.00324014047738244,0.0146064796835738,0.211942906695312
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37162,0.00476264192306287,0.00382092584502454,-0.00272637273318523,0.012251656579311,0.212617510295135
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,36992,0.00408447625540226,0.00328430985079087,-0.00235277105214785,0.0105217235629524,0.213657897003172
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,37269,0.00243780279500043,0.00196416812248662,-0.00141196672507334,0.00628757231507419,0.214577658070703
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,36861,0.0057090332879056,0.00460035555481159,-0.00330766359952511,0.0147257301753363,0.214629847752545
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,36880,0.00736250142447411,0.00593326556672422,-0.00426669908630536,0.0189917019352536,0.21467158388992
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",36880,0.00519362708454366,0.00418968559035541,-0.00301815667255294,0.0134054108416403,0.215138588427348
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,36763,0.00858418232838899,0.00693196534049722,-0.00500246973898556,0.0221708343957635,0.215610830653705
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,39636,0.00350827678515912,0.00283552573228598,-0.0020493536501214,0.00906590722043964,0.216010463147087
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39526,0.00458966822542274,0.00371309897215392,-0.00268800575999894,0.0118673422108444,0.216450005982127
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,36880,0.00449272065068356,0.00363720842778822,-0.00263620786778135,0.0116216491691485,0.216775255592798
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,39123,0.0100391862167531,0.0081503982409687,-0.00593559433554552,0.0260139667690518,0.218065291466533
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,36861,-0.00718934895786349,0.0058432853826772,-0.0186421883079108,0.00426349039218382,0.218585369032776
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,39636,0.0067526233702427,0.00549154249879184,-0.0040107999273893,0.0175160466678747,0.218850788695828
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,36823,0.00677632582381951,0.00551647183150424,-0.0040359589659288,0.0175886106135678,0.219327573868119
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,36955,-0.00442235453989066,0.00360221564662751,-0.0114826972072806,0.00263798812749925,0.219591643784177
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,36861,0.00334062555532985,0.00272345529488233,-0.00199734682263952,0.00867859793329923,0.219991369998868
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37162,0.00539622987354408,0.00440225217053923,-0.00323218438071281,0.014024644127801,0.220301005633045
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,39104,-0.0032788598958877,0.00267566051130004,-0.00852315449803579,0.00196543470626038,0.220429395270992
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,39180,-0.00456216060286536,0.00372481080767179,-0.0118627897859021,0.00273846858017135,0.220668926693767
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,36992,0.00565108751436131,0.00461932213145202,-0.00340278386328465,0.0147049588920073,0.221217265661627
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39412,0.00370626498888672,0.00303629915838235,-0.00224488136154268,0.00965741133931613,0.222237004439249
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,36880,0.00547224565477892,0.00448457715792514,-0.00331752557475436,0.0142620168843122,0.222398309194113
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,37162,-0.00857995339682882,0.00705493766923285,-0.0224076312285252,0.00524772443486757,0.223945462096103
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,36861,-0.00553129095345334,0.00455195797423778,-0.0144531285829594,0.00339054667605271,0.224333746704586
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,36880,-0.0039731362651233,0.00327033415077595,-0.0103829912006442,0.00243671867039756,0.224426462610882
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,39168,-0.00408048734795693,0.00335879478009492,-0.010663725116943,0.00250275042102911,0.224436494413773
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,37040,0.0034452743792059,0.00284163206418647,-0.00212432446659958,0.00901487322501137,0.225371328993388
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,39579,0.0045567357228169,0.00375867704890934,-0.00281027129304541,0.0119237427386792,0.225407179042448
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,37269,-0.00229245690621211,0.00189249779140298,-0.00600175257736195,0.00141683876493774,0.225787734634784
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,39455,0.00303522113071083,0.00250644058312085,-0.00187740241220604,0.00794784467362769,0.225926470293811
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37255,-0.00406562360279136,0.00336529803144611,-0.0106616077444257,0.00253036053884301,0.227030308198904
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,39462,0.00890119852439859,0.00737109473565235,-0.00554614715748002,0.0233485442062772,0.227227259836284
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36823,-0.00822350728629806,0.00681389516874326,-0.0215787418170348,0.00513172724443873,0.227504066739491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39526,0.00290663087947846,0.00241232057905965,-0.00182151745547845,0.00763477921443537,0.228256693157075
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,36880,-0.00512274636927305,0.00425433425479177,-0.0134612415086649,0.00321574877011883,0.228564551878197
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,39654,0.00363728838255003,0.00302124686470298,-0.00228435547226782,0.00955893223736787,0.228645789406854
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,36916,0.00559025620433398,0.00464687767639705,-0.00351762404140423,0.0146981364500722,0.228993978033554
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37162,-0.00754884442900762,0.00628021330307184,-0.0198580625030284,0.00476037364501319,0.229384192742418
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37164,-0.00485450974738271,0.00404088564637641,-0.0127746456142805,0.00306562611951506,0.229638633709563
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37255,0.00261040913819531,0.00217411306153624,-0.00165085246241571,0.00687167073880634,0.229898449188841
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,36992,-0.00580462118491955,0.00483838723267203,-0.0152878601609567,0.00367861779111762,0.230277894774744
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,39194,0.00696369567036651,0.00581061785453997,-0.00442511532453182,0.0183525066652648,0.230763773970567
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36823,0.00520662201580904,0.00434699388762168,-0.00331348600392944,0.0137267300355475,0.231036401846684
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37221,0.0038288805024095,0.00319886679400776,-0.00244089841384571,0.0100986594186647,0.231348643868621
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,36880,-0.00333064913849543,0.00278641919435432,-0.0087920307594299,0.00213073248243903,0.23198672206245
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39428,0.00250277370749462,0.0020941551247449,-0.00160177033700538,0.00660731775199463,0.232057761806017
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,39194,0.00888188765328467,0.00743986161155334,-0.00570024110535989,0.0234640164119292,0.232565910145513
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,39589,0.00284093746490439,0.00238509143291134,-0.00183384174360184,0.00751571667341062,0.233623945403688
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,36847,0.00703136999655807,0.00590688351788159,-0.00454612169848985,0.018608861691606,0.233924257656641
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,36992,0.00320277283980577,0.00269481327617926,-0.00207906118150558,0.00848460686111712,0.234660848080917
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,36763,0.00329482804568787,0.0027802305699096,-0.00215442387133494,0.00874407996271069,0.236004086028295
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,36861,0.00446765215207283,0.00377118535172866,-0.00292387113731535,0.011859175441461,0.236166232065037
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,36847,0.00471432301556258,0.00398210545002419,-0.00309060366648484,0.01251924969761,0.236484462531113
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,36847,0.00578137167884639,0.00488391745716744,-0.0037911065372018,0.0153538498948946,0.23653195294548
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37164,-0.00524229450404087,0.00443235742963992,-0.0139297150661351,0.00344512605805337,0.236937181673178
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,36976,0.0101801736853921,0.00860824118463748,-0.00669197903649735,0.0270523264072816,0.236987046486189
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,39104,0.0054125541153366,0.00458274731240985,-0.00356963061698671,0.0143947388476599,0.237593329035342
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39477,0.0027295101017575,0.00231268086597528,-0.00180334439555406,0.00726236459906906,0.237924896696145
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36763,-0.00580544855863551,0.00492353818925383,-0.015455583409573,0.003844686292302,0.238372680668521
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,36880,0.00660453486108263,0.00561751449426369,-0.00440579354767419,0.0176148632698395,0.239735658688131
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,37162,-0.00550243028087,0.00468105923677631,-0.0146773063849516,0.00367244582321157,0.23982998294635
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,36916,-0.00540078287339266,0.00459781497013823,-0.0144125002148636,0.00361093446807826,0.240160735543513
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39319,0.00242751373816184,0.00206912719331302,-0.00162797556073169,0.00648300303705537,0.240731750412883
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,39568,0.00318848374907593,0.00271885532691255,-0.00214047269167266,0.00851744018982453,0.240922497377888
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,37247,-0.00568925617343925,0.00485702775273258,-0.0152090305687951,0.0038305182219166,0.241481859828232
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39281,0.0118487016193862,0.0101180779632886,-0.00798273118865948,0.0316801344274318,0.241600419556737
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,37162,0.00326026180660305,0.00278619183968924,-0.00220067419918785,0.00872119781239395,0.2419626336719
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,37203,0.0108353494495146,0.00927203469013396,-0.00733783854314794,0.0290085374421772,0.242584514498448
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,39541,0.00450049022940836,0.00385537614583733,-0.0030560470164328,0.0120570274752495,0.243096203146177
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39123,-0.00870313233424033,0.00745899591840484,-0.0233227643343138,0.00591649966583315,0.243311417300191
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,39274,0.00472663561444186,0.00406224976475978,-0.00323537392448731,0.012688645153371,0.244624665335265
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,36880,-0.00438545880238529,0.00378095420721916,-0.0117961290485348,0.00302521144376426,0.246119341511995
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36789,-0.00347940302357457,0.00300148820424885,-0.00936231990390231,0.00240351385675318,0.246386531385334
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,39601,-0.00297465269738461,0.00256676996149563,-0.00800552182191605,0.00205621642714683,0.246511565251888
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,37255,0.00280183023552249,0.00241813657944383,-0.00193771746018742,0.0075413779312324,0.246610998568845
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36823,-0.00870057508142518,0.00751809426498793,-0.0234360398408015,0.00603488967795117,0.247178427575019
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39204,0.0042828997017907,0.00370611925968339,-0.00298109404718874,0.0115468934507701,0.24785156789612
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,37269,-0.00326636050720642,0.00282691470640121,-0.00880711333175279,0.00227439231733996,0.247927459369107
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39123,-0.00811163772367641,0.0070289051505838,-0.0218882918188207,0.00566501637146783,0.248502567455206
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,37193,0.00641126543832142,0.00555595744463128,-0.00447841115315588,0.0173009420297987,0.248544649247129
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,36763,-0.00570970026946581,0.00495153481615453,-0.0154147085091287,0.00399530797019706,0.248884645111953
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,39485,0.00343147296465539,0.00297634008131197,-0.00240215359471608,0.00926509952402686,0.248962800764985
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,36916,0.00450412928948824,0.00391532646478107,-0.00316991058148265,0.0121781691604591,0.250007778562187
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39428,0.00266073659292673,0.00231308562519662,-0.00187291123245865,0.00719438441831211,0.250039730805653
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37162,0.00407636168778221,0.00354552360877545,-0.00287286458541766,0.0110255879609821,0.250280581647499
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,36992,0.0074421286807663,0.00650496959395646,-0.00530761172338837,0.020191869084921,0.252617203166131
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,36880,0.00261019321477134,0.0022844137748685,-0.00186725778397092,0.0070876442135136,0.253222710053464
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,39455,-0.00373987764840434,0.00327437804718892,-0.0101576586208946,0.00267790332408594,0.253403967630863
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,36847,0.00473903029013085,0.00416623534031143,-0.00342679097687956,0.0129048515571413,0.25535757089099
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,39438,0.0052405567049534,0.00461400170547473,-0.00380288663777707,0.0142840000476839,0.256060838739317
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,39194,0.00635479933576198,0.00559619648896922,-0.00461374578261769,0.0173233444541417,0.256160531568419
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39194,-0.00415608077609216,0.00366164995625572,-0.0113329146903534,0.00302075313816905,0.256381405575879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37203,-0.00598085350587241,0.00527733132286481,-0.0163244228986874,0.00436271588694262,0.257105310822459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,36955,0.00679964260913094,0.00601272399106381,-0.00498529641335413,0.018584581631616,0.258129162791535
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,37216,-0.00355093674559915,0.00314121799086571,-0.00970772400769594,0.00260585051649765,0.258315020269975
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,36823,0.00960354514003121,0.00851703631098744,-0.00708984602950418,0.0262969363095666,0.259523901917204
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,36955,0.00719391995881305,0.00641396170758196,-0.00537744498804759,0.0197652849056737,0.26205273173937
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,39636,-0.00363886269318597,0.00324920039263663,-0.0100072954627538,0.00272957007638183,0.262763183068325
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,39455,0.00346055428962246,0.00309373201277775,-0.00260316045542193,0.00952426903466684,0.263341747906678
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,37203,-0.0025729046410683,0.00230062999582681,-0.00708213943288884,0.00193633015075224,0.263439520648149
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39194,0.00341732265291877,0.0030569775523708,-0.00257435334972801,0.00940899865556554,0.263638059322245
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,39194,0.00472977274412907,0.00423382608723197,-0.0035685263868456,0.0130280718751037,0.263953052927017
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,39496,0.00276174061127215,0.00247839223484108,-0.00209590816901637,0.00761938939156067,0.265156517487646
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39268,-0.0143361522252201,0.0128772096907562,-0.0395754832191023,0.0109031787686621,0.265599178960783
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,39472,0.00268845713744028,0.0024166764735921,-0.00204822875080024,0.0074251430256808,0.265958005533344
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,39428,0.00206928528628673,0.00186077377403789,-0.00157783131082754,0.00571640188340099,0.266131775157462
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",36861,0.00761048966153247,0.00685666728216685,-0.00582857821151457,0.0210495575345795,0.267046366696887
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37162,0.0103836134320043,0.00935744652100533,-0.00795698174916619,0.0287242086131747,0.2671652089512
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,39306,0.00561117829779597,0.00506078212007712,-0.00430795465755518,0.0155303112531471,0.267552916829393
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39123,-0.00558098976546536,0.00504296062898599,-0.0154651925982779,0.00430321306734718,0.268446497439653
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,39074,0.00654495253109586,0.00592305938013499,-0.00506424385396872,0.0181541489161604,0.26917982547115
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39428,-0.00423656845668885,0.00383710771173232,-0.0117572995716842,0.0032841626583065,0.269565485041648
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,36955,-0.00435166183260157,0.00394470780128176,-0.0120832891231138,0.00337996545791068,0.269976942339858
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,36992,0.00720760788484368,0.00656128340773491,-0.00565250759431673,0.0200677233640041,0.272004776527135
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39123,0.0039656421968803,0.00361353683762068,-0.00311689000485623,0.0110481743986168,0.272466825674879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37162,-0.00277548989099441,0.00253155266343922,-0.00773733311133528,0.00218635332934646,0.272942584592376
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,38483,0.00458089702869384,0.00419344959621852,-0.00363826417989445,0.0128000582372821,0.274678940239318
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39104,0.00582926244873209,0.00534398697978874,-0.00464495203165383,0.016303476929118,0.27537542030741
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,36880,0.00544932131927675,0.00500419711518631,-0.00435890502648842,0.0152575476650419,0.276196973812561
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,36861,-0.00346464390856325,0.00318528195686499,-0.00970779654401864,0.00277850872689214,0.276746929410387
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,36916,0.00686454843386533,0.00631129235543806,-0.00550558458279327,0.0192346814505239,0.276765691008244
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39123,0.00469165652493963,0.00431653915359965,-0.0037687602161157,0.0131520732659949,0.277097826921916
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,36823,-0.00506674783873535,0.00466364715809397,-0.0142074962685995,0.00407400059112883,0.277307909655153
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,36880,0.00654997619214861,0.00603230916294091,-0.00527334976721558,0.0183733021515128,0.277581584955871
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,39428,-0.00728494121191711,0.0067163517462689,-0.0204489906346041,0.00587910821076992,0.278090843672318
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37221,-0.00426456991910008,0.00393616211151296,-0.0119794476576655,0.00345030781946533,0.278636507286895
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,36847,0.00626710779866118,0.00578553740976421,-0.00507254552447667,0.017606761121799,0.278724341524957
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36823,0.00551884862898447,0.00510532659327509,-0.00448759149383471,0.0155252887518037,0.279719006601656
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",36880,0.00271240154531902,0.00251044637895518,-0.00220807335743314,0.00763287644807117,0.279964623043956
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39455,-0.00384160298065929,0.00355605985314266,-0.0108114802928189,0.00312827433150032,0.280027036535042
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39187,0.00255683685560121,0.00236847466696781,-0.0020853734916557,0.00719904720285812,0.280369686774302
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,39591,0.00769124903730623,0.0071262668036303,-0.00627623389780916,0.0216587319724216,0.280479382530284
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39531,-0.00249518547557284,0.0023151911461924,-0.00703296012210993,0.00204258917096425,0.281164850815485
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37247,0.0100011103672874,0.00928529948900225,-0.00819807663115702,0.0282002973657318,0.281460023524385
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,37247,0.00761667323810185,0.00708693161259205,-0.00627371272257857,0.0215070591987823,0.282507349553568
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,37269,-0.00389238710000923,0.00362234665881458,-0.0109921865512858,0.00320741235126734,0.282597156362081
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,39123,0.0134314757854831,0.0125030999557364,-0.0110746001277602,0.0379375516987265,0.282727575343649
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39187,0.00549768639430601,0.00511843586590037,-0.00453444790285871,0.0155298206914707,0.282797691750967
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36482,-0.00455931436579123,0.00424563795864056,-0.0128807647647267,0.00376213603314427,0.282897091700295
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37221,0.00715013941582501,0.00666685200795442,-0.00591689051976564,0.0202171693514157,0.283519779781484
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37126,-0.00497992788864,0.00464586751814207,-0.0140858282241985,0.00412597244691845,0.283783185358809
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37221,0.00634081072749358,0.00592652372133393,-0.00527517576632092,0.0179567972213081,0.284682799766116
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,36992,0.00370816624742216,0.00346955035450475,-0.00309215244740714,0.0105084849422515,0.285191955738158
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,36992,0.00506270022232183,0.0047503352999064,-0.00424795696549473,0.0143733574101384,0.286554296252217
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39123,0.00859436917202506,0.0080814605248571,-0.00724529345669485,0.024434031800745,0.287587580971782
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,36823,0.00330813757828504,0.00312005363168501,-0.00280716753981759,0.00942344269638766,0.289036898091416
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,36880,0.00322181409171601,0.00306523120933627,-0.00278603907858308,0.0092296672620151,0.293240656798698
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,36847,-0.00430414229976761,0.00409866483838041,-0.0123375253829932,0.003729240783458,0.293677543374754
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,39654,0.00643138498541716,0.00612785765795525,-0.00557921602417515,0.0184419859950095,0.293949848359942
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,36823,0.00903442153614541,0.0086114911333799,-0.0078441010852792,0.02591294415757,0.294146916036833
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,39123,0.00774705362963156,0.00739045739469689,-0.00673824286397435,0.0222323501232375,0.294540292276505
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,36823,0.00595203520167817,0.00567927001245366,-0.005179334022731,0.0170834044260873,0.294646083052929
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39428,0.00780431127150023,0.00744787681673803,-0.00679352728930632,0.0224021498323068,0.294721319218327
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39578,0.00238984311145549,0.0022810233482636,-0.00208096265114117,0.00686064887405216,0.29479056761153
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39104,0.00363073143892354,0.0034687999183054,-0.00316811640095504,0.0104295792788021,0.295263400923404
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,37247,0.00309850141991746,0.00296073953891118,-0.00270454807634845,0.00890155091618337,0.295336377918098
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37203,0.00419109748560279,0.0040052534912316,-0.00365919935721115,0.0120413943284167,0.295396201025364
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39123,0.00715325275693169,0.00684395641977877,-0.0062609018258347,0.0205674073396981,0.295951172946009
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,36763,0.00526473115353618,0.0050424942670874,-0.00461855760995513,0.0151480199170275,0.296472205459408
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,39104,-0.00398840025430173,0.00382546267180262,-0.0114863070910349,0.00350950658243142,0.297154076716204
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,38957,0.00239507459566214,0.0023004129969022,-0.00211373487826618,0.00690388406959046,0.297823370075794
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39531,-0.00256863089342524,0.00246931377114115,-0.00740848588486189,0.00227122409801141,0.298254131249229
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,39194,-0.0040055611104345,0.00385117666418418,-0.0115538673722355,0.0035427451513665,0.298316259574437
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39460,0.00554691970874428,0.00533774592484371,-0.0049150623039494,0.016008901721438,0.29873420867915
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,36880,0.00802949075672223,0.00772699968489844,-0.00711542862567871,0.0231744101391232,0.298756457715478
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39355,0.00856470208595949,0.00824747406891784,-0.00760034708911947,0.0247297512610385,0.29907109445969
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,39420,0.00395423862644308,0.00381726800419734,-0.0035276066617837,0.0114360839146699,0.30027400271658
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,36880,-0.00383782574237537,0.00370491893085519,-0.0110994668468515,0.0034238153621008,0.300281517974341
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36823,0.00601777487522448,0.00581206404129879,-0.00537387064572115,0.0174094203961701,0.300505294481556
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,37221,-0.00341348515001953,0.00330195245196132,-0.00988531195586371,0.00305834165582465,0.30125962932004
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,36880,-0.00437353624053592,0.0042314781087268,-0.0126672333336404,0.0039201608525686,0.301356522582623
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39462,-0.0134570514553138,0.0130893266816643,-0.0391121317513758,0.0121980288407482,0.303922422650616
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,39601,-0.00309100251950922,0.0030289970776454,-0.0090278367916942,0.00284583175267575,0.307521613203228
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39124,0.00694566664404483,0.00681838064679845,-0.00641835942368013,0.0203096927117698,0.308377373508594
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,36880,0.00264803414697151,0.00260053783899587,-0.00244902001746039,0.00774508831140341,0.308572317999347
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,36880,0.00456887232579921,0.00448809962102698,-0.00422780293141367,0.0133655475830121,0.308699158542928
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,39499,0.00292363815498166,0.00287231674769411,-0.00270610267049879,0.00855337898046212,0.308757246286298
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,36823,0.00302431251412582,0.00297300090833529,-0.00280276926621135,0.008851394294463,0.309050035819865
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,37255,0.00394281413597393,0.00387932131621085,-0.00366065564379934,0.0115462839157472,0.309473863932379
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39485,0.00767671851789427,0.00755805457145329,-0.00713706844215418,0.0224905054779427,0.309788457506396
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,36916,0.00229998902266601,0.00226584690088782,-0.00214107090307413,0.00674104894840615,0.310093045971314
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36763,0.00759492116374662,0.00750350404869065,-0.00711194677168705,0.0223017890991803,0.311470332679827
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36763,-0.00444302000075347,0.00439150460093594,-0.0130503690185879,0.00416432901708097,0.311686718723112
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,36880,0.00186507742244927,0.0018445659928102,-0.00175027192345873,0.00548042676835727,0.311978721177373
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",36847,-0.00359746252963625,0.00356006845855779,-0.0105751967084095,0.00338027164913703,0.312273728636362
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36763,0.00684875214183241,0.00677814632540048,-0.00643641465595253,0.0201339189396173,0.312315555352453
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,39187,-0.0020080918816776,0.00198939926372039,-0.00590731443856957,0.00189113067521436,0.312801277200018
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,36955,0.00335128709804541,0.00332007217412022,-0.00315605436323022,0.00985862855932103,0.312801470370821
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,36847,-0.0046092906765151,0.00456914891058051,-0.0135648225412529,0.0043462411882227,0.313097260152153
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,39463,-0.00526040628980433,0.0052165900849975,-0.0154849228563994,0.00496411027679076,0.313279016998304
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,36916,-0.00389410880203025,0.00386310192957658,-0.0114657885840004,0.00367757097993986,0.313461348077898
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,36880,0.00737813075207158,0.00732426708264491,-0.00697743272991245,0.0217336942340556,0.313784234285859
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39355,0.00305226378123802,0.00303167374191586,-0.00288981675291707,0.0089943443153931,0.314051258478357
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,37203,-0.0049520097914156,0.00491930897360571,-0.0145938553796828,0.00468983579685159,0.314123329664335
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,39187,0.00942827416098132,0.00937035006789657,-0.00893761197209596,0.0277941602940586,0.314344726677334
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,36847,0.00486933236693983,0.0048426097261707,-0.00462218269635475,0.0143608474302344,0.314667003842373
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39520,-0.00457135750985483,0.00454872075467048,-0.013486850189009,0.0043441351692993,0.314924298878767
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36763,0.00319334878553404,0.00318004942657406,-0.00303954809055111,0.00942624566161919,0.315310573585678
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36823,0.00364498018396779,0.00363183558828352,-0.00347341756906791,0.0107633779370035,0.315581792188978
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,38875,0.00278215737153107,0.00277342830644514,-0.0026537621091014,0.00821807685216354,0.315806580717985
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,36538,0.00601455888505129,0.00602719934337353,-0.00579875182796083,0.0178278695980634,0.318346489784817
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,36763,0.0039036044225115,0.00391318166611239,-0.00376623164306878,0.0115734404880918,0.318515977013829
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,36880,0.00285616319207714,0.00286843860596673,-0.00276597647561765,0.00847830285977192,0.319405340966733
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,36882,-0.00334426229969085,0.00336387145820493,-0.00993745035777252,0.00324892575839083,0.320159143164569
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37247,0.00467260320081099,0.00470574622645871,-0.00455065940304808,0.01389586580467,0.320749734513619
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39194,0.00332787816488688,0.00336016519400915,-0.00325804561537106,0.00991380194514481,0.321999181648629
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39485,-0.00222205465551083,0.00224536517069952,-0.00662297039008189,0.00217886107906024,0.322376607716615
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39566,-0.00264769500990208,0.00268003359716475,-0.00790056086034499,0.00260517084054083,0.323201025691459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,39104,0.00303596758744958,0.00307409229749836,-0.0029892533156472,0.00906118849054636,0.323365845253855
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,39642,-0.00474267544881449,0.00480390767628962,-0.0141583344943422,0.00467298359671317,0.323534025529108
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,39397,0.00297114368910979,0.00301235713119969,-0.00293307628804161,0.00887536366626118,0.32399279190883
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,39589,0.00500215360097472,0.00508002810879925,-0.00495470149227181,0.0149590086942213,0.324801706855177
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,39123,-0.00671977585851192,0.00683049445172191,-0.0201075449838869,0.00666799326686302,0.325234732603344
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37145,-0.00355339451397979,0.00361218212591118,-0.0106332714807657,0.00352648245280613,0.325269405691642
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,36916,0.00579142332501158,0.00589414206943732,-0.00576109513108557,0.0173439417811087,0.325836838196777
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,39187,-0.0100538823038487,0.0102440357680464,-0.0301321924092195,0.0100244278015222,0.326393085073131
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36763,-0.00427550674093309,0.00435656001221687,-0.0128143643648782,0.00426335088301199,0.326417216622245
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,36861,0.00736486920983462,0.00752203053161089,-0.00737831063212272,0.022108049051792,0.327546433338841
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,36861,0.00413218184810688,0.00423287635601593,-0.00416425580968435,0.0124286195058981,0.328978780843486
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,39636,0.00660746962103402,0.00676878105960158,-0.00665934125578507,0.0198742804978531,0.328996612109818
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,36880,0.00742088493406917,0.00760420910259456,-0.00748336490701616,0.0223251347751545,0.329137105072987
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36763,-0.00257308995580124,0.00264020563329501,-0.00774789299705946,0.00260171308545698,0.32978809721166
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,39428,-0.00280181124827203,0.00288058105502676,-0.00844775011612448,0.00284412761958043,0.3307405616758
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,39160,0.00409708190380273,0.00423132275817918,-0.00419631070222845,0.0123904745098339,0.332923220875097
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",36880,0.00305504463987547,0.00316172298964516,-0.00314193241982905,0.00925202169957998,0.333933185498997
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,36763,0.00356709573515377,0.0036933544510487,-0.00367187898890168,0.0108060704592092,0.334155921775792
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,39395,0.00458470907516872,0.0047497192608708,-0.00472474067613805,0.0138941588264755,0.334430742730918
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,39636,0.00571076498238119,0.00591683444091678,-0.0058862305218157,0.0173077604865781,0.334473866681262
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37221,0.00757542593105891,0.00785654765003703,-0.00782340746301367,0.0229742593251315,0.334954820736107
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39462,-0.00799190074139466,0.00830014211718766,-0.0242601792910825,0.00827637780829316,0.335631730309738
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,36880,0.00692271733199068,0.00723908337912984,-0.0072658860911038,0.0211113207550852,0.338940554079162
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,37255,-0.00270569668515503,0.0028342174940213,-0.00826076297343678,0.00284936960312672,0.339770791607873
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36719,-0.00443528773156457,0.00465111708286882,-0.0135514772139875,0.00468090175085831,0.340306852793098
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",38698,-0.00238723760055704,0.00250619569960437,-0.0072993811717816,0.00252490597066752,0.340842192572812
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,37203,0.00790713976736543,0.00831276072316393,-0.00838587125003586,0.0242001507847667,0.341518337513531
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36763,-0.00534397248055232,0.00563902054034838,-0.0163964527396351,0.0057085077785305,0.343312296579092
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,39393,0.0033234777266522,0.00351049991388053,-0.00355710210455364,0.010204057557858,0.343794282721641
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,36763,0.0051739264600704,0.00547612678716186,-0.00555928204276685,0.0159071349629076,0.344771899841151
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,39068,0.00281968495127638,0.00299051181804076,-0.00304171821208352,0.00868108811463628,0.345759380957613
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,39636,0.00816283316579982,0.00868190158986631,-0.00885369395033816,0.0251793602819378,0.347123482644407
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,39194,0.00502403409362367,0.00534704289828631,-0.00545616998701749,0.0155042381742648,0.347442720801186
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,39531,0.00470766494385489,0.00501642344714406,-0.00512452501254747,0.0145398549002572,0.348027990265722
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37221,0.00644031066953611,0.00687292519650399,-0.00703062271561171,0.0199112440546839,0.348747858692324
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,36880,-0.00256243966413318,0.00274241966278628,-0.00793758220319429,0.00281270287492794,0.350130279805291
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36287,-0.00409151832804565,0.00438046626435114,-0.0126772322061739,0.00449419555008258,0.350303773760043
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,36861,0.00484205602013752,0.00519100883287051,-0.00533232129228867,0.0150164333325637,0.350953031039071
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,39130,0.00730376532932796,0.00783267662435205,-0.00804828085440206,0.022655811513058,0.351107085116899
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,36880,0.00359933120785668,0.00386413648284787,-0.00397437629852515,0.0111730387142385,0.351628054687105
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,39123,0.00723612344011481,0.00778019103986047,-0.00801305099801172,0.0224852978782413,0.352350068203288
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,39032,0.00688252739188018,0.00740478044523986,-0.00763084228078994,0.0213958970645503,0.352660525903642
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,39068,-0.00361070950416131,0.00389293145431978,-0.0112408551546281,0.00401943614630547,0.353680230279032
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,36847,0.00482045982859209,0.0052085924605752,-0.00538838139413531,0.0150293010513195,0.354733134399797
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,39636,-0.00756817072202452,0.00818237435175707,-0.0236056244514684,0.00846928300741935,0.355014017865326
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,39568,-0.00223966250915447,0.00242262456163814,-0.00698800664996523,0.00250868163165629,0.355252386953921
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37143,-0.00332875273886005,0.00360640062584507,-0.0103972979655164,0.00373979248779628,0.356018255776183
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,37203,-0.00243629303281664,0.00264499505167996,-0.00762048333410937,0.00274789726847609,0.357017996925082
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37164,0.00215480507527303,0.00233970347517457,-0.00243101373606912,0.00674062388661518,0.357081700295333
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39123,0.00617729303106286,0.00671698196644895,-0.00698799162317708,0.0193425776853028,0.357769208818185
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,39428,-0.0149935382715549,0.0163584476775522,-0.0470560957195573,0.0170690191764475,0.359386747169946
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,36763,0.00648433423822802,0.007089220868202,-0.0074105386634479,0.0203792071399039,0.360380102120341
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,37247,0.00548362970001773,0.0059956656049226,-0.00626787488563057,0.017235134285666,0.360419424653117
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,39568,0.0046668718420421,0.00511686223849171,-0.00536217814540166,0.0146959218294859,0.361753070484742
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,36880,0.00502178525391565,0.00551399704994015,-0.00578564896396705,0.0158292194717984,0.362453144711731
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,39485,0.00469855605866376,0.00516121461166077,-0.00541742458019135,0.0148145366975189,0.362648024632045
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,38979,-0.00686929639265634,0.00756596582436919,-0.02169858940842,0.00795999662310728,0.363935222495964
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,36861,-0.00540195233037122,0.00596083472885674,-0.0170851883989304,0.00628128373818799,0.364825946339967
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36823,-0.00436969164050709,0.00482464101288319,-0.0138259880257581,0.00508660474474396,0.365110734853961
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36763,-0.0035317813854075,0.00390598426367314,-0.0111875105422069,0.00412394777139185,0.36590835421914
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,37145,0.0036088334035091,0.00399248305333906,-0.00421643338103546,0.0114341001880537,0.366061868366034
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,36819,0.0069459126080547,0.00768666390849012,-0.00811994865258594,0.0220117738686953,0.366208366421602
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,36916,0.0048049772887622,0.00531764133078376,-0.00561759971957396,0.0152275542970984,0.366229335403503
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,39104,-0.00413007386504306,0.00457105387253926,-0.01308933945522,0.00482919172513389,0.366260739494714
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,36861,0.00816918090973394,0.00907544691030836,-0.00961869503447045,0.0259570568539383,0.368062742873333
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,39601,0.00279416047633779,0.00310558439403626,-0.00329278493597328,0.00888110588864887,0.368282878266516
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,39415,0.00852930137722441,0.00948437277979813,-0.0100600692711799,0.0271186720256287,0.368507081943304
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37221,0.00330215690944664,0.00367333859938375,-0.00389758674534551,0.0105019005642388,0.368694914285078
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,37164,-0.00355120093508089,0.00395719244374745,-0.0113072981248259,0.0042048962546641,0.369520292301914
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",36847,0.00311009497035436,0.00347167044069163,-0.00369437909340123,0.00991456903410996,0.370350431446808
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,36763,-0.00479498911125489,0.00535770762406315,-0.0152960960544187,0.00570611783190889,0.370820470624766
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37247,0.00569642334140317,0.00637859706314479,-0.00680562690236061,0.018198473585167,0.37184574632115
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,37221,-0.00370971982547533,0.0041543510888875,-0.0118522479596948,0.00443280830874418,0.371888915348518
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,36847,0.00353879858568346,0.0039705584899222,-0.00424349605456405,0.011321093225931,0.372807188006477
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,39654,0.00471908916445516,0.00530411699443701,-0.00567698014464138,0.0151151584735517,0.373639424817609
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,37173,0.00442883968125794,0.00498289610240828,-0.00533763667946228,0.0141953160419782,0.374122891611809
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,36861,0.00564169067122441,0.00636007907437963,-0.00682406431455967,0.0181074456570085,0.375070651885382
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,39462,-0.0060486244515608,0.00682063391848554,-0.0194170669317924,0.00731981802867085,0.375193983152788
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",36880,0.00354825313163251,0.00400183974868452,-0.00429535277578915,0.0113918590390542,0.375281572501975
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39431,0.00313844476354026,0.0035401877872794,-0.00380032329952736,0.0100772128266079,0.375351996625549
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,36861,0.00182406906563034,0.00205918366751072,-0.00221193092269068,0.00586006905395136,0.375730913611002
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,37162,0.00271569544767027,0.00307724952490731,-0.00331571362114805,0.00874710451648859,0.377519175110937
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,37203,-0.00177432669019135,0.0020167926636791,-0.00572724031100238,0.00217858693061969,0.378997004618856
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39104,0.00604596538829354,0.00687425209583317,-0.00742756871953947,0.0195194994961266,0.379139873895989
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,39355,-0.00683035478445004,0.00776621943362442,-0.0220521448743539,0.00839143530545383,0.379146870895644
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,36861,0.00554116269918942,0.00630516524316015,-0.00681696117740449,0.0178992865757833,0.379510961988234
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,36849,-0.00292345504191976,0.00332855954453201,-0.0094474317492025,0.00360052166536298,0.379801022891741
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,36992,-0.00390394406507601,0.00444675150124283,-0.012619577007512,0.00481168887735993,0.379997609851323
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37221,0.00470224030945579,0.00538673853510923,-0.00585576721935829,0.0152602478382699,0.38271819036122
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39104,0.0108277524129461,0.0124585739294268,-0.0135910524887305,0.0352465573146226,0.384806417618749
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,39123,0.00739049837305888,0.00851807563036348,-0.00930492986245355,0.0240859266085713,0.385613653590576
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,38842,0.00355796888307172,0.00410588888952029,-0.00448957334038804,0.0116055111065315,0.386201616976019
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",36880,-0.0046641070032268,0.00538600661468501,-0.0152206799680094,0.00589246596155582,0.386524668672975
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,37119,0.00360720398474359,0.00417316753410716,-0.00457220438210644,0.0117866123515936,0.38739535544612
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37162,0.00211811585553604,0.0024569117620857,-0.00269743119815193,0.00693366290922402,0.38864601833164
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,36880,0.00349523199685976,0.00405569942508659,-0.00445393887630995,0.0114444028700295,0.388810109819267
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37243,0.00194313767801376,0.00225486463051094,-0.00247639699778768,0.0063626723538152,0.388839286307107
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,36831,-0.00303428942904723,0.00352203688272817,-0.00993748171919444,0.00386890286109998,0.388970865351666
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,37164,-0.0078290292681364,0.00911673033826103,-0.025697820731128,0.0100397621948552,0.390492405559325
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37162,-0.00849444822937591,0.00989999025242245,-0.0278984291241239,0.0109095326653721,0.390894331244401
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39520,0.00533063914948682,0.00622094584523839,-0.00686241470718044,0.0175236930061541,0.391521718183563
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37247,-0.00186137313362871,0.00217518964163878,-0.00612474483124071,0.00240199856398329,0.392163649198837
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37128,0.00232585131582723,0.00271899880256428,-0.00300338633719875,0.00765508896885322,0.392341893559165
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,36955,-0.0042214081326362,0.00494640844100386,-0.0139163686770038,0.00547355241173135,0.393437825462621
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,39428,0.00223779097000789,0.00262379018995567,-0.00290483780230523,0.007380419742321,0.393736789499611
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,39462,-0.00320307135871952,0.00376198099863726,-0.0105765541160485,0.00417041139860951,0.394542953101383
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39462,0.00534198644328849,0.00627695973675249,-0.00696085464074639,0.0176448275273234,0.394756937071494
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39455,0.00170035142618231,0.0019987402208386,-0.00221717940666134,0.00561788225902596,0.394943172486769
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39445,-0.00179896630034386,0.0021197399308372,-0.00595365656478477,0.00235572396409705,0.39607675675308
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39123,0.00265912455084434,0.00313686830860261,-0.00348913733401678,0.00880738643570547,0.396618666997162
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,36847,0.00514476087173773,0.00606946151785663,-0.00675138370326126,0.0170409054467367,0.396650955808226
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,39455,-0.00391067013027465,0.00462023337522378,-0.0129663275457133,0.00514498728516396,0.397330513181298
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39123,-0.00453123510952506,0.00535859744183385,-0.0150340860955194,0.00597161587646929,0.397789183761459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,37221,0.00422356334166858,0.00499796836775056,-0.00557245465912252,0.0140195813424597,0.398095385998568
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,36847,0.00283372660614019,0.00335576536038098,-0.00374357350020654,0.00941102671248692,0.398442521719869
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39194,-0.00471763370865127,0.0055904501051645,-0.0156749159147737,0.00623964849747114,0.398753689587679
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,36916,0.00601759628424932,0.00715103355757309,-0.00799842948859393,0.0200336220570926,0.400083908383103
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,39485,0.00504403807394285,0.00599485944667942,-0.00670588644154881,0.0167939625894345,0.400140694218632
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,37164,-0.00778963319156607,0.00928802241787842,-0.0259941571306078,0.0104148907474756,0.401667420964277
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,37247,0.00391409038910797,0.00466974064081053,-0.00523860126688067,0.0130667820450966,0.401944411774459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,39194,0.002820310196688,0.0033722512994094,-0.00378930235015441,0.00942992274353042,0.402983625382106
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,39194,0.00578093947521051,0.0069230166744925,-0.00778817320679479,0.0193500521572158,0.403713303375578
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,39654,0.00220626528748811,0.00264675405837651,-0.00298137266692984,0.00739390324190606,0.404534195736064
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39462,0.00271256693655196,0.00325582972728507,-0.00366885932892678,0.0090939932020307,0.404778174510445
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,39531,-0.00598615620204946,0.00719544312707871,-0.0200892247311237,0.00811691232702482,0.405457614830006
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,39194,0.0035597433803069,0.00428037214522354,-0.00482978602433124,0.0119492727849451,0.405623709503181
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37203,-0.00279268112049894,0.00335980029245188,-0.00937788969370463,0.00379252745270674,0.405873677615144
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,39104,0.00473426309823212,0.0057020164450108,-0.00644168913398904,0.0159102153304533,0.406394726445022
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,36880,0.00418069812448142,0.00503981212742296,-0.00569733364526758,0.0140587298942304,0.406817945391934
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,39495,0.00489110098077579,0.00589901403458285,-0.0066709665270066,0.0164531684885582,0.407039068449581
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39123,0.00459023266702689,0.00553750775223769,-0.00626328252735898,0.0154437478614128,0.40715480978571
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,36880,0.00217964956905436,0.00263436178923265,-0.00298369953784163,0.00734299867595034,0.408030864272697
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,36992,-0.00597216888091795,0.00721821976152227,-0.0201198796135016,0.0081755418516657,0.40804073685269
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39578,-0.00460269404402995,0.00557135543969984,-0.0155225507058416,0.00631716261778174,0.408740309638486
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39458,0.00745338934939574,0.00903432026681653,-0.0102538783735647,0.0251606570723561,0.409379983679483
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,39654,-0.0027983139016239,0.00339599677150562,-0.00945446757377491,0.00385783977052712,0.409950383513355
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,37243,0.00185913106885286,0.00226125089292443,-0.00257292068127904,0.00629118281898475,0.410995872712962
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,39455,-0.00346759997834442,0.00422520386746241,-0.0117489995585707,0.00481379960188191,0.411833559115464
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,36861,0.00308449768194159,0.00375970602768807,-0.00428452613232703,0.0104535214962102,0.411998590878361
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39526,0.00194416865710747,0.00237172327618729,-0.00270440896421961,0.00659274627843455,0.412383981559295
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",36992,-0.00317975043086648,0.00387916808092727,-0.0107829198694839,0.00442341900775098,0.412403264798907
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,36736,-0.00507367358971975,0.0061943907151418,-0.0172146793913977,0.00706733221195817,0.412759236681823
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,36763,0.00388473705426802,0.00474995563392662,-0.00542517598822816,0.0131946500967642,0.413460374329324
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37221,0.00659084216101438,0.00806014955670928,-0.00920705097013582,0.0223887352921646,0.41353966738018
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,36847,-0.00854649027631912,0.0104570373863657,-0.029042283553596,0.0119493030009577,0.413775249692175
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,36880,0.00120110564536003,0.00146967610998366,-0.00167945953020795,0.00408167082092801,0.413796247005094
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,39531,-0.00225101970075949,0.0027572655787395,-0.00765526023508892,0.00315322083356993,0.414286764635267
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,39623,-0.00377223967653773,0.00462306812281362,-0.0128334531972524,0.00528897384417698,0.414535699393153
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37203,0.00183995854294078,0.00225726782622892,-0.0025842863964679,0.00626420348234947,0.415015199587451
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37164,-0.00542189790800233,0.00665944612894716,-0.0184744123207388,0.00763061650473411,0.415564827931833
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36763,-0.00330836838756246,0.00406630430444533,-0.0112783248242753,0.00466158804915039,0.415886602724355
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,39589,0.00906595257986223,0.0111688360135303,-0.0128249660066572,0.0309568711663816,0.416965849604962
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37164,-0.00588689555764707,0.00725257657749202,-0.0201019456495314,0.00832815453423729,0.416980642604349
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,36880,0.00143435196235358,0.00176926732618907,-0.00203341199697699,0.00490211592168415,0.417551243799155
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",36916,-0.00581983346837201,0.00718479497614169,-0.0199020316216097,0.00826236468486569,0.41794367804274
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",36861,0.00275816543810594,0.00340721219973543,-0.0039199704733755,0.00943630134958739,0.418238540784282
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,39654,0.00244779717268687,0.00303945116505331,-0.00350952711081761,0.00840512145619136,0.420635043543244
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,39589,0.00377585114243591,0.00469556530304505,-0.00542745685153238,0.0129791591364042,0.421333764252356
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,37196,-0.002199479258775,0.00274111203341926,-0.00757205884427675,0.00317310032672675,0.422334263064823
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39428,-0.00185302987303288,0.00231138074269245,-0.00638333612871009,0.00267727638264433,0.422740254258961
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39485,-0.00196169077225672,0.00244830284620115,-0.00676036435081098,0.00283698280629754,0.4230024034217
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,36976,0.00701115991952501,0.00877941509019568,-0.0101964936572585,0.0242188134963085,0.424542880376216
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36823,0.00238341273913759,0.00298943200514509,-0.0034758739909468,0.00824269946922197,0.425304047504722
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39187,0.00339266358864157,0.00425776986243045,-0.00495256534172211,0.0117378925190052,0.425570134195018
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39187,-0.00385540582694573,0.00484925803452276,-0.0133599515746103,0.00564913992071888,0.426596836598078
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39104,0.00266999383910849,0.00336535235276912,-0.00392609677231899,0.00926608445053597,0.427570935667611
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,39531,-0.00178230511314958,0.00224889091673538,-0.00619013130995092,0.00262552108365177,0.428066352965775
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,36861,-0.00459588685681065,0.00580438839941524,-0.0159724881196645,0.00678071440604322,0.428495238274312
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36823,0.00416906174607655,0.00526648981177888,-0.00615325828501005,0.0144913817771632,0.428597118040168
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,37221,0.00300962734926255,0.00380979763543431,-0.0044575760161887,0.0104768307147138,0.429559726617568
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,39123,-0.00741070623132556,0.00938565900730343,-0.0258065978856403,0.0109851854229892,0.429787247404986
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,36880,0.00214455179550443,0.00273410499631613,-0.00321429399727519,0.00750339758828405,0.432837586970889
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36763,0.00435335813641167,0.00556918940566737,-0.00656225309869638,0.0152689693715197,0.434414085058405
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,36847,0.00408776305671401,0.00523867253665064,-0.00618003511512124,0.0143555612285493,0.43522619412516
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37221,0.00334010816417377,0.00428134191221965,-0.00505132198377675,0.0117315383121243,0.435314400429192
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,36880,-0.00207084125891487,0.00265904281651498,-0.00728256517928422,0.00314088266145448,0.436117081936624
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39455,-0.00356707970108434,0.00459134547341224,-0.0125661168289723,0.00543195742680365,0.437221872261034
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,37243,-0.00162728434184576,0.00210128284044243,-0.00574579870911292,0.0024912300254214,0.438694274765648
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,36929,0.0036152223636737,0.00468230023470335,-0.00556208609634486,0.0127925308236923,0.440067504747273
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37221,0.00178248719122108,0.00231608133440585,-0.0027570322242144,0.00632200660665655,0.441543500249519
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,39428,0.00286921016444685,0.00372920167217106,-0.00444002511300843,0.0101784454419021,0.441674006901588
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,37093,0.00195813677067683,0.00254518873288437,-0.00303043314577653,0.00694670668713019,0.441700912030131
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39296,0.00216430063984107,0.0028174765375371,-0.00335795337373164,0.00768655465341378,0.44239847967509
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,39194,-0.00375079252296524,0.00490845337255838,-0.0133713611331797,0.00586977608724919,0.444790346613838
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,36992,0.00234140623401288,0.00306459490455191,-0.00366519977890885,0.00834801224693462,0.444870781189097
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37162,-0.00266658742317461,0.00350030775988567,-0.00952719063255052,0.0041940157862013,0.446184482356192
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,37243,-0.00171089123669295,0.00224590505131364,-0.00611286513726768,0.00269108266388177,0.446203852817275
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,37019,0.00186276292822201,0.00244640503893154,-0.0029321909480838,0.00665771680452783,0.446415358141285
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,39194,-0.00464288372257038,0.0061051240774378,-0.0166089269143485,0.0073231594692077,0.4469741113405
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,36955,-0.00520993863592151,0.00685675061098994,-0.0186491698334618,0.00822929256161876,0.447372816876857
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39123,-0.00233558664480061,0.00307389955593115,-0.00836042977442566,0.00368925648482443,0.447379007578682
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,36763,-0.00479511470370609,0.0063144886162844,-0.0171715123916235,0.00758128298421134,0.447638077003017
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39123,-0.00378900338569884,0.00499585565568776,-0.0135808804708468,0.00600287369944918,0.448206196790568
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,37162,0.00247850125852543,0.00327002069917602,-0.00393073931185958,0.00888774182891043,0.448496969693362
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,39458,-0.00190082117207834,0.00251982873735196,-0.00683968549728818,0.0030380431531315,0.450653695643787
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39428,-0.00253262991877059,0.00335822366060678,-0.00911474829355987,0.00404948845601869,0.45076644735894
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39123,0.00236771757367573,0.00314256039498319,-0.00379170080049133,0.00852713594784279,0.451200154179581
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,37203,-0.00390374471804487,0.00518813981152562,-0.0140724987486351,0.00626500931254534,0.45180261411281
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,36992,-0.00353139437303606,0.00469699265252156,-0.0127374999719783,0.00567471122590621,0.452160444723701
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39104,-0.00250686231185288,0.00333532103134595,-0.00904409153329094,0.00403036690958518,0.452297398711201
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39541,0.00172069775768961,0.00229239138464023,-0.00277238935620523,0.00621378487158446,0.452897566833211
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39104,0.00435053824815778,0.00580519867328394,-0.00702765115147874,0.0157287276477943,0.453615482210101
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,39589,0.00183402681596115,0.0024492227998578,-0.00296644987176014,0.00663450350368245,0.453977388309363
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36763,0.0038859527909273,0.00518959696557668,-0.00628565726160299,0.0140575628434576,0.453994088544111
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37247,0.00260291801561512,0.00349165721263911,-0.00424073012115753,0.00944656615238778,0.456002664558308
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39568,-0.00146790174864308,0.00197672324026236,-0.0053422792995573,0.00240647580227115,0.457739389104703
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,36916,-0.00232476213733096,0.00313165761927841,-0.00846281107111665,0.00381328679645473,0.457893916206099
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,36864,0.00442807706014973,0.00597855044905887,-0.00728988182000564,0.0161460359403051,0.458913234978901
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39123,-0.00433958452513348,0.00588502301784985,-0.0158742296401192,0.00719506058985221,0.460894177021802
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,36880,-0.00261062157662791,0.00354100726375828,-0.00955099581359414,0.00432975266033832,0.460981851371788
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,36861,-0.00271581583806198,0.00368458805284764,-0.00993760842164335,0.00450597674551939,0.46109099046984
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,36861,0.00351532092557259,0.00479162422645217,-0.00587626255827366,0.0129069044094188,0.463182833439796
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,36916,-0.0031271774780321,0.00427336952497046,-0.0115029817469742,0.00524862679091,0.464315026994167
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,39194,0.00339069260295728,0.00463463721079568,-0.00569319633020226,0.0124745815361168,0.464425428496632
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,36847,-0.0023085753200355,0.00315747415046617,-0.00849722465494919,0.00388007401487819,0.464703660399437
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39194,0.00433784748134847,0.00593785177556147,-0.00730034199875201,0.015976036961449,0.465070830154353
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,37269,0.00111160270389634,0.00152164895721959,-0.00187082925225406,0.00409403466004674,0.4650826500934
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,36992,-0.0044966573747054,0.00615883384834283,-0.0165679717174573,0.00757465696804655,0.465333492339149
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,39499,0.00190008448508611,0.00261109324385341,-0.00321765827286658,0.00701782724303881,0.466810464987334
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,39541,0.0027112572391056,0.00372955625471973,-0.00459867302014508,0.0100211874983563,0.467258612844828
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,36955,-0.00443166311817736,0.00610850882088914,-0.0164043404071201,0.00754101417076535,0.468164950099974
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37221,-0.00296838127375578,0.00411480422676625,-0.0110333975582176,0.00509663501070607,0.470682409072623
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,37076,0.00190910206676782,0.00265471309388136,-0.00329413559723965,0.00711233973077529,0.472069902848009
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,39194,-0.00296956454468591,0.0041302892709368,-0.011064931515722,0.00512580242635022,0.47216923850973
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,36880,-0.00494966957020171,0.00689074840065287,-0.0184555364354813,0.00855619729507791,0.472581807973155
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,39123,0.00277452192621592,0.00386306070511439,-0.00479707705580828,0.0103461209082401,0.472633968085112
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,39104,0.00286481444393851,0.00399021292165091,-0.00495600288249728,0.0106856317703743,0.472793216195254
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,37221,-0.00513628458659008,0.00715610726319668,-0.0191622548224556,0.00888968564927541,0.472925560870945
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39187,0.00391399093397658,0.00546992864748987,-0.00680706921510356,0.0146350510830567,0.474282458961418
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,39654,-0.00169010802472832,0.00236504377622673,-0.00632559382613271,0.00294537777667608,0.474854740742817
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37269,0.00109825869754144,0.00153804113751135,-0.00191630193198081,0.0041128193270637,0.475201054590977
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,36847,0.00415389577405376,0.00583930157925448,-0.00729113532128502,0.0155989268693926,0.476869239960774
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37247,0.00291866335204922,0.00410493425240714,-0.00512700778266878,0.0109643344867672,0.47708887882047
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,36955,0.00512024232878179,0.00722133759702855,-0.00903357936139416,0.0192740640189577,0.478310716734379
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,39481,0.00384415439073312,0.00545398978241197,-0.00684566558279434,0.0145339743642606,0.480924816668683
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,39104,0.0043866972179283,0.00622753364370974,-0.00781926872374279,0.0165926631595994,0.481192650085504
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39104,0.00396450776972324,0.0056290333753965,-0.0070683976460539,0.0149974131855004,0.481259420209002
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,39524,0.00247556957358623,0.00352225313400159,-0.00442804656905687,0.00937918571622934,0.482168235900658
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,39608,0.00164161919181794,0.00233706380380206,-0.00293902586363409,0.00622226424726997,0.482423039459881
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39319,0.00683427119297616,0.00973077135229362,-0.0122380406575193,0.0259065830434717,0.482480632655935
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,36861,-0.00303723146636932,0.00432725180134895,-0.0115186449970133,0.00544418206427463,0.482764287818125
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37247,0.00168024181902511,0.00240409268869931,-0.00303177985082554,0.00639226348887575,0.484621657615818
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,38700,0.00232348222364048,0.00332949813129921,-0.00420233411370598,0.00884929856098694,0.485283905712495
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37255,-0.00356366581047418,0.0051093835398198,-0.013578057548521,0.00645072592757263,0.485518425168801
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,39601,-0.00327766285317857,0.00470049949165616,-0.0124906418568247,0.00593531615046751,0.485625162128513
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,39462,-0.00503703421003503,0.00722547093771711,-0.0191989572479606,0.0091248888278905,0.485737290709364
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39541,-0.00252661082974714,0.00362637030334903,-0.00963429662431124,0.00458107496481696,0.485980813712414
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,36880,0.0038101986770657,0.00548254747166675,-0.00693559436740112,0.0145559917215325,0.48708793396366
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37162,0.00411034834303918,0.00591885432227582,-0.00749060612862142,0.0157113028146998,0.487412744307243
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,37243,0.0014879528043887,0.00214349043124587,-0.00271328844085321,0.0056891940496306,0.487586440565901
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39462,-0.00625497437544859,0.00901297046140559,-0.0239203964798035,0.0114104477289064,0.487694836333446
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,39599,-0.00131810650408794,0.00190397733747645,-0.00504990208554177,0.0024136890773659,0.488765170665306
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,39194,-0.00180166395924216,0.00260730430600478,-0.00691198039901152,0.00330865248052721,0.489572400076971
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",36928,0.00512771050510982,0.00742085107094505,-0.00941715759394248,0.0196725786041621,0.489586660958232
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39123,0.00267222626157102,0.00388279954198529,-0.00493806084072016,0.0102825133638622,0.491324165964794
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,39187,-0.00770726226660688,0.0112093606050687,-0.0296776090525415,0.0142630845193278,0.491732056570597
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,36971,-0.00335243394500381,0.0048831089246809,-0.0129233274373784,0.00621845954737076,0.492387385928918
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,39589,-0.00176975786423923,0.00258540812054063,-0.00683715778049887,0.00329764205202041,0.493658736926958
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,37269,-0.00176212007770752,0.00257546309310171,-0.00681002774018687,0.00328578758477184,0.493864138078167
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37164,-0.00325865220793649,0.00476498882030214,-0.0125980302957287,0.00608072587985571,0.494067166597317
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",36847,0.0039665463250176,0.00580539451906183,-0.00741202693234358,0.0153451195823788,0.494460508798273
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,39531,0.00128006767302107,0.00187350429280112,-0.00239200074086912,0.00495213608691127,0.494460774878058
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,37221,-0.00375004610810397,0.00549935989673989,-0.0145287915057141,0.00702869928950621,0.495310805569319
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,37269,0.00118484107205728,0.00173789681367836,-0.00222143668275231,0.00459111882686686,0.495398476476309
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,36847,0.00417239013643658,0.00612350004428315,-0.00782966995035839,0.0161744502232316,0.495647969996716
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,36880,0.00236774221424619,0.00348509788884951,-0.00446304964789885,0.00919853407639124,0.496903153577588
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,39541,0.00121297378336264,0.00178545269324944,-0.00228651349540627,0.00471246106213154,0.496917142925827
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,36847,0.00722188762418198,0.0106343366815567,-0.0136214122716692,0.0280651875200332,0.497080653969917
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,36861,-0.00311888741868356,0.0045955044701675,-0.0121260761802119,0.00588830134284474,0.49735185734772
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39123,0.00221980601749029,0.00328076939588274,-0.00421050199843988,0.00865011403342046,0.498663202754651
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,36651,0.00227117966010601,0.00337356728549048,-0.00434101221945533,0.00888337153966736,0.50081505977477
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39187,-0.00371653186490998,0.00552418439836483,-0.0145439332857051,0.0071108695558851,0.501101144050123
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,39654,0.00240321409430141,0.0035722660919218,-0.00459842744586531,0.00940485563446814,0.501121550692616
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39559,-0.00474833396334284,0.00707588291291751,-0.0186170644726612,0.00912039654597548,0.502193289585992
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39462,-0.00619335015167667,0.00923031339213868,-0.0242847644002685,0.0118980640969151,0.5022439766781
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36763,0.00202894277517853,0.00303373940664664,-0.00391718646184887,0.00797507201220594,0.503640262768834
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,36763,0.00351029752015497,0.0052530024382823,-0.00678558725887835,0.0138061822991883,0.503989146984766
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,39428,-0.00425593825242565,0.00637783361749929,-0.0167564921427243,0.00824461563787296,0.504589818786179
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37221,0.00622550314854031,0.0093399087401598,-0.0120807179821729,0.0245317242792535,0.50507254948962
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36823,0.00376607725737837,0.00565600626360976,-0.00731969501929676,0.0148518495340535,0.50551651671094
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,36880,-0.00362561078205219,0.00544768086858475,-0.0143030652844783,0.00705184372037392,0.505722066477879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39187,-0.00191260376094394,0.00287459442586406,-0.0075468088356375,0.00372160131374962,0.505838770816514
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39571,0.00173139125184086,0.00260721222872123,-0.00337874471645275,0.00684152722013446,0.506650769782343
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39194,0.00169225346749191,0.00254926173469868,-0.00330429953251751,0.00668880646750133,0.506815266075752
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,36715,0.0020298002031122,0.0030597335628409,-0.00396727758005596,0.00802687798628037,0.507092535031439
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39462,0.00230980416324453,0.00348711191136619,-0.0045249351830332,0.00914454350952226,0.507735871265641
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37162,-0.00192014896406011,0.00289940736603953,-0.00760298740149758,0.00376268947337737,0.507819390122004
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37221,-0.0018906525734036,0.00285711468287234,-0.00749059735183339,0.00370929220502618,0.50815305812281
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,39319,0.00292888497231601,0.00442919635803544,-0.00575233988943346,0.0116101098340655,0.508450829115406
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,39462,-0.00274507219553326,0.00416300479514292,-0.0109045615940134,0.00541441720294687,0.509651088729089
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,36861,0.00211313644081927,0.00321798274379758,-0.00419410973702399,0.00842038261866253,0.511408560738255
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39104,0.00389701996011321,0.00593583568803828,-0.00773721798844182,0.0155312579086682,0.511497192650817
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,36861,0.00214108057470371,0.0032717028021879,-0.00427145691758458,0.00855361806699199,0.512850855999478
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,36847,0.00273425987334178,0.00418396092569614,-0.00546630354102266,0.0109348232877062,0.513439733517015
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37247,0.00436092212407487,0.00669582044154166,-0.0087628859413468,0.0174847301894965,0.514870880674959
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37221,-0.00345021564311958,0.00529795332148654,-0.0138342041532332,0.00693377286699404,0.514906152647928
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,36763,-0.0042234333180135,0.00648669223659418,-0.0169373501017381,0.00849048346571109,0.51499926292617
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,39485,-0.00240819526409201,0.00371014104753292,-0.00968007171725653,0.0048636811890725,0.516293637969226
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,39123,0.00547329109373611,0.00843739334767555,-0.011063999867708,0.0220105820551802,0.516545980222616
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36763,-0.00468705949772209,0.00722670249132003,-0.0188513963807093,0.00947727738526517,0.516625132996916
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,39458,0.00205524775467175,0.00316895177863617,-0.00415589773145514,0.00826639324079865,0.516634294271749
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,39194,0.00287255169467138,0.00443499430311123,-0.00582003713942663,0.0115651405287694,0.517188232315756
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,36763,0.00146114678647648,0.00225918458694576,-0.00296685500393722,0.00588914857689017,0.517800326441316
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,38907,-0.00173348312846138,0.00268825196532535,-0.00700245698049906,0.0035354907235763,0.51904334536449
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,36763,0.00236803516616009,0.00368303488790826,-0.0048507132141401,0.00958678354646028,0.520263605766259
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,36992,-0.00227080942795297,0.00353257524332746,-0.00919465690487479,0.00465303804896885,0.520352765357416
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,36847,0.00264393675940343,0.00411919491513997,-0.0054296852742709,0.0107175587930778,0.520977484810015
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,39136,0.0026627310212624,0.00417584659973318,-0.00552192831421462,0.0108473903567394,0.523711102533804
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,36880,-0.00163584828413668,0.0025688516320873,-0.00667079748302778,0.00339910091475442,0.52426595093201
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,36847,-0.00258286243394759,0.00407754573523728,-0.0105748520750127,0.00540912720711748,0.526460941959042
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,39104,0.00308289160518644,0.00489483077123361,-0.00651097670643143,0.0126767599168043,0.528818264500604
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,36992,0.0023288577907446,0.00373195156853888,-0.0049857672835916,0.0096434828650808,0.532617817665604
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,39589,-0.0026238038894519,0.00420895989463526,-0.010873365282937,0.00562575750403321,0.533040722792751
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,36880,0.00159138626080394,0.00255421112545394,-0.00341486754508578,0.00659764006669366,0.533266952028283
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37162,0.00468331558852648,0.00752447286002745,-0.0100646512171273,0.0194312823941803,0.533682735253364
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37221,0.00352885334239646,0.0057054507506902,-0.00765383012895633,0.0147115368137492,0.536253128127737
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,36916,-0.00229153054885661,0.00370617574923469,-0.0095556350173566,0.00497257391964338,0.53638852949966
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,39462,0.00217031337452968,0.00351290766269337,-0.00471498564434932,0.00905561239340867,0.536709233514235
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39330,0.00212794317611294,0.00346756558812436,-0.00466848537661082,0.00892437172883669,0.539442378844024
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,36861,0.00278758045381143,0.00455194257086876,-0.00613422698509133,0.0117093878927142,0.54028860286554
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,36880,-0.00188597481060882,0.00308183318190261,-0.00792636784713793,0.0041544182259203,0.54057194472841
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36763,0.00325772129494009,0.00533375195845535,-0.0071964325436324,0.0137118751335126,0.541359953100844
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36823,0.00168892689116054,0.00276609420835671,-0.00373261775721861,0.00711047153953969,0.541487664922457
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,39485,-0.00202166937795282,0.00331394228578295,-0.0085169962580874,0.00447365750218176,0.541838130341238
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,37203,-0.00314375935885608,0.00515873003433662,-0.0132548702261559,0.0069673515084437,0.542266435223981
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,36861,-0.00189317223008065,0.0031069973475431,-0.00798288703126513,0.00419654257110383,0.542319966442474
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39187,-0.0042641684889571,0.00701488536327292,-0.018013343800972,0.00948500682305783,0.543280218202867
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,39589,0.00123450117045962,0.0020332864225613,-0.00275074021776052,0.00521974255867977,0.543763310653917
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,37164,0.00310158039116247,0.00511897287296597,-0.00693160643985084,0.0131347672221758,0.544592661481621
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39104,-0.0031687278107683,0.00523544126229437,-0.0134301926848653,0.00709273706332868,0.545025192189554
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,36967,-0.00276280267648918,0.00456801046484226,-0.01171610318758,0.00619049783460165,0.545312683509843
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,36857,0.00187660604183252,0.00310886257909244,-0.00421676461318866,0.00796997669685371,0.546099989157225
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,36847,0.00227553113829813,0.00377561840182236,-0.0051246809292737,0.00967574320586995,0.546725312082946
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,39319,-0.00338973927079724,0.00563031473375219,-0.0144251561489515,0.00764567760735705,0.547149057219616
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,36847,0.00199396712589042,0.0033190277909063,-0.00451132734428593,0.00849926159606676,0.548005216721473
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39531,-0.00223132662668087,0.00371474751556326,-0.00951223175718486,0.00504957850382313,0.548070762413983
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,39606,0.003645687247266,0.00607058061089643,-0.00825265075009101,0.015544025244623,0.548148723309401
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39104,-0.00334876363432577,0.00559357922156726,-0.0143121789085976,0.00761465163994606,0.549395596261596
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37221,0.00176195444975955,0.00294896651738786,-0.00401801992432066,0.00754192882383977,0.550196207687249
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,36880,-0.00253570209364104,0.00424466619353219,-0.0108552478329641,0.00578384364568205,0.550260906940061
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36763,0.00296614984006844,0.00497180729652419,-0.00677859246111897,0.0127108921412559,0.550789523613526
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,36763,0.00280838233947893,0.00473665993386884,-0.006475471130904,0.0120922358098619,0.553256614079022
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,36916,-0.0025176322700586,0.00424700708196264,-0.0108417661507054,0.00580650161058819,0.553324742685563
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37164,-0.00233820664555185,0.00394496357228844,-0.0100703352472372,0.00539392195613348,0.553387948115855
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39526,0.00176117970427296,0.00297219840900247,-0.00406432917737187,0.00758668858591779,0.5534904411599
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,36861,0.00161139028585606,0.00273241287161632,-0.00374413894251193,0.00696691951422404,0.555381325937922
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39428,-0.00166091987555183,0.00282549891756585,-0.00719889775398089,0.00387705800287723,0.556653642014204
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,36992,0.00330230015700819,0.00562546311265275,-0.0077236075437912,0.0143282078578076,0.557195971705173
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,36847,0.00170849295407277,0.00291383568371968,-0.0040026249860178,0.00741961089416334,0.557658992131334
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39462,-0.00184782185971157,0.00315535367949557,-0.00803231507152288,0.00433667135209975,0.558143194976003
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,36992,0.00353691412819391,0.00604947208533185,-0.00832005115905652,0.0153938794154443,0.55878356298876
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,39194,0.00337913503488787,0.00578239155758475,-0.00795435241797825,0.014712622487754,0.55897117247286
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,36992,0.00422945155549839,0.00726664070393178,-0.0100131642242079,0.0184720673352047,0.560552426043839
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37247,0.00365251694644846,0.00628202810657196,-0.00866025814243259,0.0159652920353295,0.560965500642055
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,36847,0.00310621511999057,0.00535209171113581,-0.00738388463383562,0.0135963148738168,0.561672954105574
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,36808,-0.00483245273829688,0.00833314092413715,-0.0211654089496057,0.0115005034730119,0.561987424460582
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,36861,-0.00288194251260531,0.00498250920655474,-0.0126476605574526,0.00688377553224197,0.562996572765237
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,39589,0.00289784165466258,0.00501262958874978,-0.00692691233928698,0.0127225956486121,0.563199753895788
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36823,-0.00370209781080346,0.00641250457767548,-0.0162706067830474,0.00886641116144047,0.563730581458944
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39477,-0.00149276557825318,0.00259686402321975,-0.00658261906376389,0.00359708790725753,0.565412217182996
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,37255,0.00198804459905701,0.00347502850301714,-0.00482301126685658,0.00879910046497059,0.567268017990442
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,36861,0.00225126321978534,0.00393546515429135,-0.00546224848262571,0.00996477492219638,0.567301841451058
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,39455,0.00451865494711794,0.00792620587707632,-0.0110167085719516,0.0200540184661875,0.568624831186469
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,36861,0.00304525428219264,0.00534333033881924,-0.00742767318189307,0.0135181817462783,0.568744376778606
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36823,0.00250364523592614,0.00439436700970932,-0.00610931410310412,0.0111166045749564,0.568864620996378
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,36880,-0.00216256881562459,0.00379585037681596,-0.00960243555418387,0.00527729792293468,0.568878467370363
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,37203,0.00131502849803109,0.00231041814481604,-0.00321339106580836,0.00584344806187053,0.569248511386491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,39589,-0.00114441335408205,0.00201186626764168,-0.00508767123865974,0.00279884453049565,0.56947878378984
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,37167,0.00472891803506279,0.0083529242020022,-0.0116428134008615,0.0211006494709871,0.571309131606264
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39485,-0.00327708926986963,0.00579023644165158,-0.0146259526955067,0.00807177415576746,0.571423895971577
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,39029,0.00346592203301736,0.00612567691556205,-0.00854040472148426,0.015472248787519,0.571536897977209
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,36847,-0.00236683362681606,0.00418363945325494,-0.0105667669551957,0.00583309970156361,0.571583795900242
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,36955,0.00249260665569433,0.00441175420057398,-0.00615443157743066,0.0111396448888193,0.5720892150065
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,36763,0.00175741168119125,0.00313184780846143,-0.00438101002339315,0.00789583338577565,0.574710877953777
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37247,-0.00149869133069933,0.00267266172507638,-0.00673710831184902,0.00373972565045036,0.574978747341257
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37221,0.00180001347617516,0.00321311699855615,-0.00449769584099488,0.00809772279334521,0.575347477597274
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39123,-0.00313257029181376,0.00560101599346487,-0.0141105616390049,0.00784542105537738,0.57597502964807
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,39314,0.00164388615775886,0.00294753071642414,-0.00413327404643245,0.00742104636195017,0.577046471629646
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,36916,-0.00156527307578235,0.00281370968680237,-0.00708014406191499,0.00394959791035029,0.57801422479758
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39396,0.00111229419704524,0.00200576591277241,-0.00281900699198868,0.00504359538607917,0.579211917936297
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,36847,0.00152255757566232,0.00277165886532946,-0.00390989380038342,0.00695500895170805,0.582788351765369
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,39104,0.00321445320457216,0.00586318574009626,-0.00827739084601651,0.0147062972551608,0.583533100608003
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,37221,-0.00101896983417894,0.0018610452478538,-0.00466661851997238,0.0026286788516145,0.584027287596691
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,36763,-0.00175740929440994,0.00321050634858013,-0.00805000173762699,0.00453518314880712,0.584118559420964
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,37247,-0.00264633231205439,0.00483506939885192,-0.0121230683338042,0.00683040370969537,0.584168149477437
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,36955,0.00161237948375526,0.00294974993056782,-0.00416913038015766,0.00739388934766818,0.584652567449867
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,37164,-0.0123279002004679,0.0225825010243676,-0.0565896022082284,0.0319338018072926,0.585140821392782
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,36880,-0.00260277559540753,0.00478050814653394,-0.0119725715626141,0.006767020371799,0.586137594686553
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,36861,-0.00257121934225013,0.00472267127316497,-0.0118276550376535,0.00668521635315321,0.586147315588361
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39037,0.00087970814752181,0.00161697710316504,-0.00228956697468167,0.00404898326972529,0.586418891467483
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,36932,-0.00174748853751506,0.00321347698699325,-0.00804590343202182,0.00455092635699171,0.586588875883285
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,36992,0.00402213603501754,0.00740599276380841,-0.0104936097820469,0.018537881852082,0.587076056362062
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,39123,-0.00140241596161478,0.00258363078577587,-0.00646633230173549,0.00366150037850593,0.587270116467267
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39187,-0.00207180545325621,0.00381850492990165,-0.00955607511586345,0.00541246420935102,0.587434243143267
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,39654,-0.00233111322152069,0.00430512827318387,-0.0107691646369611,0.00610693819391969,0.588189137747914
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39462,0.00160919760624792,0.00297258954340791,-0.00421707789883159,0.00743547311132742,0.588277583766579
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,37203,0.00181795318260883,0.00336130313252487,-0.00477020095713991,0.00840610732235758,0.588621986005565
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,36763,0.00551629992422168,0.0102138831952102,-0.0145029111383903,0.0255355109868337,0.589152584660633
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,39601,0.000770368665130311,0.00142943900944474,-0.00203133179338139,0.00357206912364201,0.58994254459047
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37162,0.00246424945969083,0.0045749036833382,-0.00650256175965204,0.0114310606790337,0.590141194046056
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,36847,0.00180143783365631,0.00335469147074404,-0.004773757449002,0.00837663311631463,0.591283735879325
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,36741,0.0038365305992841,0.00716337732289314,-0.0102036889535865,0.0178767501521546,0.592261540494604
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,36763,0.00378111035352409,0.00706518272296751,-0.0100666477834922,0.0176288684905404,0.592538401808591
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,36847,-0.00188135942296263,0.00351816200729748,-0.00877695695726569,0.00501423811134044,0.592827952404401
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,39636,-0.00177805765382931,0.00333173454425458,-0.00830825736056829,0.00475214205290967,0.593575420793159
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37243,-0.00218380897497168,0.00409363464507171,-0.0102073328793122,0.00583971492936887,0.593721311606983
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,39123,0.00391415667928475,0.00733836170858217,-0.0104690322695363,0.0182973456281058,0.59377662934097
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37162,-0.00235976577060467,0.00443325969309074,-0.0110489547690625,0.00632942322785318,0.594536653315908
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,37162,-0.00181683246084155,0.00342874576376249,-0.00853717415781603,0.00490350923613292,0.596202639079277
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,36763,0.00314519376172165,0.00597843839215241,-0.00857254548689708,0.0148629330103404,0.598835489046541
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,36880,-0.00202751632605869,0.00385785093700009,-0.00958890416257886,0.00553387151046148,0.599206179802521
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37164,-0.00495332370954565,0.00944133431989441,-0.0234583389765387,0.0135516915574474,0.599840997560748
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36763,-0.00191007352988714,0.00364173722583976,-0.00904787849253307,0.0052277314327588,0.599943632358611
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37083,-0.00140025622401469,0.0026849072187932,-0.00666267437284936,0.00386216192481997,0.602007648259768
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,36847,0.00237531962866852,0.00456131145443635,-0.00656485082202673,0.0113154900793638,0.60254769130732
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,37164,0.0026231128870656,0.00505653608994887,-0.00728769784923417,0.0125339236233654,0.603939320790042
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,39589,-0.00301137897564889,0.00580993166561479,-0.0143988450402539,0.0083760870889561,0.604245575270809
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,36955,0.00194430545364344,0.00375870017953709,-0.00542274689824927,0.00931135780553614,0.604968931077854
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,36916,-0.000803349996323186,0.00155347227438543,-0.00384815565411863,0.00224145566147226,0.605073295469062
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,39194,0.00140504996312624,0.00271942256711091,-0.00392501826841113,0.00673511819466362,0.605392775862133
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39428,-0.00270651225489673,0.00524224335848459,-0.0129813092375265,0.00756828472773307,0.605660244092131
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36763,0.00261157230150428,0.00506429388126862,-0.00731444370578222,0.0125375883087908,0.606084808832539
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,36861,0.00270238024820198,0.0052564004114179,-0.0076001645581771,0.0130049250545811,0.607182614262468
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,36880,0.00213258678819723,0.00417282316711788,-0.00604614661935382,0.0103113201957483,0.609314131961173
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,36880,0.00243640778303215,0.00476763793874221,-0.00690816257690259,0.0117809781429669,0.609338868370667
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,38959,0.00157786762878573,0.00308926685935769,-0.00447709541555535,0.0076328306731268,0.609528324380066
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,39355,-0.00160606233216262,0.00314615163614912,-0.0077725195390149,0.00456039487468965,0.609719478794561
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,39231,0.00186378308065089,0.00365104952955745,-0.00529227399728171,0.0090198401585835,0.609723745398785
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39123,0.00206448905522275,0.00404794362623925,-0.00586948045220619,0.00999845856265169,0.610052590899364
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,36823,0.00289331736818675,0.00567442239649605,-0.0082285505289455,0.014015185265319,0.610139336490674
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,36825,-0.0018256676371524,0.00358720556100679,-0.0088565905367257,0.0052052552624209,0.61080428665897
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,39194,0.00126932600172391,0.00250099448074504,-0.00363262318053638,0.00617127518398419,0.611791630112532
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39330,-0.00392244370363033,0.00773343344747743,-0.0190799732606861,0.0112350858534254,0.612017815935774
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,39123,-0.00155570022517497,0.00307518595545343,-0.0075830646978637,0.00447166424751376,0.612942751553152
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,37164,-0.00299240478677848,0.00591556732568042,-0.0145869167451121,0.00860210717155514,0.61296893966361
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,36823,0.0022094183506366,0.00438881217424953,-0.00639265351089248,0.0108114902121657,0.614677571862872
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37164,0.00114198772508886,0.00227228824203872,-0.00331169722930703,0.00559567267948476,0.615274148587254
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36763,-0.00128060759247976,0.00254988635925567,-0.00627838485662088,0.00371716967166136,0.615520747282727
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",37269,0.00071084164945486,0.00141991657173827,-0.00207219483115214,0.00349387813006186,0.616645685444332
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,36823,-0.00380046615002386,0.00761821490758225,-0.0187321673688851,0.0111312350688373,0.617882865862545
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,36823,0.00158895339197398,0.00318522376568587,-0.00465408518877031,0.00783199197271828,0.617892931198999
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37255,0.00601749892457607,0.0120672035053304,-0.0176342199458716,0.0296692177950237,0.618023570034622
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,39485,-0.00198996758165154,0.00399095025227076,-0.00981223007610224,0.00583229491279916,0.618054413906999
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,37269,0.0011280749833218,0.0022639504062026,-0.00330926781283529,0.00556541777947889,0.618297190127805
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,36916,-0.00267294304987919,0.00536995630338888,-0.0131980574045214,0.00785217130476302,0.618662833952802
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",36847,0.00263997777247517,0.00530993436958387,-0.00776749359190921,0.0130474491368596,0.619072986963748
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,36880,-0.0020689889664578,0.00416508233526199,-0.0102325503435713,0.00609457241065571,0.619376800417643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,37164,0.00149814788813401,0.00302151413610867,-0.00442401981863899,0.00742031559490701,0.620025139191248
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36823,0.00140894706367616,0.00284401463468731,-0.00416532162031097,0.00698321574766328,0.620321081887592
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39123,-0.00140447566488195,0.00283526742581171,-0.0069615998194729,0.00415264848970901,0.620354043135261
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,37221,0.00336810396532443,0.00681957471309159,-0.00999826247233509,0.0167344704029839,0.621393997733667
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,36861,0.00179413330691162,0.00364503661389025,-0.00535013845631327,0.00893840507013651,0.622577696209213
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,39462,0.00209869669857442,0.00427495271438028,-0.00628021062161093,0.0104776040187598,0.62348410085651
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,39104,-0.00267495163060739,0.00544911727004944,-0.0133552214799043,0.00800531821868951,0.623507129952955
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,36823,0.00391446603946137,0.00801041102274816,-0.011785939565125,0.0196148716440478,0.625082374528034
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,39194,-0.00212573152692752,0.00435087642801026,-0.0106534493258276,0.00640198627197258,0.625149545477647
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,36861,-0.00115446630274833,0.00238000595171654,-0.00581927796811275,0.00351034536261609,0.627636203599025
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,36847,0.00191640841341772,0.00397403311027866,-0.00587269648272845,0.00970551330956389,0.629649219138038
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39187,0.00135486402050055,0.00282151226145521,-0.00417530001195167,0.00688502805295277,0.631098909031586
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,36916,-0.0012525041183225,0.00261806259331881,-0.00638390680122736,0.00387889856458236,0.632367680421119
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",36899,-0.00332151044142358,0.00696239837411398,-0.016967811254687,0.0103247903718398,0.633324840249338
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37186,-0.00168856025372334,0.0035433928835462,-0.00863361030547389,0.00525648979802722,0.633699540383739
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,36880,0.00117106075063964,0.00246421484170853,-0.00365880033910908,0.00600092184038836,0.634633731461857
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,37203,-0.00389353352800981,0.00821052550207445,-0.0199861635120757,0.0121990964560561,0.635356526386446
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,36992,0.00277110352134745,0.00585209361982068,-0.00869899997350109,0.014241207016196,0.635848022723259
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39462,0.00176872562897672,0.00373630472318459,-0.00555443162846507,0.00909188288641851,0.635942546852267
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,36763,0.00140379802294355,0.00297732445711123,-0.00443175791299446,0.00723935395888155,0.637294582979378
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,37243,-0.00243451110001325,0.00516727226739765,-0.0125623647441126,0.00769334254408615,0.637548459350474
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39104,-0.00165324644861559,0.00350917165232356,-0.00853122288716978,0.0052247299899386,0.637560938507506
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39485,-0.00144298873837895,0.0030646804281602,-0.00744976237757294,0.00456378490081505,0.637758425698354
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39123,0.0024774248917564,0.0052666008791177,-0.0078451128313143,0.0127999626148271,0.638074108810514
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,37162,-0.00206743153999905,0.00440404735499148,-0.0106993643557824,0.00656450127578425,0.638763937529047
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37099,-0.00237985887531861,0.00508390881716651,-0.012344320156965,0.00758460240632775,0.639709730784975
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,37164,-0.00142888661609089,0.00306197332051701,-0.00743035432430423,0.00457258109212245,0.640754386926264
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,36992,0.00179165444183567,0.00385357733187554,-0.00576135712864038,0.00934466601231172,0.641987664119057
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,36847,0.00164948974484878,0.00355073205324779,-0.00530994507951689,0.00860892456921445,0.642262475949442
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,36880,0.00132897313358725,0.00286203976178871,-0.00428062479951862,0.00693857106669312,0.642408902169963
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,36847,0.00137546428000176,0.00296398175695231,-0.00443393996362476,0.00718486852362829,0.642613173062965
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37221,0.00190918604693034,0.00412401359316011,-0.00617388059566348,0.00999225268952416,0.643412623345384
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,39194,-0.00119675746739869,0.00258555187179953,-0.00626443913612578,0.00387092420132839,0.643469077469739
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,36847,0.00145596724512444,0.00314611477516565,-0.00471041771420023,0.00762235220444912,0.643528312848391
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36823,-0.00346113561326722,0.00748909744473767,-0.0181397666049531,0.0112174953784186,0.643977170080239
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,36992,0.00145006685242891,0.0031486388795313,-0.00472126535145244,0.00762139905631027,0.645138316116594
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36823,0.0048025673882783,0.0104284397393066,-0.0156371745007625,0.0252423092773191,0.645146825633688
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,36992,-0.00145779514471486,0.00319631084777415,-0.00772256440635219,0.00480697411692248,0.648335469407801
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,39455,0.00174365722293294,0.00382366652305219,-0.00575072916224936,0.00923804360811523,0.64838430024391
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,39589,-0.00305769300439419,0.00670905328585311,-0.0162074374446663,0.0100920514358779,0.64857180148856
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,39194,-0.00448906779229438,0.00989804208941992,-0.0238892302875574,0.0149110947029687,0.650173184365977
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,39549,0.0024370256802378,0.00539878561996319,-0.00814459413489005,0.0130186454953657,0.651705918537061
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39428,-0.0012946635145442,0.0028692285874663,-0.00691835154597816,0.00432902451688975,0.651834970167289
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39104,-0.00329927743056412,0.00731216998345673,-0.0176311305981393,0.0110325757370111,0.651849491852972
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,39601,-0.00149044355223234,0.00330796844254058,-0.00797406169961187,0.00499317459514719,0.652311996408071
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,39559,-0.00166661496344391,0.0036995006801432,-0.00891763629652457,0.00558440636963676,0.652358385895837
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36823,0.00302082296432858,0.00670673423214229,-0.0101243761306703,0.0161660220593275,0.652418128377839
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36742,-0.000995866554572217,0.00221516964147433,-0.0053375990518619,0.00334586594271747,0.653030815952548
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36823,-0.00180383434898978,0.00403134800337137,-0.00970527643559765,0.0060976077376181,0.65455663961629
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,39344,-0.00188099633096827,0.00420668811602371,-0.0101261050383748,0.0063641123764382,0.654777426470506
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,39104,-0.00151471735832995,0.00339383943935904,-0.00816664265947367,0.00513720794281376,0.655377188761745
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,39194,0.00210883952708113,0.00478101994342042,-0.0072619595620229,0.0114796386161852,0.659157424261474
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,36861,0.00187410194340805,0.00425063872354482,-0.0064571499547398,0.0102053538415559,0.659293869948891
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,39194,-0.00256220731899921,0.00583209587158898,-0.0139931152273136,0.00886870058931519,0.660429793220502
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39187,-0.00335712041901103,0.00766604836772408,-0.0183825752197502,0.0116683343817282,0.661450268763417
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,36992,0.00174169370750306,0.00400001962895325,-0.00609834476524531,0.00958173218025144,0.663264153578562
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,36899,0.00211918476529524,0.0049017281604335,-0.00748820242915441,0.0117265719597449,0.665506017352756
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37247,0.00121956794570763,0.00282186270993763,-0.00431128296577013,0.0067504188571854,0.665613931844091
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36763,-0.00209919638572931,0.00485790723286152,-0.0116206945621379,0.00742230179067927,0.665662139689595
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,36992,0.00221909530058536,0.00516092057806995,-0.00789630903243175,0.0123344996336025,0.667217201877151
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,39341,-0.00252627858284493,0.00591731483000447,-0.0141242156496537,0.00907165848396383,0.669436565444531
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,37140,-0.00210316882853744,0.00495321073165135,-0.0118114618625741,0.00760512420549922,0.671130259428101
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36763,-0.00181398211865591,0.00429539170630708,-0.0102329498630178,0.00660498562570597,0.672806942451981
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,36763,0.00191231789134898,0.00454596513578125,-0.00699777377478227,0.0108224095574802,0.674008756897626
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,36861,-0.00179384451210581,0.00427834070618925,-0.0101793922962367,0.00659170327202511,0.675015042243512
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,36916,0.00335952540795008,0.00803514306791457,-0.0123893550051625,0.0191084058210626,0.675878287982752
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,36880,0.00155169392553726,0.00371541777914773,-0.00573052492159229,0.0088339127726668,0.676220150611034
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36823,-0.00198284500401478,0.00475161405454763,-0.0112960085509281,0.00733031854289857,0.676466774939926
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,36909,0.00238784969259732,0.00574123821480166,-0.00886497720841394,0.0136406765936086,0.67748158520734
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,36823,0.00184237275443214,0.00444235013003753,-0.00686463350044142,0.0105493790093057,0.678347272984011
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,36992,0.000829078193027416,0.0020001985482569,-0.00309131096155611,0.00474946734761094,0.678516559865609
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39496,0.00205883744271432,0.00496742292535521,-0.0076773114909819,0.0117949863764105,0.678537366488863
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,39187,-0.00176097049500021,0.0042631649495838,-0.0101167737961845,0.00659483280618404,0.679563925436444
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37221,0.00126100171029969,0.00305283377079723,-0.00472255248046289,0.00724455590106227,0.67957002426014
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,36989,-0.000902602678022335,0.00218788542069286,-0.00519085810258033,0.00338565274653566,0.679946560786942
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36823,0.00155033241029088,0.00379878971890132,-0.00589529543875572,0.00899596025933747,0.683198370327502
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,36916,-0.00297693383466343,0.00731000861642299,-0.0173045507228525,0.0113506830535256,0.683838123938518
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,37052,0.000848562646986464,0.00208572547940768,-0.00323945929265259,0.00493658458662551,0.6841302708764
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,36880,0.00102908766830604,0.00253012920428102,-0.00392996557208477,0.00598814090869684,0.684210922518709
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,36861,-0.00206090932305914,0.00508854882809082,-0.0120344650261172,0.00791264637999886,0.685477696254358
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36823,0.00225262230198992,0.00558540050863196,-0.00869476269492873,0.0132000072989086,0.686730524495913
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,39355,-0.00234752176885149,0.00585571261618974,-0.0138247184965834,0.0091296749588804,0.68850369913707
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,36861,0.00275153821112714,0.00687165692091451,-0.0107169093538653,0.0162199857761196,0.688855230700202
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,36861,-0.00171430128174909,0.00429198664940226,-0.0101265951145775,0.00669799255107935,0.68959132467254
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,39455,0.000845869457632828,0.00212429220095309,-0.00331774325623523,0.00500948217150089,0.690496654059502
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,36847,0.00141587802967573,0.00356201501344444,-0.00556567139667538,0.00839742745602683,0.691010379108371
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,36992,0.00156503523027766,0.00393912197029472,-0.00615564383149999,0.00928571429205531,0.691148878044847
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39432,-0.0022718617316099,0.0057211804853796,-0.0134853754829539,0.00894165201973411,0.691301831166819
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,37221,-0.00126885361314792,0.00319694323108719,-0.00753486234607881,0.00499715511978297,0.691450871925343
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39104,-0.00161756005153536,0.00407895548086507,-0.00961231279403089,0.00637719269096017,0.691696017972741
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,39330,-0.0010188833696772,0.0025717169926678,-0.0060594486753061,0.00402168193595169,0.691972036872152
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39415,-0.00619512899388022,0.0156681728188216,-0.0369047477187705,0.0245144897310101,0.692556479392305
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,37247,0.00359302990718473,0.00911394347901773,-0.01427029931169,0.0214563591260595,0.693414571366913
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,38905,0.00320266945618945,0.00812445381610946,-0.0127212600233851,0.019126598935764,0.69343831464183
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,39531,0.00198872597654563,0.00504574923475195,-0.00790094252356819,0.0118783944766594,0.693484077357512
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,39428,0.00142153002675221,0.00362167488664959,-0.00567695275108098,0.0085200128045854,0.694689780638315
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,39601,0.00209241140860768,0.0053381873263748,-0.00837043575108694,0.0125552585683023,0.695085600324224
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39455,-0.00102250275251436,0.00260960360898339,-0.00613732582612181,0.00409232032109309,0.695194554128009
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,39187,-0.00200729878668827,0.00516588827431387,-0.0121324398043435,0.00811784223096693,0.697601369092567
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,39441,0.00430928951446541,0.0111538373004389,-0.0175522315943949,0.0261708106233257,0.699242661903932
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,37243,-0.00209778414602466,0.00543179794601884,-0.0127441081202216,0.00854853982817226,0.699351735378939
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37164,-0.00216929464352367,0.00564422743214788,-0.0132319804105335,0.00889339112348618,0.700733908161728
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,39583,-0.00319769131534385,0.00832016322316792,-0.019505211232753,0.0131098286020653,0.700739010640516
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,36916,-0.000887021209181502,0.00231272802867691,-0.00541996814538825,0.00364592572702524,0.701326760442395
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,36861,0.00271776653345535,0.007091497359994,-0.0111815682921329,0.0166171013590436,0.701546182800555
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39319,-0.00245522815128649,0.00644236705195941,-0.0150822675731269,0.010171811270554,0.703129648026296
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,39589,0.00136776559159281,0.00360349130939073,-0.00569507737481302,0.00843060855799865,0.70427234915424
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,36955,0.00176313973343029,0.004651901569675,-0.00735458734313272,0.0108808668099933,0.704683279179801
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,36954,-0.000690295519491371,0.00182648078849108,-0.00427019786493389,0.00288960682595115,0.705483466049207
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,36763,0.00137448370141723,0.00367654655315565,-0.00583154754276784,0.0085805149456023,0.70852098499906
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,36992,0.000945166684248044,0.00253270566992305,-0.00401893642880114,0.00590926979729723,0.709017384978919
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36823,0.00125595574331653,0.00337822402299755,-0.00536536334175867,0.00787727482839174,0.710063107848054
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",36916,0.0022465827673987,0.00605480838022633,-0.00962084165784491,0.0141140071926423,0.71061322522518
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37210,0.00063572511986457,0.00172066078163209,-0.00273677001213434,0.00400822025186348,0.711786775572734
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,36861,-0.00150626593942059,0.00407857823847062,-0.009500279286823,0.00648774740798183,0.711901839348355
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39187,-0.00108788064863645,0.00297112315672155,-0.00691128203581068,0.00473552073853778,0.714257425572982
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,39042,0.000976357163699271,0.00267013269487158,-0.00425710291824902,0.00620981724564756,0.714625092759022
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,39194,0.00103430287036409,0.0028302712740667,-0.00451302882680663,0.00658163456753481,0.714785979194129
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,36741,-0.00129074425440463,0.00356332778830719,-0.00827486671948672,0.00569337821067745,0.717186385298831
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39477,0.00294037884578712,0.00812097286593157,-0.0129767279714388,0.018857485663013,0.71730313869211
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,36880,-0.00131377917875387,0.00363622195396587,-0.00844077420852697,0.00581321585101923,0.71787883022789
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36823,-0.00126569060608767,0.00351477351323185,-0.00815464669202209,0.00562326547984675,0.71877410384014
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,37243,0.00449939304893741,0.012549745626807,-0.0200981083796043,0.0290968944774792,0.71995664766906
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39123,0.001642098415031,0.00460321802292086,-0.00738020890989388,0.0106644057399559,0.721300302806283
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,39499,-0.000751998139916075,0.00210984012002236,-0.0048872847751599,0.00338328849532774,0.721527883886289
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,36928,0.000986909741894733,0.00277274661408169,-0.00444767362170537,0.00642149310549484,0.721897375189283
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36763,0.00282518204011236,0.00797209125758849,-0.0128001168247611,0.0184504809049858,0.723057150880452
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39428,-0.00377543151691807,0.0106658587871699,-0.0246805147397711,0.0171296517059349,0.723363715661574
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39123,-0.00146588983528918,0.00414372742573609,-0.00958759558973192,0.00665581591915356,0.723522964270737
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,37162,-0.00136165544346362,0.00389037894576182,-0.00898679817715679,0.00626348729022955,0.726340096490835
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36763,0.00195661754741341,0.0056181039787102,-0.00905486625085857,0.0129681013456854,0.72764331325013
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37164,0.00154442981563048,0.00443678146991852,-0.00715166186540981,0.0102405214966708,0.727773186493472
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,39654,0.00103885484613756,0.00299884461015956,-0.00483888058977518,0.0069165902820503,0.729033119877422
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,36992,0.00136012259236175,0.00393401489555169,-0.00635054660291957,0.00907079178764307,0.729548451196071
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,37164,-0.0010166488207525,0.0029432257306204,-0.00678537125276849,0.00475207361126349,0.729784412977309
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39428,-0.00315782622623558,0.00914708136035486,-0.0210861056925311,0.0147704532400599,0.729928014205677
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,39194,0.00162026179168328,0.00470339709890007,-0.00759839652216084,0.0108389201055274,0.730484563563404
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,39187,0.00163495492195922,0.00475595797230335,-0.00768672270375535,0.0109566325476738,0.731024286914858
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,36992,-0.000877732390498671,0.00256487175599649,-0.0059048810322518,0.00414941625125446,0.732196357586403
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,37247,0.00221413811504515,0.00648800436694795,-0.0105023504441728,0.0149306266742631,0.732908618253355
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,37200,0.000692180636049455,0.00203237070716706,-0.00329126594999799,0.0046756272220969,0.733426948316666
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,37224,-0.00312387588761342,0.00918174794117519,-0.0211201018523168,0.01487235007709,0.733691400786613
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,36763,0.00167579503926444,0.00498340507649934,-0.00809167891067425,0.0114432689892031,0.736669156444209
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,39601,0.00118942202665729,0.00354965598457207,-0.00576790370310396,0.00814674775641855,0.737568677732613
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,39531,-0.00108506483707586,0.00324587523993958,-0.00744698030735744,0.00527685063320573,0.738165105103245
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,36847,0.00193221789967035,0.00580647506473241,-0.00944847322720518,0.0133129090265459,0.739313898168862
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37164,0.000620296840566982,0.00186436448018317,-0.00303385754059203,0.00427445122172599,0.73935701261851
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",36847,-0.00180716643710184,0.00547911455762402,-0.0125462309700449,0.00893189809584124,0.741535359377272
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39330,-0.000967448661326497,0.00293813912569358,-0.00672620134768591,0.00479130402503291,0.741954299735742
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,39462,0.000973837788281607,0.00296973327414556,-0.00484683942904368,0.0067945150056069,0.742975998641349
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,37221,-0.00152229619559321,0.00464309733901694,-0.0106227669800664,0.00757817458888,0.743021216557571
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",36847,-0.0010872881244409,0.0033170853388995,-0.00758877538868392,0.00541419913980211,0.743080379687922
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37247,0.000923908438522707,0.00283649921437726,-0.00463563002165673,0.00648344689870214,0.744640493148806
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,37164,0.00292827319097563,0.00901385180599571,-0.014738876348776,0.0205954227307272,0.745289581967359
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,39526,0.00131317386683719,0.0040532762713472,-0.00663124762500332,0.00925759535867771,0.745958899833878
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39541,0.000744938579557367,0.00229970765199687,-0.0037624884183565,0.00525236557747123,0.745997403628483
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37247,-0.000708040642637821,0.00219147084068246,-0.00500332349037545,0.0035872422050998,0.746632940604684
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37221,0.00219863745287076,0.00681936554586501,-0.0111673190170247,0.0155645939227662,0.74714674284982
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,39601,0.000876343849708731,0.00272057566438449,-0.00445598445248486,0.00620867215190232,0.747368455051782
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,39411,-0.00101183816089647,0.00314418349821434,-0.00717443781739658,0.00515076149560364,0.747599093925339
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,36861,0.000838351844880283,0.00261008632821549,-0.00427741735842207,0.00595412104818264,0.748066530378567
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37164,0.000754776779777295,0.00235604561600478,-0.00386307262759207,0.00537262618714666,0.748702638087153
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36823,0.00157581178825032,0.00500063196814724,-0.00822542686931827,0.0113770504458189,0.752673939264371
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,39434,-0.0025055640356326,0.0079709145298855,-0.0181285565142082,0.013117428442943,0.753268459250382
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,36861,-0.00254747167676966,0.0081054102127558,-0.018434075693771,0.0133391323402317,0.7533039867219
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,36847,0.00143259787233869,0.00457505509651492,-0.00753451011683054,0.0103997058615079,0.754185361146073
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,39355,-0.00101794974008986,0.00325339901646888,-0.00739461181236887,0.00535871233218916,0.754370079596069
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37247,0.000919394225662627,0.00293991846077527,-0.0048428459574569,0.00668163440878215,0.754492571267457
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,39618,0.00143294877552414,0.00459446460055095,-0.00757220184155573,0.010438099392604,0.755131517935417
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,39104,-0.00144622600589043,0.0046443753229677,-0.0105492016389071,0.00765674962712625,0.755506298280122
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39194,-0.00187016981624295,0.00601108879517629,-0.0136519038547885,0.00991156422230257,0.75571381274701
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,39588,-0.00071652376540751,0.00230392923568484,-0.00523222506734979,0.00379917753653477,0.755804319290755
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39187,0.000913646566641296,0.00294134452613003,-0.00485138870457356,0.00667868183785615,0.75609232998077
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,39194,-0.00132740051768308,0.0042740131583135,-0.00970446630797754,0.00704966527261138,0.756128324777911
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36855,0.00132723332206624,0.00428198454127106,-0.00706545637882504,0.00971992302295751,0.756598465784877
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,36763,0.00190623871243698,0.00619937282304969,-0.0102445320207404,0.0140570094456144,0.7584764249884
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37243,0.00091832304374148,0.00300065247961645,-0.00496295581630676,0.00679960190378972,0.759578318837118
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,36763,-0.00111969318296438,0.00366598241093456,-0.00830501870839612,0.00606563234246736,0.76004546520064
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37162,-0.00101997638252654,0.00336579878445583,-0.00761694200005996,0.00557698923500687,0.761863269506971
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,36992,-0.00161055124782088,0.00535424757059677,-0.0121048764861906,0.0088837739905488,0.763572909815357
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39104,0.00171953603103367,0.00576700276566352,-0.00958378938966681,0.0130228614517342,0.765579125401554
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37203,0.000956239053285056,0.00323578388943802,-0.00538589737001347,0.00729837547658358,0.767601441513622
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,36847,-0.00190742434914701,0.00645695912873078,-0.0145630642414593,0.0107482155431653,0.767688712535283
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,39104,0.00176515417383406,0.00598048299053284,-0.0099565924876103,0.0134869008352784,0.767881610296533
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39123,0.000921630943119956,0.00313405818571015,-0.00522112310087194,0.00706438498711185,0.768708951852787
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39194,0.0009781868121277,0.00333513345315431,-0.00555867475605475,0.00751504838031015,0.769298776389368
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,36861,0.00175441872890893,0.00598557234674293,-0.00997730307070721,0.0134861405285251,0.769444555725541
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,36880,0.000833042130185104,0.00284432502028486,-0.00474183490957322,0.00640791916994343,0.769619782503518
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,37221,-0.000704358211282027,0.00242008651767522,-0.00544772778592547,0.00403901136336141,0.771020325178345
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,36763,-0.00118086363890237,0.00406981848781385,-0.00915770787501751,0.00679598059721277,0.771705281498869
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,37255,-0.00144409455283609,0.00498323061371566,-0.0112112265557188,0.0083230374500466,0.771980953773667
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39104,-0.00170348285520158,0.00589691393258245,-0.0132614341630632,0.00985446845266001,0.772679585455917
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37164,-0.000735358656844383,0.0026004680111801,-0.00583227595875738,0.00436155864506861,0.777350588174794
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39187,0.00129674204333839,0.0046097456261101,-0.0077383593838374,0.0103318434705142,0.778480833234051
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39466,0.00138601970795331,0.00494752408660732,-0.00831112750179702,0.0110831669177036,0.779370807341218
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,39462,0.0022192734656246,0.00792761557776855,-0.0133188530668018,0.017757399998051,0.779525773506686
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,36847,0.00117048019604213,0.0041838424300291,-0.00702985096681491,0.00937081135889916,0.779664762893848
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,36847,0.00118719859141934,0.00424831159562443,-0.00713949213600455,0.00951388931884322,0.779902737157187
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,39462,-0.00143761725386683,0.0051658339689539,-0.0115626518330165,0.00868741732528282,0.780791011896301
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36763,0.00105945792158595,0.00381073618428617,-0.00640958499961494,0.00852850084278684,0.78100226952565
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39355,-0.00108597234684494,0.00391443003816171,-0.00875825522164189,0.00658631052795201,0.781455361622104
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,36861,0.00168928587201788,0.00609046480468651,-0.0102480251451677,0.0136265968892034,0.78150395696285
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,36880,0.00104678384644011,0.00379399901632174,-0.00638945422555049,0.00848302191843072,0.782625509964175
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,37162,0.00117631577249953,0.00427410395853417,-0.00720092798622745,0.00955355953122651,0.783152256642125
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39545,-0.000504805245090888,0.00183486429342715,-0.0041011392602081,0.00309152877002632,0.783228909116657
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37203,0.000952255517566109,0.00346936613481057,-0.0058477021066626,0.00775221314179482,0.783723783443756
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37184,-0.00197775755195592,0.00724032884136056,-0.0161688020810226,0.0122132869771108,0.784735790076531
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,39485,0.00278575618757267,0.0103322656617583,-0.0174654845094736,0.0230369968846189,0.787458493168192
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,36880,-0.000528771646058946,0.00196342494901281,-0.00437708454612406,0.00331954125400617,0.787694952641728
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37247,-0.000764891629567938,0.00285667130246612,-0.00636396738240153,0.00483418412326565,0.788891255583557
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37203,0.000935905921026318,0.00350513356508104,-0.00593415586653253,0.00780596770858516,0.789465734036654
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,39579,0.00136347018364167,0.00510685612504578,-0.00864596782144806,0.0113729081887314,0.78948190718516
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,37224,-0.00102908350144072,0.00386150809946466,-0.00859763937639145,0.00653947237351001,0.789860138069281
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37162,0.00142239357512743,0.00536964371221607,-0.00910210810081607,0.0119468952510709,0.791094386958551
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39428,-0.00175182165019653,0.0066578302217865,-0.0148011688848981,0.011297525584505,0.792460162017601
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,39589,-0.00107124870076406,0.00408989342765611,-0.00908743981897004,0.00694494241744191,0.793382194767267
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36763,0.00139025906420646,0.00537064447655064,-0.00913620410983279,0.0119167222382457,0.79574557324406
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,36916,-0.00116568513902678,0.00451746805619896,-0.0100199225291767,0.00768855225112317,0.79638069307126
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,36880,-0.000859962087777799,0.00334591778762783,-0.00741796095152834,0.00569803677597274,0.797168904116784
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,36861,0.000838451575106416,0.00327805021797558,-0.00558652685212573,0.00726343000233856,0.798126867901218
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,39601,-0.000749752345165047,0.0029443657351616,-0.00652070918608178,0.00502120449575169,0.799004866246779
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37162,-0.000936393920834953,0.00370538656165958,-0.00819895158168773,0.00632616374001783,0.800495221246522
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,37203,0.00164293627338892,0.00650404201782078,-0.0111049860815398,0.0143908586283176,0.800579588518644
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,36880,-0.000476851485135433,0.00189834339825211,-0.00419760454570957,0.00324390157543871,0.801668677848862
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39123,-0.00265496629162163,0.0105952161148281,-0.0234215898766846,0.0181116572934414,0.802141111745553
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,37247,-0.00198695775244692,0.00794867598679048,-0.0175663626865563,0.0135924471816624,0.802611914045168
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37203,-0.000989102815592848,0.0039758449023537,-0.0087817588242061,0.0068035531930204,0.803536502212732
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,36992,0.00130985565741748,0.0052657602062429,-0.0090110343468186,0.0116307456616536,0.80355856562633
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,36916,-0.000613654632537727,0.00247236415973509,-0.00545948838561849,0.00423217912054304,0.803979421820505
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,37255,-0.0019316726460026,0.00786488768564056,-0.0173468525098581,0.0134835072178529,0.805990291007317
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,39206,0.00063970133239199,0.0026094848877367,-0.00447488904757195,0.00575429171235593,0.806347819559616
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,39654,-0.000364073078421615,0.00148664358532071,-0.00327789450565021,0.00254974834880698,0.806540258679779
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,39455,-0.00071412780245309,0.00291758727686669,-0.00643259886511181,0.00500434326020563,0.806640534779854
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,36880,0.00115604983687028,0.00472640642900654,-0.00810770676398253,0.0104198064377231,0.806774982146153
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,39194,0.00109803459625262,0.00449422041012233,-0.00771063740758715,0.00990670660009239,0.806985246550973
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,39055,-0.00242657885588807,0.00993349322564667,-0.0218962255781555,0.0170430678663794,0.807015444760934
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",36880,-0.000595650816261033,0.00245965954118564,-0.00541658351698489,0.00422528188446282,0.808653990167721
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,36880,0.00131541560709201,0.00543674592630985,-0.00934060640847529,0.0119714376226593,0.808823621042069
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,36847,0.000781038832466448,0.0032309954594109,-0.00555171226797892,0.00711378993291182,0.808990910739801
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,36847,0.0017724706046631,0.00733758775578634,-0.0126092013966781,0.0161541426060043,0.809124808562315
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,36847,0.000942427629476855,0.00391989310905787,-0.00674056286427656,0.00862541812323027,0.810007281108439
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,36880,-0.00120060939670304,0.00499678791933239,-0.0109943137185945,0.00859309492518845,0.810120078862489
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39104,0.00103664309448678,0.00433938068116111,-0.00746854304058899,0.00954182922956256,0.811192712212405
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36823,0.000707778063487326,0.00297490729801232,-0.00512304024061682,0.00653859636759147,0.811950180857084
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39428,-0.0013056163047288,0.00550700509955394,-0.0120993462998545,0.00948811369039693,0.812595782109224
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,36916,0.00142476647031847,0.00602477024018511,-0.0103837832004443,0.0132333161410813,0.813060401550713
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,36861,0.00105057724945522,0.00446392626131164,-0.00769871822271559,0.00979987272162603,0.813942329395442
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,39498,0.000691239374881826,0.00294470243229816,-0.00508037739242257,0.00646285614218623,0.8144137533151
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,36741,0.000717812341393735,0.00307483560679543,-0.0053088654479253,0.00674449013071277,0.815417907371586
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,39104,0.0012072169445117,0.005171881158236,-0.00892967012563085,0.0113441040146543,0.815439078882022
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,36916,0.000823923616105154,0.00353370803584958,-0.00610214413416002,0.00774999136637033,0.815640060042801
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,36880,0.00157863504164541,0.00681927426741119,-0.0117871425224805,0.0149444126057713,0.816933266595943
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37255,0.000513092115609381,0.00224048585523748,-0.00387826016065607,0.00490444439187483,0.818865339384414
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,36847,0.00105642682207206,0.00463684802380374,-0.00803179530458327,0.0101446489487274,0.81977985807285
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,36916,-0.000991866147634969,0.00436513756207111,-0.00954753576929434,0.0075638034740244,0.820252913685605
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36823,0.00149494086504653,0.00660520147317989,-0.0114512540223861,0.0144411357524791,0.820950199928169
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37164,0.000519672460626363,0.00230258733929062,-0.00399339872438325,0.00503274364563598,0.8214456496627
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37203,-0.000699372052515821,0.00310277533169848,-0.00678081170264484,0.0053820675976132,0.821670096163062
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37221,0.00147707823021699,0.00657733237087827,-0.0114144932167044,0.0143686496771384,0.822316606087977
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,39606,0.000653395075436755,0.00291132119054232,-0.00505279445802619,0.0063595846088997,0.822423814784077
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,36823,-0.00107293599032111,0.00479027941039681,-0.0104618836346989,0.00831601165405664,0.822775068570774
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,39455,-0.00173638007925454,0.0077601077203793,-0.016946191211198,0.0134734310526889,0.822949271195363
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,39187,0.000922137026597387,0.00413963150631058,-0.00719154072577135,0.00903581477896613,0.82372675895511
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39477,-0.00566574947518587,0.0255712819763516,-0.055785462148835,0.0444539631984633,0.824654069205755
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37181,-0.000733764993336301,0.00331707645519839,-0.00723523484552515,0.00576770485885255,0.824933759906862
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,39582,-0.000639283708147688,0.00290959209909592,-0.00634208422237569,0.00506351680608032,0.826095368468801
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37247,-0.000903684186871564,0.00412755222744315,-0.00899368655266014,0.00718631817891701,0.826700674784077
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39462,0.000858538846119296,0.00392529570557431,-0.00683504073680636,0.00855211842904495,0.826871505381814
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,36861,0.000667484934988011,0.00306494955959183,-0.00533981620181197,0.00667478607178799,0.827604053165027
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39428,-0.000852781877512428,0.00391642901799067,-0.00852898275277413,0.00682341899774928,0.8276309572087
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37221,-0.000654436262300417,0.00302068007079805,-0.00657496920106459,0.00526609667646376,0.828483049004149
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,36709,-0.000827742709509324,0.00382497229000276,-0.00832468839791474,0.00666920297889609,0.828675755888093
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39104,0.000819187636190571,0.0037861671424828,-0.00660169996307572,0.00824007523545686,0.828707579271616
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36763,0.000477586420258326,0.00221368075529253,-0.00386122786011503,0.00481640070063169,0.829191552189994
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,37162,-0.000514462198491794,0.00239600635790161,-0.00521063465997895,0.00418171026299536,0.829991769897235
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,36880,0.000721884318421639,0.00342042669908054,-0.00598215201177623,0.0074259206486195,0.832850971371096
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,36955,-0.000992993075704212,0.0047119983268897,-0.010228509796408,0.0082425236449996,0.833095821978702
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,39635,0.000433807046077206,0.00207590241458251,-0.0036349616865045,0.00450257577865892,0.834472311065405
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39194,0.000677817001872839,0.00327173539476361,-0.00573478437186383,0.00709041837560951,0.835877192910653
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,36992,0.00101302479833243,0.00489991604102504,-0.00859081064207666,0.0106168602387415,0.836213698190309
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39541,-0.000492737870437579,0.00238981360634716,-0.00517677253887802,0.00419129679800286,0.836651097526196
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,39085,0.00122420562478345,0.00602729539459589,-0.0105892933486245,0.0130377045981914,0.83905166492643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,39636,-0.000616590661478162,0.00304515673565572,-0.00658509786336338,0.00535191654040705,0.839542324626285
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,36847,0.000743878985211776,0.00369759064451714,-0.00650339867804183,0.00799115664846538,0.840561617037917
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,36955,0.000376169583290392,0.00188212352225867,-0.0033127925203366,0.00406513168691738,0.84158984432466
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,36880,0.00163504175331617,0.00818385089008785,-0.014405305991256,0.0176753894978884,0.841649029309833
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37164,-0.000755015525705016,0.00378387840626898,-0.00817141720199222,0.00666138615058219,0.841847593986909
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,36847,0.000919064880346551,0.00471450227292317,-0.00832135957458286,0.010159489335276,0.845439825394408
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,39635,0.000461970412698947,0.00237118458441867,-0.00418555137276165,0.00510949219815955,0.845531112084853
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39462,0.00143155040270135,0.00742133061857377,-0.0131142576097032,0.0159773584151059,0.84704245644102
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,36955,-0.000477319638729018,0.00248796090086612,-0.00535372300442662,0.00439908372696858,0.847861453131928
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,37203,-0.00113981841494885,0.00598047763595698,-0.0128615545814245,0.0105819177515268,0.848849966717615
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37243,0.000446260447706674,0.00234578539707718,-0.00415147893056461,0.00504399982597795,0.849124676864321
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37164,0.00168487930892319,0.008920502567336,-0.0157993057230554,0.0191690643409017,0.850192099865752
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37243,-0.000647429730218478,0.00343209792238775,-0.00737434165809847,0.00607948219766151,0.850378251887665
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,39455,-0.000390560251586375,0.00207273826771205,-0.00445312725630198,0.00367200675312923,0.850544333802396
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36763,0.000432841714826558,0.00229812538443126,-0.00407148403865871,0.00493716746831182,0.850608876237516
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,36992,-0.0012686483886276,0.00677105890113113,-0.0145399238348446,0.0120026270575894,0.851378774719235
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,39187,-0.000452758783400075,0.00242014224208199,-0.00519623757788077,0.00429072001108062,0.851600947059379
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39355,-0.000480650051498497,0.00257045898313565,-0.00551874965844436,0.00455744955544737,0.851671041391404
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39118,-0.000794472118979672,0.00427874001028499,-0.00918080253913825,0.00759185830117891,0.852699073989712
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,37050,0.00175430216060719,0.00948136256982104,-0.0168291684762421,0.0203377727974564,0.85321132576192
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39104,-0.00135897160582002,0.00742633731128743,-0.0159145927359434,0.0131966495243033,0.854805634915073
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39104,-0.000882498613510348,0.00484292330322382,-0.010374628287829,0.00860963106080833,0.855409175180682
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,36880,0.00145575308318102,0.00803324232424736,-0.0142894018723438,0.0172009080387059,0.856200889616172
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,39462,-0.00128575782857345,0.00711659445983206,-0.0152342829698443,0.0126627673126974,0.856628748306593
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37221,-0.00106002430886744,0.00591209076731979,-0.0126477222128142,0.0105276735950794,0.857706793281067
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37164,-0.00269621937544947,0.0150909061445136,-0.0322743954186961,0.0268819566677972,0.858203463266039
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,36880,0.00151490074358152,0.00850756418426158,-0.0151599250575712,0.0181897265447342,0.858674708347125
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37247,-0.00045913973110182,0.00258318086249952,-0.00552217422160089,0.00460389475939725,0.858928413367221
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,36880,0.000867616713723128,0.00488603057247414,-0.00870900320832619,0.0104442366357724,0.859062894919081
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39541,0.000593179807232173,0.00334428128563138,-0.00596161151260533,0.00714797112706967,0.859219062292091
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36823,-0.000930720111038015,0.00526680657268286,-0.0112536609934964,0.00939222077142039,0.859735689581189
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,37269,0.000314025536279924,0.00178524593210842,-0.00318505649065257,0.00381310756321242,0.860374942383425
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,36992,-0.000832147090607538,0.00473262208051315,-0.0101080863684133,0.00844379218719823,0.860428654347876
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,36847,-0.00106869804919417,0.00610257897243298,-0.0130297528351628,0.0108923567367745,0.860986347191892
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,39654,0.000373836415799626,0.00214953123605387,-0.00383924480686596,0.00458691763846521,0.861934327106547
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,39403,-0.0011631462458,0.00671295472902535,-0.0143205375146897,0.0119942450230897,0.862442417928122
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,39093,-0.00133925648490394,0.00776130927308599,-0.0165514226601525,0.0138729096903446,0.863003229953545
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,37162,-0.00145062701245403,0.00854027128327373,-0.0181895587276705,0.0152883047027625,0.865125103728488
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39462,0.00080286445016229,0.00473143548989996,-0.00847074911004163,0.0100764780103662,0.865258359628003
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",37162,0.000655911097208224,0.00386701553841102,-0.00692343935807737,0.00823526155249382,0.865314148721403
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36763,-0.000612119091843028,0.00361072864374707,-0.00768914723358729,0.00646490904990123,0.865384247572234
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,39123,0.000900748689484271,0.0053475982552477,-0.00958054389080123,0.0113820412697698,0.866239576001154
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,36992,0.000953639351117718,0.00575493064702121,-0.0103260247170439,0.0122333034192793,0.868389243069136
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,36880,-0.000700798385260491,0.00423910149346909,-0.0090094373124599,0.00760784054193892,0.868696639747186
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,39462,-0.0013502506264555,0.00818606231046552,-0.0173949327549679,0.0146944315020569,0.868989438132506
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39123,0.000434314782112664,0.00263377007398417,-0.00472787456289631,0.00559650412712164,0.86902314222662
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,36861,0.000971171326339071,0.00589209559089204,-0.0105773360318093,0.0125196786844875,0.869083519663037
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39455,-0.000650396551044152,0.00399977040485562,-0.00848994654456116,0.00718915344247286,0.870828906597932
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,36880,-0.000395468808108621,0.00243713967881666,-0.00517226257858928,0.00438132496237203,0.871097765460853
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,36847,-0.00104057937902149,0.00648093074773416,-0.0137432036445804,0.0116620448865375,0.87244243962299
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,36955,-0.000398208462115412,0.00248912859774231,-0.00527690051369035,0.00448048358945952,0.872900150953309
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,39104,0.000839314596320726,0.00532899882558947,-0.00960552310183464,0.0112841522944761,0.874853380204636
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,36916,0.00101720453156963,0.00646837756244547,-0.0116608154908235,0.0136952245539627,0.875044016429184
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,39654,0.000450226615072178,0.00287878174204819,-0.00519218559934227,0.00609263882948662,0.875723879546299
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37164,0.000535186863144533,0.00344612156200542,-0.00621921139838609,0.00728958512467516,0.876586324124241
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37221,0.000317599879162874,0.00205217659296577,-0.00370466624305003,0.00433986600137578,0.877011040373845
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,36861,-0.00056347333011766,0.00367213071477484,-0.00776084953107636,0.00663390287084104,0.878049161118867
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37162,0.000618196682445902,0.00405204762363671,-0.00732381665988205,0.00856021002477385,0.87874452083856
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,37190,0.00141394966167786,0.00940730602790503,-0.017024370153016,0.0198522694763717,0.880527665598827
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,36847,-0.000616688297800618,0.00415887100120956,-0.00876807546017135,0.00753469886457011,0.882122141226747
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,39428,-0.000770823480528618,0.00520613300942218,-0.0109748441789961,0.00943319721793885,0.88229689063208
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,36955,0.000529154396138043,0.00361246140970967,-0.00655126996689291,0.007609578759169,0.883544609690704
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,39589,-0.000597979161629734,0.00411491785630147,-0.00866321815998061,0.00746725983672115,0.884460294034907
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,36992,0.00113936945345249,0.00799642582722937,-0.0145336251679171,0.0168123640748221,0.886699342345359
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,36880,0.000583335979300718,0.00411573254721472,-0.00748349981324014,0.00865017177184158,0.887293040443673
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39516,-0.00107454013894567,0.00760130231077826,-0.0159730926680711,0.0138240123901797,0.887585359478448
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,36992,-0.000531112076798886,0.00376164304788292,-0.00790393245064941,0.00684170829705163,0.887720917755152
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,36847,-0.000806129877727553,0.00572481885285252,-0.0120267748293185,0.0104145150738634,0.888019828521301
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,39601,-0.000248827165545042,0.00178070628172706,-0.00373901147773007,0.00324135714663999,0.888871152427431
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,39485,0.000290997642245921,0.00211161374961551,-0.00384776530700048,0.00442976059149232,0.890393867044641
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39428,-0.000815931222876039,0.00594697427518406,-0.0124720008022368,0.0108401383564847,0.890873711003082
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39355,0.000929203644842453,0.00679464658895814,-0.0123883036695155,0.0142467109592004,0.891226097786831
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,36992,0.000653685358959604,0.00478000070779252,-0.00871511602831374,0.0100224867462329,0.891227251096758
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37162,0.000766053108486881,0.00565104147880556,-0.010309988189972,0.0118420944069458,0.892171565789695
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",36916,0.000397120432875835,0.00295738509046029,-0.00539935434442633,0.006193595210178,0.893182597055371
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,39123,-0.000693213109238376,0.00516292047884344,-0.0108125372477715,0.00942611102929476,0.893192788769323
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,36852,-0.000497999381351935,0.00371713742937687,-0.00778358874293059,0.00678758998022672,0.893425390940216
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,39498,0.000209939221463874,0.00157374017698436,-0.00287459152542547,0.00329446996835322,0.893877682830658
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39355,0.000418768986443251,0.00314127117930789,-0.00573812252500021,0.00657566049788671,0.893948477171622
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,36763,0.000531414846057376,0.00400517357642427,-0.00731872536373419,0.00838155505584894,0.894446967274415
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,36992,0.000755008257581278,0.00577017903484684,-0.0105545426507185,0.0120645591658811,0.895898764237386
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39104,0.000786551391586922,0.00606277428332899,-0.0110964862037379,0.0126695889869117,0.896778214655677
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,36861,0.000448434615506186,0.00346425234460121,-0.00634149997991219,0.00723836921092456,0.897006619220818
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,36992,-0.000592244413199024,0.00458269884648114,-0.00957433415230206,0.00838984532590401,0.89717389113272
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,37221,-0.000733148652895928,0.00573740880700366,-0.0119784699146231,0.0105121726088312,0.898321979019083
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36763,-0.000998787867320648,0.0078197716183349,-0.0163255402392571,0.0143279645046158,0.898367928325297
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39428,0.000345592936983751,0.00271339785219628,-0.00497266685332096,0.00566385272728846,0.898652929179443
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36763,0.000731572374029249,0.0058130185081359,-0.0106619439019171,0.0121250886499756,0.899852173163411
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37164,-0.000590921347798766,0.0046975173299238,-0.00979805531444941,0.00861621261885188,0.899896668453671
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,36955,0.00039686731359114,0.0031748325161851,-0.00582580441813167,0.00661953904531394,0.900522256235377
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39187,-0.00100009162455942,0.00805620592851154,-0.016790255244442,0.0147900719953232,0.901206688958962
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,36916,-0.000334336214287545,0.00270520656382814,-0.0056365410793907,0.00496786865081561,0.90164198098928
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,36763,0.000491361407873032,0.00403852759123215,-0.00742415267094198,0.00840687548668804,0.903163583525198
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39355,-0.00123149820726123,0.0101826205764559,-0.0211894345371148,0.0187264381225923,0.90373925046191
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36823,0.000603595830763999,0.00500755199776221,-0.00921120608484994,0.0104183977463779,0.904059644310553
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37247,-0.000764101107634331,0.00636769761151372,-0.0132447884262012,0.0117165862109326,0.904487844203556
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39123,0.000684275301776216,0.00572589941063751,-0.0105384875430733,0.0119070381466257,0.904876681096945
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39404,0.00026681396089978,0.00223951767952478,-0.00412264069096879,0.00465626861276835,0.905166811119858
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,39194,-0.000919936483749231,0.0078837025042126,-0.0163719933920059,0.0145321204245075,0.907108587278402
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,36847,-0.000271563773761243,0.0024469010389536,-0.00506748981011031,0.00452436226258782,0.911631833174797
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,37181,0.000550764590347246,0.00517215446320268,-0.00958665815753002,0.0106881873382245,0.91519804952434
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,36929,0.0012718787275643,0.0121207412303659,-0.0224847740839528,0.0250285315390814,0.916429809747657
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,37162,0.000412743336177667,0.00395373093218554,-0.00733656929090598,0.00816205596326132,0.916858823053518
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,36880,0.000341679805713734,0.00331621332957397,-0.00615809832025126,0.00684145793167873,0.917938347307146
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,36763,-0.000273023039815147,0.00271796266326486,-0.00560022985981428,0.00505418378018398,0.919987634047989
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,36861,0.000611960999262762,0.00611588152133575,-0.0113751667825553,0.0125990887810808,0.920297542581222
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,39104,-0.000426792936311897,0.00432811147888726,-0.00890989143493093,0.00805630556230714,0.921449670775338
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,36847,0.000448207683768891,0.00454555824955868,-0.00846108648536612,0.0093575018529039,0.921454732427347
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,36847,0.000347122256725045,0.00355675268507748,-0.00662411300602682,0.00731835751947691,0.922255254527049
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",39654,-0.000416535811063182,0.00427679641335123,-0.00879905678123158,0.00796598515910522,0.922414514602551
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,36861,-0.000307336253286067,0.00316841271149501,-0.00651742516781629,0.00590275266124415,0.922727905757576
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37203,-0.000576672758387545,0.0059962782660659,-0.0123293781598767,0.0111760326431016,0.923385654014394
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",36861,-0.000355615012443733,0.00370916069047745,-0.00762556996577954,0.00691433994089207,0.92362156299389
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,39355,-0.000514277992110416,0.00537232422134763,-0.0110440334659518,0.0100154774817309,0.923738460124697
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,36880,-0.000366673272109481,0.00389525027281269,-0.00800136380682235,0.00726801726260339,0.925004681807976
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,36861,0.000524090981112903,0.00559474929548713,-0.0104416176380419,0.0114897996002677,0.925368439028433
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,39485,-0.000425360104927363,0.00454658908265313,-0.00933667470692751,0.00848595449707278,0.925463211843017
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39485,-0.000353592339820687,0.00383840006021978,-0.00787685645785146,0.00716967177821008,0.926604148032248
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,39104,-0.000384047419996643,0.00423237307164776,-0.00867949864042626,0.00791140380043297,0.927700072327126
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,39530,0.000471775580443693,0.00520081363153607,-0.009721819137367,0.0106653702982544,0.927722735873089
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37221,-0.000212507730754607,0.00234918023249025,-0.00481690098643551,0.00439188552492629,0.92792279781679
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,39432,-0.000235069290154602,0.0026153025802375,-0.0053610623474201,0.00489092376711089,0.928381985171302
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39428,0.000670921583481419,0.00763455832151538,-0.0142928127266887,0.0156346558936516,0.929973581919526
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39428,-0.000211166548446901,0.00241456429599063,-0.00494371256858854,0.00452137947169474,0.93031074984774
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,39187,-0.000231628237649754,0.00264949740763106,-0.00542464315660662,0.00496138668130712,0.93033610823785
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,39531,0.000603570243490651,0.00693413056545386,-0.0129873256647989,0.0141944661517802,0.930638177090058
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,37164,0.000517054670793089,0.00609934661835279,-0.0114376647011784,0.0124717740427646,0.932443877100524
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,36847,-0.000313660457382391,0.0037167210545646,-0.00759843372432901,0.00697111280956422,0.93274635857203
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,36880,0.000629612527252546,0.00761598113070979,-0.0142977104889386,0.0155569355434437,0.934115337158244
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,37091,-0.000319202047866818,0.0038691375364464,-0.00790271161930176,0.00726430752356812,0.934250794457526
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,36880,-0.000379580803459796,0.00461622786639113,-0.00942738742158642,0.00866822581466683,0.934467142486232
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,36916,-0.000145697920204338,0.00177595741992487,-0.00362657446325708,0.00333517862284841,0.934616950859267
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,39104,0.000234565329818736,0.0028758643405555,-0.00540212877767004,0.00587125943730752,0.934995005357787
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39462,0.000242413487759905,0.00299365809127513,-0.00562515637113935,0.00610998334665916,0.935462376283253
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,36861,-0.00029574652631224,0.00371287319175862,-0.00757297798215913,0.00698148492953465,0.936513446421253
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39355,0.000409630137669068,0.00514550039886392,-0.00967555064410421,0.0104948109194424,0.936548997273369
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,36992,0.00117263677562087,0.0149076382335693,-0.028046334162175,0.0303916077134167,0.937304213139686
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,36955,0.000400464944679777,0.00509500733650591,-0.00958574943487181,0.0103866793242314,0.937352456247068
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,36992,0.000459024380732568,0.00594631002458279,-0.0111957432674497,0.0121137920289148,0.938469787427276
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,39342,-0.00085788437598249,0.0111567597209896,-0.0227251334291222,0.0210093646771572,0.938709153832576
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39485,-0.000197912926320262,0.00260253640470226,-0.0052988842795367,0.00490305842689617,0.939383377974099
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,39104,0.000298699250428136,0.00393758904394774,-0.00741897527570942,0.0080163737765657,0.939532779889212
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,39428,0.000731787491069403,0.00990313252337806,-0.0186783522547516,0.0201419272368904,0.941095281799964
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39541,0.000181736437396884,0.00248767938798057,-0.00469411516304504,0.0050575880378388,0.941763632611442
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,36763,-0.000228682847797777,0.00314435052727795,-0.00639160988126256,0.00593424418566701,0.942023615976532
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",36847,-0.000248108572524914,0.00360827291157985,-0.00732032347922142,0.00682410633417159,0.945180945008311
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,37177,0.000172588833653177,0.00253752447947563,-0.00480095914611905,0.00514613681342541,0.945775042672807
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,39526,-0.000179977825491156,0.00266002560383349,-0.00539362800900481,0.00503367235802249,0.946057041472061
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36763,-0.000307766821420163,0.00485484643476925,-0.00982326583356789,0.00920773219072756,0.949454009576857
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,36847,-0.000211050020492452,0.00335632557120689,-0.00678944814005797,0.00636734809907306,0.949862062190333
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,36992,0.000416853613470774,0.00668661506734904,-0.0126889119185333,0.0135226191454749,0.95029187404358
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,39455,-0.000302017150776663,0.00493555007592284,-0.00997569529958543,0.0093716609980321,0.951206959354664
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,36880,-0.000154853975557963,0.00256877013223994,-0.00518964343474824,0.00487993548363232,0.951930960857237
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39482,0.000182459957082384,0.00315465803745704,-0.00600066979633341,0.00636558971049818,0.953878224589818
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36823,0.000276184629771506,0.00478821688148481,-0.00910872045793872,0.00966108971748173,0.954004409840678
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39082,-0.000272667737213236,0.00505643513426838,-0.0101832806003793,0.0096379451259528,0.956995737915565
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,36823,0.000212230449008271,0.00396556933024724,-0.00756028543827632,0.00798474633629286,0.957319830499007
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,39589,0.000306792049386349,0.00573373303390386,-0.0109313246970652,0.0115449087958379,0.957329049186561
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,36861,0.000308122486592996,0.00576752050331166,-0.0109962176998979,0.0116124626730838,0.957395154456668
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,36955,0.00029348319043988,0.00587082038406033,-0.0112133247623184,0.0118002911431981,0.960131036353414
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37221,-0.000249657710544248,0.00510005555230069,-0.0102457665930536,0.0097464511719651,0.960958346741207
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39359,0.000106285875815832,0.00224088469021076,-0.00428584811699726,0.00449841986862892,0.9621709004704
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39455,-0.00017423164585361,0.00375980363498241,-0.00754344677041913,0.00719498347871191,0.963039377725829
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37221,0.000187587948811316,0.00452608655658798,-0.00868354170210113,0.00905871759972376,0.966941030904761
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37164,0.000277754062209523,0.00735123345391526,-0.0141306635074644,0.0146861716318834,0.969861030785789
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,36861,-0.000225115438378817,0.00606609300654447,-0.012114657731206,0.0116644268544483,0.970397537190971
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,39455,-0.00011239780566926,0.00304547648895607,-0.00608153172402315,0.00585673611268463,0.970560066993443
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37201,-6.91741627963853e-05,0.00193296166478753,-0.00385777902577995,0.00371943070018718,0.971453062930872
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36763,0.000158401186160028,0.00443634913224782,-0.00853684311304571,0.00885364548536576,0.971517921638075
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39355,-0.000170750902871336,0.00478242141474822,-0.00954429687577786,0.00920279507003518,0.971518971161496
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,39654,-0.000221248091398769,0.00621984957852471,-0.0124121532653072,0.0119696570825097,0.971624665780571
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,39462,-0.000101802984298562,0.00304886008075681,-0.00607756874258191,0.00587396277398479,0.973363623624316
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,36861,-0.000124661560012978,0.00377671480472548,-0.00752702257727491,0.00727769945724896,0.973668790071448
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,36847,0.000134182533157055,0.00417830122525298,-0.00805528786833879,0.0083236529346529,0.974381547519179
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,39520,-9.43142141342765e-05,0.00296488245149253,-0.00590548381905963,0.00571685539079108,0.974623642574623
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36823,8.33350605862092e-05,0.00263512456850632,-0.00508150909368618,0.0052481792148586,0.974771844566757
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37030,0.00012213553631945,0.00388343557838679,-0.00748939819731866,0.00773366926995756,0.974910860179229
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37203,8.9739556355436e-05,0.00288115781197721,-0.0055573297551199,0.00573680886783077,0.975152757650274
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36763,9.04601312636651e-05,0.0029566563795199,-0.00570458637259533,0.00588550663512266,0.975592694068281
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,36916,-0.000195764870157769,0.00671604045065577,-0.0133592041534431,0.0129676744131275,0.976746340632577
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39343,0.000232553252952591,0.00822591291620147,-0.0158902360628023,0.0163553425687075,0.977446537298345
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,37243,-0.000162931366335505,0.00595631237782713,-0.0118373036268767,0.0115114408942057,0.978177492878715
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,37164,-0.000120838449473667,0.00522903007970514,-0.0103697374056957,0.0101280605067484,0.98156356832962
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,39464,-7.66143725445702e-05,0.00396954227350699,-0.00785691722861828,0.00770368848352914,0.984601596969179
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39068,6.89227519946491e-05,0.00381738600461209,-0.00741315381704505,0.00755099932103435,0.98559525516478
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,36992,-7.70383890649327e-05,0.00466484367865857,-0.00922013199923572,0.00906605522110586,0.986824055440871
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39428,6.14188971153378e-05,0.00385599941171309,-0.00749633994984232,0.00761917774407299,0.987291932832741
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,36847,4.79642941819462e-05,0.00305082632097427,-0.00593165529492763,0.00602758388329152,0.987456637216229
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39403,3.35179397917391e-05,0.00223593998116388,-0.00434892442328947,0.00441596030287295,0.988039930372385
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,36847,6.90843985155368e-05,0.00507998913645422,-0.00988769430893474,0.0100258631059658,0.989149865750063
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37221,6.87454165428346e-05,0.00536166585173251,-0.0104401196528529,0.0105776104859386,0.989770282000624
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39541,-2.80191646464561e-05,0.00242938263996017,-0.00478960913896838,0.00473357080967547,0.990797994330027
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37162,3.47123408393916e-05,0.0030533996373901,-0.00594995094844521,0.00601937563012399,0.990929684046309
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36823,-5.59607605131839e-05,0.00569923062970637,-0.0112264527947377,0.0111145312737113,0.992165853619709
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39068,-5.29619085025761e-05,0.00576973874072742,-0.0113616498403283,0.0112557260233232,0.9926762415484
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,36880,2.00311490974041e-05,0.0022803020628385,-0.00444936089406605,0.00448942319226086,0.992991271727151
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,36861,2.01573067982557e-05,0.00289685373151943,-0.00565767600697982,0.00569799062057633,0.994448200855809
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,39149,1.78422243985642e-05,0.00268353965210031,-0.00524189549371803,0.00527757994251516,0.994695182417428
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,36823,2.54018239591469e-05,0.00642810114883908,-0.0125736764277655,0.0126244800756837,0.99684708433265
